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Whole	   body	   homeostasis	   requires	   the	   coordinated	   actions	   of	   multiple	   organs	   to	   sustain	  
blood	  perfusion,	  maintenance	  of	  blood	  oxygenation	  and	  nutrient	  supply.	  Each	  organ	  has	  an	  
unique	  role	  herein	  and	  in	  order	  to	  fulfill	  this	  task	  efficiently,	  tissue-­‐specific	  vascular	  networks	  
with	   defined	   functional	   properties	   and	   branching	   architecture	   have	   emerged	   during	  
evolution.	   Organ-­‐specific	   vascular	   networks	   and	   tissue	   functions	   are	   dependent	   on	  
angiocrine	   mechanisms	   and	   intensive	   cross-­‐talk	   between	   vascular	   cells	   and	   cells	   of	   the	  
surrounding	  organs.	  Nerves	  critically	  depend	  on	  blood	  vessels,	  as	  small	  changes	  in	  vascular	  
supply	  can	  have	  profound	  effects	  on	  neuronal	  function,	  survival	  and	  regeneration.	  While	  it	  is	  
appreciated	   that	   neurons	   can	   secrete	   vascular	   growth	   factors,	   little	   is	   known	   how	   the	  
developing	   nervous	   system	   becomes	   vascularized.	   In	   the	   present	   work,	   we	   focused	   on	  
neurovascular	  cross-­‐talk	  between	  the	  developing	  spinal	  cord	  and	  surrounding	  blood	  vessels	  
in	   the	   trunk	  of	   the	   zebrafish.	  Using	   tissue-­‐specific	   and	   inducible	   loss-­‐	   and	   gain-­‐of-­‐function	  
approaches,	  we	  show	  that	  neurons	  produce	  Vegfaa	  and	  sFlt1	  to	  dynamically	  regulate	  spinal	  
cord	  vascularization.	  Loss	  of	  sFlt1	  or	  gain	  of	  Vegfaa	  promotes	  angiogenesis	  along	  the	  spinal	  
cord,	  whereas	  combining	  both	  promotes	   ingrowth	   into	   the	  neural	   tube.	  This	  suggests	   that	  
these	   events	   correlate	   with	   neuronal	   differentiation	   and	   associated	   changes	   in	   neuronal	  
metabolism.	   High-­‐resolution	   in	   vivo	   analysis	   of	   cellular	   behavior	   at	   single	   cell	   level	  within	  
growing	  angiogenic	  sprouts	  shows	  that	  neurons	  attract	  new	  blood	  vessels	  exclusively	  from	  
veins.	  The	  process	  of	  venous	  sprouting	  requires	  adequate	  nuclear	  positioning	  prior	  to	  sprout	  
initiation,	  which	  is	  driven	  by	  the	  Vegfaa-­‐Kdrl-­‐PI3/Akt	  pathway	  and	  is	  independent	  of	  Notch.	  
Based	  on	  the	  differences	  of	  the	  cellular	  and	  molecular	  signature	  –	  with	  previously	  described	  
primary	  and	   secondary	   sprouting	  modes	  –	  we	   termed	   the	  process	   'tertiary	   sprouting'.	  We	  
propose	   that	   the	   spinal	   cord	  uses	  a	   two-­‐tiered	  mechanism	  to	   regulate	   lateral	  and	   internal	  
vascularization	   involving	   neuronal	   sFlt1	   and	   Vegfaa.	   Altogether,	  we	   show	   that	   spinal	   cord	  
neurons	  and	  tertiary	  sprout-­‐capillaries	  form	  a	  neurovascular	  unit,	  which	  is	  tightly	  regulated	  
by	  neurovascular	  cross-­‐talk.	  	  





Die	   Homöostase	   des	   Körpers	   erfordert	   das	   koordinierte	   Zusammenspiel	   verschiedener	  
Organe,	   um	   die	   Durchblutung,	   die	   Sauerstoffversorgung	   und	   die	   Nährstoffversorgung	   auf	  
zellulärer	  Ebene	  zu	  gewährleisten.	  Jedes	  Organ	  spielt	  hierbei	  eine	  spezifische	  Rolle	  und	  hat	  
im	   Laufe	   der	   Evolution	   ein	   gewebespezifisches	   Blutgefäßsystem	   mit	   einzigartiger	  
Morphologie	   und	   funktionalen	   Eigenschaften	   entwickelt.	   Organspezifische	   vaskuläre	  
Netzwerke	   und	   die	   Funktion	   von	   Geweben	   sind	   von	   angiokrinen	  Mechanismen	   und	   dem	  
engen	   cross-­‐talk	   zwischen	   Endothelzellen	   und	   Zellen	   des	   umgebenden	   Organs	   abhängig.	  
Nerven	  reagieren	  besonders	  empfindlich	  auf	  Schwankungen	  in	  der	  Blutversorgung	  und	  nur	  
geringe	  Veränderungen	  können	  deren	  Funktion	  beeinträchtigen	  oder	  sogar	  zum	  Absterben	  
führen.	   Es	   ist	   hinreichend	   bekannt,	   dass	   Neuronen	   vaskuläre	   Wachstumsfaktoren	  
sekretieren,	   jedoch	  der	   genaue	  Ablauf	  der	  Vaskularisierung	  des	  Nervensystems	  und	  deren	  
molekulare	  Steuerung	  ist	  weitgehend	  unbekannt.	  	  
In	   der	   vorliegenden	  Arbeit	   untersuchen	  wir	   den	   neurovaskulären	   cross-­‐talk	   zwischen	   dem	  
sich	   entwickelnden	   Neuralrohr	   und	   den	   unmittelbar	   angrenzenden	   Blutgefäßen	   im	  
Modelsystem	   Zebrafisch.	   Durch	   die	   Verwendung	   von	   gewebespezifischen,	   induzierbaren	  
loss-­‐	   und	   gain-­‐of-­‐function	   Experimenten	   konnten	   wir	   zeigen,	   dass	   Neuronen	   Vegfaa	   und	  
sFlt1	   produzieren	   und	   so	   die	   Vaskularisierung	   des	   Neuralrohr	   dynamisch	   steuern	   können.	  
Der	  Verlust	  von	  sFlt1	  oder	  die	  Hochregulation	  von	  Vegfaa	  regte	  die	  laterale	  Vaskularisierung	  
entlang	  des	  Neuralrohrs	  an,	  wohingegen	  die	  Kombination	  von	  beidem	  das	  Einwachsen	  von	  
Gefäßen	   in	   das	   Neuralrohr	   bewirkte.	   Dies	   legt	   nahe,	   dass	   diese	   Ereignisse	   mit	   der	  
neuronalen	  Differenzierung	  und	  der	  anschließenden	  Änderung	  der	  metabolen	  Aktivität	  von	  
Neuronen	  korrelieren.	  Hochaufgelöste	   in	   vivo	   Analysen	  der	   zellulären	  Verhaltensmuster	   in	  
angiogenen	  Gefäßsprossen	  zeigte,	  dass	  ausschließlich	  venöse	  Gefäßsprosse	  zur	  Bildung	  des	  
perineuralen	   vaskulären	   Netzwerkes	   beitragen	   können.	   Diese	   venöse	   Gefäßsprossung	  
erfordert	   die	   adäquate	   Positionierung	   des	   endothelialen	   Zellkerns	   in	   unmittelbarer	   Nähe	  
zum	   Ort	   der	   Sprossungsinitiierung,	   die	   durch	   den	   Vegfaa-­‐Kdrl-­‐PI3K/Akt	   Signalweg	  
unabhängig	   von	   Notch	   induziert	   wird.	   Bedingt	   durch	   die	   molekularen	   und	   zellulären	  
Unterschiede	  zu	  den	  bekannten	  primären	  und	  sekundären	  Sprossungsprozessen	  bezeichnen	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wir	   den	   Prozess	   als	   `tertiäre	   Sprossung’.	   Wir	   postulieren,	   dass	   das	   Neuralrohr	   einen	  
zweistufigen	  sFlt1/Vegfaa-­‐abhängigen	  Mechanismus	  verwendet	  um	  die	  laterale	  und	  interne	  
Vaskularisierung	  zu	  steuern.	  Zusammenfassend	  zeigen	  wir,	  dass	  Neuronen	  des	  Neuralrohrs	  
und	   perineuralen	   Kapillaren,	   die	   aus	   den	   tertiären	   Sprossen	   gebildet	   werden,	   eine	  
neurovaskuläre	  Einheit	  bilden,	  welche	  durch	  die	  fein	  abgestimmte	  Regulation	  der	  Neuronen	  






3 Introduction	  	  
 
The	  vascular	  system	  supplies	  organs	  throughout	  the	  entire	  human	  body	  and	  is	  estimated	  to	  
have	   a	   total	   length	   of	  more	   than	   100,000	   km	   in	   an	   average	   human	   being	   (Aird	   2005).	   It	  
supplies	   oxygen,	   nutrients,	   signaling	  molecules	   and	   immune	   cells	   to	   its	   target	   organs	   and	  
removes	  CO2	  and	  waste	  products	  (Carmeliet	  2003;	  Adams	  &	  Eichmann	  2010).	  	  
	  
The	   circulation	   connects	   the	   heart,	   lungs	   and	   target	   tissues	   and	   consists	   of	   a	   hierarchical	  
system	   of	   arteries,	   arterioles,	   capillaries,	   venules	   and	   veins	   to	   safeguard	   the	   function	   of	  
organs	  and	   cells	   (Adams	  &	  Eichmann	  2010;	  Herbert	  &	  Stainier	  2011).	   In	   adults,	   growth	  of	  
blood	   vessels	   is	   tightly	   controlled	   and	   an	   imbalance	   in	   this	   process	   contributes	   to	   various	  
inflammatory,	  ischemic,	  infectious	  and	  immune	  disorders	  as	  well	  as	  cancer	  (Carmeliet	  2003;	  
Carmeliet	  2005).	  	  
Blood	  vessel	  growth	  and	  the	  integrity	  of	  the	  vascular	  homeostasis	  have	  tremendous	  effects	  
on	  disease	  progression.	  When	  a	  tumor	  lesion	  exceeds	  a	  few	  millimeters	  in	  diameter,	  hypoxia	  
and	  nutrient	   deprivation	   can	   trigger	   an	   'angiogenic	   switch'	   and	   the	   tumor	   starts	   to	   secret	  
molecules	  to	  activate	  vascularization	  from	  adjacent	  tissues	  to	  promote	  its	  growth	  and	  finally	  
becomes	   harmful	   (Hanahan	   &	   Folkman	   1996;	   Bergers	   &	   Benjamin	   2003).	   The	   relatively	  
simple	  but	  ingenious	  idea	  to	  block	  this	  process	  in	  order	  to	  restrict	  tumor	  growth	  was	  already	  
put	  forward	  in	  1971	  (Folkman	  1971).	  In	  2004,	  the	  first	  anti-­‐angiogenic	  agents	  were	  approved	  
by	  the	  U.S.	  Food	  and	  Drug	  Administration	  (FDA)	  for	  the	  treatment	  of	  cancer	  and	  eye	  disease	  
(Al-­‐Husein	   et	   al.	   2012).	   Anti-­‐angiogenic	   therapy	   is	   nowadays	   routinely	   used	   as	   adjuvant	  
therapy	  for	  the	  treatment	  of	  many	  cancers	  (Al-­‐Husein	  et	  al.	  2012).	  	  
	  
Despite	   these	   encouraging	   advances,	   tumor	   resistance	   and	   compensation	   by	   alternative	  
signaling	  pathways	  as	  well	  as	  side	  effects	  such	  as	  bleeding	  require	  angiogenesis	  research	  to	  
identify	  therapeutic	  targets	  exclusively	  present	   in	  growing	  blood	  vessels	   (Elice	  et	  al.	  2012).	  
Recent	  research	   identified	  promising	  targets	  such	  as	  glycolytic	  endothelial	  metabolism	  and	  
molecules	  specific	  to	  pathological	  angiogenesis,	  which	  can	  possibly	  be	  targeted	  with	  fewer	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side	  effects	  and	  cannot	  be	  compensated	  by	   the	   tumor	   (De	  Bock	  et	  al.	  2013;	  Dewerchin	  &	  
Carmeliet	  2012).	  	  
	  
Coronary	  artery	  disease	  (CAD)	  was	  the	  leading	  cause	  of	  death	  worldwide	  in	  2010	  (Moran	  et	  
al.	  2014).	  CAD	  is	  characterized	  by	  an	  atherosclerotic	  occlusion	  of	  a	  coronary	  artery	  resulting	  
in	  hypoperfusion	  and	  ischemia	  in	  the	  heart	  myocardium	  with	  subsequent	  infarct	  and	  heart	  
failure	   (Ambrose	   &	   Singh	   2015).	   Stimulation	   of	   collateralization	   (arteriogenesis)	   or	  
therapeutic	  angiogenesis	   could	  be	  used	   to	  prevent	  or	   treat	  CAD	   in	  a	  non-­‐invasive	  manner	  
(Simons	  2005;	  Degen	  et	  al.	  2014).	  However,	  to	  effectively	  treat	  CAD	  using	  pro-­‐angiogenic	  or	  
pro-­‐arteriogenic	   agents	  many	   hurdles	   have	   to	   be	   overcome	   and	  more	   research	   is	   needed	  
(Rubanyi	   2013).	   Another	   approach	   is	   the	   ischemic	   organ	   revascularization	   with	   vascular	  
progenitor	  cells	  injected	  into	  the	  blood	  of	  the	  patient	  (Rafii	  &	  Lyden	  2003;	  Nolan	  et	  al.	  2013;	  
Rafii	  et	  al.	  2016).	  In	  addition,	  sufficient	  blood	  vessel	  supply	  is	  extremely	  important	  to	  protect	  
neurons	  from	  neurodegenerative	  processes	  (Storkebaum	  &	  Carmeliet	  2004;	  Oosthuyse	  et	  al.	  
2001;	  Lange,	  Storkebaum,	  et	  al.	  2016).	  	  
	  
In	  the	  future	  it	  will	  be	  important	  to	  develop	  effective	  pro-­‐	  and	  antiangiogenic	  agents,	  ideally	  
locally	  modulating	  vascular	  growth.	  
	  
3.1 A	  historical	  perspective	  on	  vascular	  research	  	  
	  
Judah	  Folkman	  was	  one	  of	  the	  first	  investigators	  exploring	  the	  field	  of	  vascular	  development	  
(Folkman	   1971;	   Ribatti	   2008).	   He	   hypothesized	   that	   a	   tumor	   could	   not	   grow	   to	   a	   larger	  
volume	  than	  1	  mm3	  without	  vascularization	  and	  thus	  could	  not	  be	  harmful	  in	  a	  prevascular	  
state	   (Folkman	   1971;	   Hanahan	   &	   Folkman	   1996).	   This	   idea	   and	   the	   identification	   of	  
collateralization	   as	   an	   important	   mechanism	   to	   evade	   arterial	   occlusions	   from	   Wolfgang	  
Schaper	  boosted	  vascular	  research	  by	  the	  end	  of	  the	  1980s	  (Schaper	  et	  al.	  1988).	  	  
	  
Our	   knowledge	   of	   vascular	   development	   was	   and	   is	   vastly	   dependent	   on	   suitable	   model	  
systems,	   which	   can	   be	   used	   to	   elucidate	   the	   underlying	   processes	   of	   vascular	   growth	  
(Santhakumar	  et	  al.	  2012).	  The	  first	  model	  systems	  used	  in	  vascular	  research	  were	  the	  frog,	  
the	   pig	   and	   the	   chick	   embryo	   (Thoma	   1873;	   Sabin	   1917).	   The	   vessels	   of	   the	   chick	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chorioallantoic	  membrane	  (CAM)	  are	  readily	  accessible	  and	  can	  therefore	  be	  easily	  studied	  
without	  the	  vascular	  plexus	  formed	  in	  the	  CAM	  rapidly	  acquires	  a	  hierarchical	  organization	  
with	   emerging	   arteries	   and	   veins,	   a	   process	   known	   as	   vasculogenesis	   followed	   by	   flow-­‐
induced	  vascular	  remodeling	  (le	  Noble	  et	  al.	  2004;	  Nowak-­‐Sliwinska	  et	  al.	  2014).	  	  
	  
As	   a	   consequence,	   most	   early	   (end	   of	   1980s)	   research	   investigated	   a	   process	   termed	  
vasculogenesis,	   the	   de	   novo	   formation	   of	   blood	   vessels	   (Risau	   &	   Flamme	   1995).	   In	   the	  
middle	  of	   the	  1990s,	  mouse	  mutants	  became	  available	   and	   vasculogenesis	  was	   studied	   in	  
the	  primitive	  vascular	  plexus	  of	   the	  mouse	  yolk	   sac	   (Fong	  et	  al.	  1995;	  Shalaby	  et	  al.	  1995;	  
Carmeliet	  et	  al.	  1996;	  Ferrara	  et	  al.	  1996).	  Mouse	  vascular	  research	  was	  mainly	  restricted	  to	  
the	   yolk	   vascular	   plexus	   and	   gross	   vascular	   anatomy,	   thus	   only	   severe	   developmental	  
defects	  could	  be	  identified	  at	  this	  time	  (Fong	  et	  al.	  1995;	  Carmeliet	  et	  al.	  1996).	  The	  major	  
breakthrough	  came	  with	  the	  development	  of	  the	  mouse	  retinal	  vascular	  model,	  a	  postnatal	  
model	  characterized	  by	  a	  defined	  vascular	  plexus	  formed	  by	  angiogenesis	  in	  the	  retina	  of	  the	  
eye	   (Stone	   &	   Dreher	   1987;	   Ruhrberg	   et	   al.	   2002;	   Gerhardt	   et	   al.	   2003).	   The	   mouse	   is	   a	  
particularly	  attractive	  model	  for	  vascular	  research	  since	  genetic	  techniques	  are	  far	  advanced,	  
facilitating	  genetic	  interventions	  (Davis	  2004).	  The	  major	  disadvantage	  of	  the	  retinal	  vascular	  
model	  is	  that	  vessel	  growth	  cannot	  be	  analyzed	  in	  a	  dynamic	  manner,	  because	  the	  retina	  has	  
to	  be	  prepared	  from	  euthanized	  neonates	  (Stone	  &	  Dreher	  1987).	  	  
	  
By	   2000,	   the	   first	   zebrafish	   vascular	   reporter	   lines	   were	   established	   (Isogai	   2001).	   Using	  
zebrafish	   as	   a	  model	   system	  brings	   several	   advantages.	   They	  are	   transparent,	   develop	  ex-­‐
utero	   and	   all	   organ	   primordia	   are	   developed	   before	   36	   hours	   post	   fertilization	   (hpf)	  
(Lieschke	  &	  Currie	  2007;	  Veldman	  &	  Lin	  2008).	  Hence,	  vascular	  development	  can	  be	  followed	  
dynamically	   in	  all	  organs,	  using	   time-­‐lapse	   imaging	   (Kamei	  &	  Weinstein	  2005).	  Since	  2013,	  
zebrafish	   can	   be	   easily	   genetically	   manipulated	   using	   CRISPR/Cas	   (Clustered	   Regularly	  
Interspaced	   Short	   Palindromic	   Repeats),	   revolutionizing	   the	   use	   of	   zebrafish	   as	   a	   vascular	  






3.2 The	  vascular	  system	  	  
	  
The	  heart	  pumps	  blood	  into	  the	  lungs	  to	  be	  enriched	  with	  oxygen.	  The	  oxygen-­‐rich	  blood	  is	  
then	   spread	   throughout	   our	   body	   into	   arteries	   and	   smaller	   arterioles	   (Carmeliet	   2003;	  
Adams	   &	   Eichmann	   2010).	   From	   arterioles	   the	   blood	   is	   drained	   into	   the	   smallest	   blood	  
vessels	  –	  the	  capillaries,	  which	  are	   in	  contact	  with	  single	  cells	  and	  have	  small	  diameters	   in	  
the	   size	   range	   of	   an	   erythrocyte	   (Y	   C	   Fung	   &	   Zweifach	   1971).	   Cells	   are	   supplied	   with	  
nutrients	  and	  oxygen	  by	  capillaries	  and	  secrete	  carbon	  dioxide	  and	  waste	  products	  into	  the	  
blood,	  which	  is	  carried	  by	  venules	  and	  veins	  into	  the	  vena	  cava	  to	  be	  eventually	  released	  by	  
the	   lungs	   (Carmeliet	   2003;	   Herbert	   &	   Stainier	   2011).	   The	   lymphatic	   vascular	   system	   is	  
important	   for	   the	   reuptake	  of	  extravasated	   fluid	   from	  blood	  vessels	   and	   its	  drainage	  back	  
into	   the	   blood	   circulation	   together	   with	   the	   transport	   of	   immune	   cells	   (Adams	   &	   Alitalo	  
2007;	  Tammela	  &	  Alitalo	  2010).	  
	  
3.3 Zebrafish	  trunk	  vascular	  development	  
	  
The	   zebrafish	   vasculature	   constitutes	   an	   ideal	   model	   system	   to	   study	   developmental	  
angiogenesis	  (Isogai	  et	  al.	  2001;	  Veldman	  &	  Lin	  2008).	  Zebrafish	  embryos	  develop	  externally	  
and	  can	  therefore	  be	  dynamically	  imaged.	  They	  are	  transparent	  and	  thus	  easy	  to	  access	  and	  
in	   addition,	   they	   are	   readily	   genetically	  modified	   (Veldman	  &	   Lin	   2008;	   Isogai	   et	   al.	   2001;	  
Kamei	   &	  Weinstein	   2005;	   Hwang	   et	   al.	   2013).	   In	   contrast	   to	   the	  mouse	  model,	   zebrafish	  
embryos	  develop	  ex	  utero	  and	  do	  not	  form	  a	  yolk	  vascular	  plexus.	  	  
	  
3.3.1 Zebrafish	  trunk	  vasculogenesis	  
	  
Vasculogenesis	  in	  zebrafish	  starts	  with	  the	  differentiation	  of	  two	  distinct	  subpopulations	  of	  
angioblasts	  in	  the	  head	  and	  the	  trunk	  (Jin	  et	  al.	  2005;	  Proulx	  et	  al.	  2010).	  Trunk	  angioblasts	  
are	  specified	  in	  the	  lateral	  plate	  mesoderm	  and	  migrate	  towards	  the	  midline	  to	  coalesce	  into	  





3.3.1.1 From	  mesodermal	  precursors	  to	  endothelial	  cells	  
	  
The	   zebrafish	   cloche	   (npas4)	   mutant	   fails	   to	   generate	   the	   hematopoietic	   lineage	   and	  
angioblasts	   and	  was	   shown	   to	   be	   the	  master	   regulator	   of	   hematopoietic	   and	   endothelial	  
development	  (Stainier	  et	  al.	  1995;	  Reischauer	  et	  al.	  2016).	  The	  gene	  npas4	  (Cloche)	  is	  a	  bHLH	  
PAS	  transcription	  factor	  upstream	  of	  etv2	  and	  tal1	  driving	  commitment	  of	  mesodermal	  cells	  
to	  endothelial	  and	  hematopoietic	  cells.	  npas4	   is	  thus	  the	  earliest	  known	  angioblast	  marker	  
activating	   etv2	   (Patterson	   &	   Patient	   2006;	   Reischauer	   et	   al.	   2016).	   However,	   how	   npas4	  
expression	   and	   angioblast	   specification	   is	   activated	   in	  mesodermal	   cells	   is	   unknown.	   Cells	  
expressing	   transcription	   factors	   of	   the	   ETS	   family	   such	   as	  etv2	   upregulate	   the	   endothelial	  
markers	  kdrl	  and	   fli1a	   in	  order	   to	   initiate	  endothelial	  differentiation	   (Sumanas	  &	  Lin	  2006;	  
Reischauer	  et	  al.	  2016).	  Quadruple	  knockdown	  of	  all	  ETS	  transcription	  factors	  expressed	   in	  
the	  zebrafish,	  namely	  etv2,	  ets1,	   fli1a	  and	   fli1b	   as	  well	  as	  ectopic	  etv2	  expression	  showed	  
that	  ETS	  transcription	  factors	  are	  necessary	  and	  sufficient	  to	  drive	  angioblast	  differentiation	  
in	  zebrafish	  (Pham	  et	  al.	  2007).	  	  
	  
	  
Figure	  3-­‐1	  Angioblast	  differentiation	  from	  mesodermal	  precursors	  
Multipotent	  mesodermal	  progenitors	  upregulate	   the	   transcription	   factor	   npas4l	   (cloche)	   to	  differentiate	   into	  
endothelial	   and	  hematopoietic	   progenitors	   by	   a	   yet	   unknown	  mechanism.	   These	  progenitors	   upregulate	   the	  
transcription	  factors	  tal1	  to	  differentiate	  into	  hematopoietic	  cells	  or	  tal1	  and	  etv2	  to	  become	  endothelial	  cells.	  
It	  is	  unknown	  how	  the	  selective	  upregulation	  of	  etv2	  is	  achieved.	  Modified	  from	  (Reischauer	  et	  al.	  2016).	  
	  
3.3.1.2 From	  angioblasts	  to	  functional	  vessels	  
	  
Following	   angioblast	   specification	   angioblasts	   migrate	   to	   the	   midline.	   This	   process	   is	  
regulated	  by	  Elabela	  (Ela)-­‐Apelin	  (Apln)	  receptor	  (Aplnr)	  signaling	   in	  zebrafish	  (Helker	  et	  al.	  
2015).	  Apelin	  and	  Elabela	  are	  expressed	  at	  the	  midline	  and	  function	  as	  a	  chemoattractants	  
by	   activating	   directed	  Apelin	   receptor-­‐mediated	  migration	   (Helker	   et	   al.	   2015).	   Angioblast	  
eventually	   coalesce	   at	   the	  midline	   to	   form	   a	   chord-­‐like	   structure.	   This	   precursor	   vessel	   is	  
Introduction 
16	  
separated	   into	   the	  DA	  and	  posterior	  cardinal	  vein	   (PCV)	  by	  a	  process	   termed	  selective	  cell	  
sprouting	   (Herbert	   et	   al.	   2009).	   This	   process	   is	   considered	   to	   be	   dependent	   on	   EphrinB2-­‐
EphB4’s	   repulsive	   action.	   Repulsive	   EphrinB2-­‐EphB4	   forward	   signaling	   in	   venous	   cells	  
expressing	  EphB4	  segregates	  them	  ventrally	  from	  the	  DA	  where	  they	  form	  the	  PCV	  (Herbert	  
et	   al.	   2009;	   Kania	   &	   Klein	   2016).	   DA	   and	   PCV	   formation	   is	   completed	   by	   24hpf	   and	   this	  
simple	  vascular	  system	  consisting	  of	  the	  heart,	  DA	  and	  PCV	  starts	  to	  carry	  blood	  flow	  (Isogai	  
et	  al.	  2001;	  Isogai	  et	  al.	  2003).	  	  
	  
In	  summary,	  zebrafish	  mesodermal	  precursor	  cells	  are	  specified	  by	  an	  unknown	  stimulus	  and	  
start	   to	   express	   npas4	   and	   tal1.	   In	   a	   subpopulation	   of	   these	   npas4+,	   tal1+	   cells	   etv2	   is	  
upregulated,	   which	   activates	   endothelial	   genes	   resulting	   in	   endothelial	   specification.	  
However,	   how	   only	   some	   npas4+,	   tal1+	   cells	   are	   activated	   to	   upregulate	   etv2	   in	   order	   to	  
produce	   the	  endothelial	   lineage	   is	   currently	  unknown.	  The	  etv2+	   angioblasts	  migrate	   in	  an	  
Ela-­‐Apelin-­‐APJ-­‐receptor-­‐dependent	  manner	  to	  the	  midline	  to	  coalesce	  into	  the	  DA	  and	  PCV	  
forming	  a	  simple	  circulation.	  
	  
3.4 Arteriovenous	  differentiation	  
	  
Arteries	   and	   veins	   were	   historically	   defined	   by	   parameters	   such	   as	   direction	   of	   flow	   and	  
oxygenation	   level	   together	   with	   their	   anatomical	   and	   functional	   differences	   (Wang	   et	   al.	  
1998).	  Wang	  and	   colleagues	  were	   the	   first	   to	   show	   that	   arteries	   and	  veins	   are	   genetically	  
hardwired	  prior	  to	  the	  onset	  of	   flow.	  Their	  studies	  show	  that	  already	  prior	  to	  the	  onset	  of	  
flow	  Ephrin-­‐B2	   is	  specifically	  expressed	  in	  arteries,	  whereas	  EphB4	  is	  mainly	  found	  in	  veins	  
(Wang	  et	  al.	  1998).	   In	  EphrinB2-­‐/-­‐	  KO	  mice	  angiogenesis	  but	  not	  vasculogenesis	   is	  affected,	  
suggesting	  that	  arteriovenous	  differentiation	  is	  not	  required	  for	  vasculogenesis	  (Wang	  et	  al.	  
1998).	  	  
Since	  then,	  a	  variety	  of	  artery-­‐	  and	  vein-­‐specific	  markers	  such	  as	  Notch,	  Dll4,	  Flt4,	  Flt1,	  NRPs,	  
COUP-­‐TFII,	  connexins	  and	  other	  factors	  have	  been	  described	  (Lawson	  et	  al.	  2001;	  le	  Noble	  et	  
al.	  2004;	  Siekmann	  &	  Lawson	  2007;	  Swift	  &	  Weinstein	  2009).	  Notch	  has	  been	  identified	  as	  
the	  main	  driver	  of	  arterial	  differentiation,	  whereas	  venous	  differentiation	  was	  assumed	   to	  
be	   the	   default	   pathway	   inhibited	   by	   Notch	   in	   arterial	   ECs	   (Lawson	   et	   al.	   2001;	   Torres-­‐
Vázquez	  et	  al.	  2003).	  However,	  COUP-­‐TFII,	  an	  orphan	  nuclear	  receptor,	  was	  later	  found	  to	  be	  
Introduction 
17	  
expressed	   specifically	   in	   veins	   releasing	   venous	   ECs	   from	   the	   Notch-­‐mediated	   repression,	  
thus	  showing	  that	  the	  venous	  status	  is	  not	  default,	  but	  rather	  has	  to	  be	  activated	  (You	  et	  al.	  
2005;	  Swift	  &	  Weinstein	  2009).	  How	  COUP-­‐TFII	  is	  activated	  in	  venous	  ECs	  and	  why	  it	  is	  only	  
activated	  in	  a	  subset	  of	  ECs	  is	  yet	  poorly	  understood.	  	  
On	   the	   other	   hand,	   the	   process	   of	   arterial	   differentiation	   is	   far	   better	   appreciated.	   In	  
zebrafish	  sonic	  hedgehoc	  (Shh)	  was	  shown	  to	  be	  upstream	  of	  Vegfa	  and	  to	  be	  expressed	  in	  
the	  notochord	  where	  it	  induces	  vegfaa	  expression	  in	  adjacent	  somites	  (Lawson	  et	  al.	  2002).	  
In	  turn,	  Vegfaa	  secreted	  from	  the	  somites	  activates	  notch	  and	  dll4	  expression	  in	  the	  adjacent	  
DA	  but	  not	   in	   the	  PCV,	  which	   is	  possibly	   too	  distant	  to	  experience	  sufficient	  Vegfaa	   levels.	  
VEGFR2	  and	  NRP1	  were	  shown	  to	  upregulate	  NOTCH1	  and	  DLL4	  in	  arteries	  (Liu	  et	  al.	  2003).	  
NRP1	  acts	  hereby	  as	  a	  coreceptor	  enhancing	  VEGF-­‐A-­‐VEGFR2	  signaling	   to	  promote	  arterial	  
differentiation	   (Mukouyama	   et	   al.	   2005;	   Jones	   et	   al.	   2008).	   DLL4-­‐NOTCH	   signaling	   in	   turn	  
activates	  arterial	  markers	  such	  as	  FLT1	  and	  EFNB2	   (Funahashi	  et	  al.	  2010;	   Jakobsson	  et	  al.	  
2010;	  Siekmann	  &	  Lawson	  2007).	  After	  arteriovenous	  differentiation	  (AVD)	  is	  completed,	  ECs	  
have	   to	   be	   separated	   from	   each	   other	   to	   form	   arteries	   and	   veins,	   respectively.	   This	  
separation	  is	  considered	  to	  be	  driven	  by	  EphrinB2-­‐EphB4-­‐mediated	  EC	  repulsion	  (Füller	  et	  al.	  
2003;	  Herbert	  et	  al.	  2009).	   Interestingly,	  ephB4	   knockdown	   in	  zebrafish	   leads	   to	   increased	  
venous	  intersegmental	  vessel	  (vISV)	  numbers	  similar	  to	  dll4j16e1	  mutants	  (Leslie	  et	  al.	  2007;	  
Kawasaki	  et	  al.	  2014).	  As	  EphrinB2	  is	  known	  to	  be	  downstream	  of	  Dll4/Notch	  signaling	  it	   is	  
tempting	  to	  suggest	  that	  EphrinB2-­‐EphB4’s	  repulsive	  actions	  in	  aISVs	  and	  secondary	  sprouts	  
regulate	   venous	   remodeling	   in	   zebrafish	   (Lawson	   et	   al.	   2001;	   Siekmann	  &	   Lawson	   2007).	  
Interestingly,	   EphrinB2	   was	   also	   shown	   to	   be	   involved	   in	   VEGFR-­‐2	   internalization	   and	  
thereby	  enhances	  VEGFR2	   signaling	   (Wang	  et	  al.	   2010;	   Sawamiphak	  et	  al.	   2010);	  however	  
how	  these	  two	  functions	  are	  connected	  remains	  elusive.	  
	  
In	  addition,	  the	  importance	  of	  genetic	  determinants	  in	  arteriovenous	  differentiation	  (AVD)	  is	  
emphasized	   by	   the	   fact	   that	   hemodynamic	   forces	   are	   not	   the	   driver	   of	   AVD	   during	  
development.	  Strikingly,	  le	  Noble	  and	  coworkers	  showed	  that	  ligated	  chicken	  arteries	  which	  
reroute	   blood	   flow	   (arteries	  with	   venous	   flow)	   rapidly	   downregulate	   arterial	  markers	   and	  
induce	  venous	  markers	  at	  a	  somewhat	  slower	  pace	  (le	  Noble	  et	  al.	  2004).	  This	  experiment	  
clearly	  demonstrates	  the	  remarkable	  plasticity	  of	  blood	  vessels,	   i.e.	  differentiation	  status	  is	  




In	   summary,	   the	   formation	   of	   the	   initial	   blood	   vessels	   during	   development	   is	   genetically	  
hardwired,	   but	   vascular	   remodeling	   and	   thus	   changing	   hemodynamic	   forces	   can	   rapidly	  
reprogram	   vessel	   identity.	   However,	   the	   exact	   function	   of	   EphrinB2	   and	   EphB4	   in	   AVD	  
remains	  elusive.	   In	  addition,	  how	  flow	  regulates	  AVD	  mechanistically	   is	  poorly	  understood.	  
Arteries	   and	   veins	  have	  different	   susceptibility	   to	   a	  disease	   such	  as	   atherosclerosis,	  which	  
cannot	  be	  explained	  solely	  by	  differences	  in	  blood	  flow.	  Thus,	  understanding	  the	  differences	  
in	   endothelial	   cell	   function	   and	   vascular	   architecture	  between	  arteries	   and	   veins	   could	  be	  
key	  to	  a	  better	  comprehension	  of	  disease	  conditions	  (Cui	  et	  al.	  2015).	  
	  
3.5 Arteriolar	  and	  venular	  differences	  
	  
Arteries	   branch	   into	   smaller	   arterioles	   feeding	   the	   capillary	   bed,	   which	   drains	   into	   post-­‐
capillary-­‐,	  collecting-­‐	  and	  paramuscular	  venules	  with	  increasing	  diameter.	  Arterioles	  express	  
markers	  such	  as	  Flt1,	  Nrp1,	  Gja5	  (connexin	  40),	  Notch1,	  Dll4	  and	  Efnb2	  (Wang	  et	  al.	  1998;	  le	  
Noble	  et	  al.	  2004;	  Siekmann	  &	  Lawson	  2007;	  Bussmann	  et	  al.	  2010;	  Buschmann	  et	  al.	  2010).	  
However,	   the	  expression	   level	  of	   these	  genetic	  markers	   is	  highly	  dependent	  on	   the	  model	  
organism	  (le	  Noble	  et	  al.	  2004;	  Siekmann	  &	  Lawson	  2007).	  Moreover,	  arterioles	  experience	  
higher	  shear	  stress	  and	  blood	  pressure	  and	  are	  covered	  by	  more	  pericytes	  than	  venules.	  In	  
addition,	   higher	   VE-­‐cadherin	   levels	   in	   arterioles	   prevent	   immune	   cell	   extravasation	   and	  
decrease	  vascular	  permeability	  (Vestweber	  2015;	  Orsenigo	  et	  al.	  2012).	  	  
	  
Venules,	   in	   contrast,	   express	   genetic	   markers	   such	   as	   Flt4,	   Dab2,	   Ephb4	   and	   CoupTFII,	  
experience	  low	  shear	  stress	  and	  low	  blood	  pressure	  (Wang	  et	  al.	  1998;	  You	  et	  al.	  2005;	  L.	  D.	  
Covassin	  et	  al.	  2006;	  Hogan	  et	  al.	  2009).	  Flt4	  is	  downregulated	  during	  vein	  maturation	  and	  is	  
only	  a	  marker	   for	  early	  venous	  development	  and	  angiogenic	  endothelia	  and	  the	   lymphatic	  
system	   (Hogan	   et	   al.	   2009;	   Adams	   &	   Alitalo	   2007;	   Herbert	   &	   Stainier	   2011).	   Venules	   are	  
covered	  by	  few	  pericytes	  and	  express	   low	  VE-­‐cadherin	   levels;	   thus	   leucocyte	  extravasation	  
occurs	  mainly	   in	   post-­‐capillary	   venules	   (Vestweber	   2015).	   Of	   note,	   also	   angiogenesis	   and	  
inflammation	  reactions	  occur	  predominantly	  in	  post-­‐capillary	  venules	  and	  capillaries	  and	  not	  




In	  conclusion,	  even	  small	  blood	  vessels	  such	  as	  arterioles	  and	  venules	  exhibit	  great	  genetic	  
and	  functional	  differences	  with	  extensive	  physiological	  consequences.	  Although	  it	   is	  known	  
for	   decades	   that	   angiogenesis	   during	   wound	   healing	   or	   tumorangiogenesis	   occurs	   from	  
capillaries	  and	  the	  venular	  side	  this	  phenomenon	  is	  largely	  ignored	  in	  angiogenesis	  research.	  
Most	   sprouting	   angiogenesis	  models	   do	   not	   differentiate	   between	   arteries	   and	   veins	   and	  
sprouting	  enhancement	  or	  decrease	  is	  typically	  quantified	  in	  all	  vessels,	  but	  not	  specifically	  
for	  arteries	  and	  veins.	   If	  we	  understood	  better	   the	  differences	  between	  arteries	  and	  veins	  
and	  their	  sprouting	  behavior	  we	  could	  presumably	  target	  veins	  specifically	  or	  enhance	  vein	  
formation	  to	  induce	  angiogenesis.	  
	  
	  
Figure	  3-­‐2.	  Differences	  between	  arterioles	  and	  venules	  
Arterioles	   and	   venules	   express	   distinct	   set	   of	   markers	   and	   display	   different	   characteristics	   regarding	  
permeability,	  extravasation	  capacity	  and	  angiogenic	  potential.	  Modified	  from	  (Adams	  &	  Alitalo	  2007).	  
	  
3.6 Angiogenesis	  	  
	  
In	  the	  early	  embryo,	  the	  first	  blood	  vessel	  structures	  are	  formed	  by	  vasculogenesis	  (Risau	  &	  
Flamme	  1995).	  Vasculogenesis	   forms	   the	  major	   large	   vessels	   such	  as	   the	  primary	   vascular	  
plexus,	   the	   DA,	   the	   CV,	   the	   perineural	   vascular	   plexus	   (PNVP)	   surrounding	   the	   central	  
bervous	   system	   (CNS)	   and	   the	   early	   cranial	   vasculature	   (Herbert	   &	   Stainier	   2011).	   These	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primitive	  structures	  serve	  as	  a	  template	  and	  are	  expanded	  by	  a	  process	  called	  angiogenesis	  
(Folkman	  &	  Shing	  1992;	  Flamme	  et	  al.	  1997;	  Carmeliet	  2003).	  Angiogenesis	  is	  defined	  as	  the	  
growth	  of	  vessels	  from	  pre-­‐existing	  ones	  (Folkman	  &	  Shing	  1992;	  Flamme	  et	  al.	  1997).	  Large	  
vessels	   have	   a	   stereotyped	   pattern,	  which	   is	   comparable	   in	   different	   individuals	   from	   the	  
same	   species	   (Carmeliet	   2003;	   Eichmann	   2010).	   These	   stereotyped	   vessels	   are	   formed	   by	  
vasculogenic	  processes	  such	  as	  angioblast	  aggregation	  or	  plexus	  formation	  and	  subsequent	  
vascular	  remodeling	  (Carmeliet	  2003;	  Eichmann	  2010).	  Growth	  of	  most	  small	  vessels	  is	  non-­‐
stereotyped	   and	  mainly	   governed	   by	  metabolic	   demand	   (Adams	   &	   Eichmann	   2010).	   Two	  
types	   of	   angiogenesis	   have	   been	   described	   sprouting	   angiogenesis	   and	   the	   less	   well-­‐
understood	  but	  possibly	  important	  intussuseptive	  angiogenesis	  (Burri	  et	  al.	  2004).	  	  
	  
3.6.1 Spouting	  angiogenesis	  and	  the	  tip	  cell	  concept	  
	  
Sprouting	  angiogenesis	  is	  a	  highly	  complex	  process	  involving	  the	  selection	  of	  an	  endothelial	  
cell	  (EC),	  the	  guided	  migration	  of	  this	  EC	  and	  its	  subsequent	  connection	  with	  other	  sprouts	  
forming	  an	  anastomosis	  and	  a	  functional	  vascular	  loop	  (Ruhrberg	  et	  al.	  2002;	  Gerhardt	  et	  al.	  
2003;	   De	   Smet	   et	   al.	   2009).	   Even	   after	   years	   of	   quiescence,	   blood	   vessels	   retain	   the	  
capability	  to	  propagate	  and	  to	  form	  angiogenic	  sprouts	  (De	  Bock	  et	  al.	  2013).	  These	  sprouts	  
are	   formed	   predominantly	   in	   small	   vessels	   at	   the	   capillary-­‐	   and	   venular	   side	   (Risau	   1995;	  
Bergers	  &	  Benjamin	  2003).	  Contradictory,	  most	  vascular	  research	  in	  zebrafish	  is	  focused	  on	  
arterial	  primary	   sprouting,	  which	   is	  presumably	  a	   very	   rare	  process	  with	   limited	   relevance	  
for	  health	  and	  disease	  (Ellertsdóttir	  et	  al.	  2010).	  
	  
To	  activate	  sprouting	  from	  a	  parent	  vessel,	  pericytes	  have	  to	  be	  removed	  and	  the	  basement	  
membrane	   and	   surrounding	   extracellular	   matrix	   (ECM)	   need	   to	   be	   degraded	   (Adams	   &	  
Alitalo	  2007;	  Herbert	  &	  Stainier	  2011).	  Growth	  factors	  such	  as	  VEGF-­‐A,	  VEGF-­‐C,	  Angiopoetin	  
2	   (ANG-­‐2)	   and	   bone	   morphogenetic	   proteins	   (BMPs)	   are	   capable	   to	   activate	   sprouting	  
angiogenesis	   (Herbert	   &	   Stainier	   2011;	   Wiley	   et	   al.	   2011).	   Tightly	   regulated	   EC	   selection	  
ensures	  that	  only	  some	  ECs	  are	  selected	  upon	  growth	  factor	  exposure	  (Ruhrberg	  et	  al.	  2002;	  
Gerhardt	   et	   al.	   2003;	   Siekmann	   &	   Lawson	   2007;	   Siekmann	   et	   al.	   2013).	   Pro-­‐angiogenic	  
growth	   factors	   activate	   a	   so-­‐called	   ‘tip	   cell’	   for	   sprouting.	   VEGF-­‐A	   activates	   VEGFR-­‐2	   in	  
competing	  ECs,	  resulting	  in	  upregulation	  of	  delta	  like	  4	  (DLL4)	  (Roca	  &	  Adams	  2007;	  Phng	  &	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Gerhardt	   2009).	   DLL4	   in	   turn	   inhibits	   adjacent	   endothelial	   cells	   from	   sprout	   formation	   by	  
activation	   of	   the	   NOTCH	   pathway	   in	   these	   cells,	   a	   process	   known	   as	   lateral	   inhibition	  
(Gerhardt	   et	   al.	   2003;	   Jakobsson	   et	   al.	   2010;	   Herbert	   &	   Stainier	   2011).	   Thereby,	   ECs	  
experiencing	  the	  highest	  growth	  factor	  concentration	  are	  thought	  to	  be	  selected	  to	  become	  
tip	  cells	  and	  inhibit	  their	  adjacent	  ECs,	  the	  so-­‐called	  ‘stalk	  cells’,	  from	  adopting	  a	  tip	  cell	  fate	  
(Siekmann	  &	  Lawson	  2007;	  Hellström	  et	  al.	  2007;	  Suchting	  et	  al.	  2007).	  	  
	  
Stalk	   cells	   are	   considered	   to	   proliferate	   and	   follow	   the	   guiding	   tip	   cell	   (Gerhardt	   2008;	  
Blanco	  &	  Gerhardt	  2013).	  The	   inhibition	  of	   tip	  cell	   formation	   in	  stalk	  cells	   is	   thought	  to	  be	  
realized	   via	   a	   NOTCH1-­‐mediated	   Flt4	   down-­‐	   and	   Flt1	   (Vegfr-­‐1)	   upregulation	   (Siekmann	   &	  
Lawson	   2007;	   Funahashi	   et	   al.	   2010).	   In	   stalk	   cells	  Dll4	   is	   similarly	   upregulated	   to	   inhibit	  
adjacent	  ECs,	  not	  in	  direct	  contact	  with	  the	  tip	  cell.	  Jag1	  which	  is	  predominantly	  expressed	  in	  
stalk	  cells	  is	  thought	  to	  block	  DLL4	  –NOTCH1	  signaling	  specifically	  in	  the	  tip	  cell	  (Benedito	  et	  
al.	  2009),	  and	  the	  deacetylase	  SIRT1	  may	  deacetylate	  the	  notch	  intracellular	  domain	  (NICD)	  
in	   the	   tip	   cell	   to	   accelerate	   proteasomal	   NICD	   degradation	   and	   thus	   destabilizing	   it,	   and	  
consolidating	   tip	   cell	   identity	   (Guarani	   et	   al.	   2011).	   Tip	   cell-­‐enriched	   expression	   of	   flt4	   in	  
zebrafish	  has	  been	  observed	  in	  primary	  sprouts	  and	  its	  expression	  is	  expanded	  to	  stalk	  cells	  
in	   the	   absence	   of	   Notch	   signaling	   (Siekmann	   &	   Lawson	   2007).	   Remarkably,	   in	   flt4hu4602	  
zebrafish	  mutants	  no	  primary	  sprouting	  phenotype	  could	  be	  observed,	   suggesting	  a	  minor	  
role	  for	  Flt4	  in	  this	  particular	  sprouting	  event.	  It	  is	  currently	  debated	  if	  and	  how	  flt4-­‐deficient	  
ECs	  can	  initiate	  sprouting	  angiogenesis	  and	  whether	  FLT4	  can	  replace	  VEGFR-­‐2	  in	  retinal	  ECs	  
(Tammela	  et	  al.	  2008;	  Hogan	  et	  al.	  2009;	  Benedito	  et	  al.	  2012;	  Zarkada	  et	  al.	  2015).	  VEGFR-­‐1	  
is	   thought	   to	   act	   as	   a	  decoy	   receptor	   scavenging	  VEGFA	   in	   the	  microenvironment	  of	   stalk	  
cells	   and	   thereby	   limiting	   VEGFA	   bioavailability	   and	   VEGFR-­‐2	   signaling	   in	   these	   cells	  





Figure	  3-­‐3.	  The	  tip	  cell	  concept	  
The	   tip	  cell	   concept	   is	  a	  model	   to	  explain	  how	  ECs	  select	  only	  a	   limited	  number	  of	  TCs	   to	  expand	  a	  vascular	  
network	   in	   a	   coordinated	   manner.	   VEGFA	   activates	   VEGFR2,	   upregulating	   DLL4.	   The	   ECs	   experiencing	   the	  
highest	  VEGFA	  levels	  upregulate	  DLL4	  most	  rapidly	  and	  block	  sprouting	  and	  TC-­‐formation	  in	  adjacent	  cells	  via	  
NOTCH-­‐mediated	   lateral	   inhibition.	   Notch	   target	   genes	   such	   as	   DLL4,	   FLT1	   and	   NRARP	   activate	   SC-­‐
characteristics	  such	  as	  proliferation	  (NRARP)	  and	  prevent	  tip	  cell	  formation	  by	  limiting	  VEGFR2	  signaling	  in	  the	  
close	  microenvironment	  of	  the	  SC	  (FLT1),	  emphasized	  by	  the	  red	  dotted	  box.	  DLL4	  is	  thought	  to	  block	  adjacent	  
cells	   from	  becoming	   TCs.	   The	   TC	   is	   though	   to	  be	  protected	   from	  SC	  differentiation	  by	   SIRT1	  mediated	  NICD	  
destabilization	   and	   Jagged1	  mediated	   blockade	   of	   DLL4-­‐Notch	   signaling	   in	   the	   TC.	   TC,	   tip	   cell,	   SC,	   stalk	   cell.	  
Modified	  from	  (Herbert	  &	  Stainier	  2011).	  
	  
Strikingly,	  dll4,	  flt1	  and	  notch1a	  are	  arterial	  markers	  in	  zebrafish	  and	  other	  organisms,	  and	  at	  
least	  Dll4	  and	  Notch1a	  are	  major	  regulators	  of	  arterial	  differentiation	  (le	  Noble	  et	  al.	  2004;	  
Lawson	  et	  al.	  2001;	  Siekmann	  &	  Lawson	  2007;	  Leslie	  et	  al.	  2007).	  This	  questions	  the	  general	  
validity	  of	  the	  tip	  cell	  concept	  for	  arteries	  and	  veins	  (Siekmann	  et	  al.	  2013).	  In	  addition,	  Flt1	  
upregulation	   in	   stalk	   cells	   could	   only	   be	   shown	   in	   embryoid	   body	   experiments	   or	   in	   cell	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culture	   which	   are	   highly	   artificial	   and	   do	   not	   take	   into	   account	   AVD	   and	   blood	   flow	  
(Jakobsson	   et	   al.	   2010;	   Funahashi	   et	   al.	   2010).	   Flow	   also	   influences	   the	   expression	   of	  
arteriovenous	  markers,	   thus	   the	   interpretation	  of	   the	  data	   from	   Jakobsson	  and	   Funahashi	  
and	  coworkers	  may	  be	  misleading	  (le	  Noble	  et	  al.	  2004;	  Jakobsson	  et	  al.	  2010;	  Funahashi	  et	  
al.	   2010).	   Moreover,	   in	   zebrafish	   primary	   sprouts	   flt1,	   dll4	   and	   notch	   are	   ubiquitously	  
expressed	  in	  the	  sprout	  and	  not	  restricted	  to	  the	  tip	  or	  stalk	  cell	  (Krueger	  et	  al.	  2011;	  Leslie	  
et	   al.	   2007).	   Furthermore,	   venous	   sprouts,	   which	   originate	   from	   the	   PCV,	   do	   not	   express	  
either	   of	   the	   typical	   tip	   or	   stalk	   cell	   markers	   (flt1,	   dll4,	   notch1a),	   and	   still	   only	   a	   limited	  
number	  of	  ECs	  and	  not	  every	  EC	   in	  the	  PCV	  forms	  sprouts.	  Thus,	  one	  could	  speculate	  that	  
either	   venous	  ECs	  use	  a	  different	  mode	   for	   tip	   cell	   selection	   than	  arteries	   independent	  of	  
Dll4/Notch	   and	   Flt1,	   or	   that	   the	  model	   deduced	   by	   the	   experiments	   is	  misleading.	   In	   the	  
mouse	  retina	  the	  differences	   in	  arteriovenous	  marker	  expression	  are	  not	  as	  clear-­‐cut	  as	   in	  
the	   zebrafish	   vasculature	   and	   flow-­‐dependent	   AVD	   possibly	   takes	   place	   coincidently	   with	  
sprouting	   and	   plexus	   formation.	   Thus,	   as	   potentially	   the	   same	   genes	   are	   implied	   in	   two	  
processes	   occurring	   at	   the	   same	   time,	   it	   seems	   to	   be	   extremely	   difficult	   to	   differentiate	  
between	   arteriovenous	   differentiation	   processes	   and	   tip	   cell	   formation.	   In	   addition,	   old	  
literature	   emphasized	   that	   venules	   and	   capillaries	   are	   normally	   the	   vessels	   that	   generate	  
new	  sprouts,	  therefore	  it	  is	  at	  least	  surprising	  that	  arterial	  genes	  regulate	  this	  process	  (Risau	  
1995;	  Bergers	  &	  Benjamin	  2003).	  	  
	  
Furthermore,	  it	  is	  unclear	  if,	  for	  instance	  zebrafish	  primary	  sprouts	  follow	  a	  Vegfaa	  gradient.	  
Vegfaa	   is	   expressed	   in	   the	   somites,	   thus	   the	   bioavailability	   of	   secreted	   Vegfaa	   in	   the	  
corridors	  between	  the	  somites	  at	  the	  somite	  boundary	  should	  be	  uniform.	  Why	  the	  primary	  
sprouts	  migrate	  dorsally	  is	  therefore	  unclear.	  One	  possibility	  is	  that	  they	  follow	  the	  path	  with	  
the	  least	  physical	  constraints	  and	  that	  they	  are	  not	  guided	  but	  solely	  activated	  by	  Vegfaa	  to	  
make	  a	  sprout.	  	  
	  
In	  the	  future	  it	  will	  be	  important	  to	  clearly	  differentiate	  between	  angiogenic	  processes	  and	  
AVD,	  which	  is	  possibly	  not	  trivial	  since	  not	  all	  vascular	  systems	  are	  as	  clearly	  separated	  into	  
arteries	  and	  veins	  as	  the	  zebrafish	  trunk	  vasculature	  before	  3	  days	  post	  fertilization	  (dpf).	  In	  
conclusion,	   tip	   cell	  models	   are	   taken	   for	   granted,	   but	   the	  underlying	  processes	   and	  genes	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involved	   are	   far	   from	   being	   understood.	   Especially	   the	   differentiation	   between	   tip	   cell	  
selection	  and	  AVD	  remains	  elusive.	  
	  
3.6.1.1 Venous	  sprouting	  angiogenesis	  
	  
Secondary	   venous	   sprouts	   in	   the	   zebrafish	   emanate	   from	   the	   PCV	   to	   form	   the	   lymphatic	  
system	  and	  the	  vISVs	  and	  are	  regulated	  by	  Vegfc-­‐Flt4	  signaling.	  Specifically,	  hypochord-­‐Vegfc	  
activates	  dorsal	  PCV	  sprouting	  towards	  the	  horizontal	  myoseptum	  (HMS)	  (Isogai	  et	  al.	  2003;	  
Hogan	   et	   al.	   2009;	   Ellertsdóttir	   et	   al.	   2010).	   Why	   only	   a	   subset	   of	   venous	   ECs	   make	  
secondary	  sprouts	  in	  the	  PCV	  and	  if	  adjacent	  cells	  are	  laterally	  inhibited	  or	  unable	  to	  sprout	  
due	  to	  physical	  constraints	  is	  poorly	  understood	  (Koltowska	  et	  al.	  2015).	  	  
	  
Recent	   findings	   revealed	  a	  novel	  Bmp2b-­‐dependent	   type	  of	  venous	   sprouting	   in	   zebrafish,	  
which	   is	   independent	   of	   Vegfa-­‐Kdrl	   and	  Notch	   signaling	   (Wiley	   et	   al.	   2011).	   Furthermore,	  
also	   other	   receptor	   tyrosine	   kinases	   (RTKs)	   such	   as	   the	   fibroblast	   growth	   factor	   receptor	  
(FGFR)	   and	   other	   signaling	   pathways	   play	   a	   role	   in	   tumor	   angiogenesis	   and	   other	  
pathological	  conditions	  (Welti	  et	  al.	  2013).	  	  
	  
In	  summary,	  ECs	  show	  a	  high	  degree	  of	  heterogeneity,	  which	  is	  even	  enhanced	  in	  different	  
organ	  tissues.	  This	  complexity	  is	  currently	  heavily	  debated,	  and	  possibly	  one	  concept	  for	  all	  
sprouting	  processes	  oversimplifies	  the	  complex	  nature	  of	  endothelial	  cells	  (Nolan	  et	  al.	  2013;	  
Rafii	  et	  al.	  2016).	  The	  remarkable	  diversity	  of	  ECs	  entails	  chances	  for	  tissue	  specific	  vascular	  
repair	   since	   they	   could	   potentially	   allow	   for	   localized	   induction	   of	   vascularization,	   e.g.	   in	  
ischemic	  myocardium	  after	  artery	  occlusion.	  On	  the	  downside,	  it	  makes	  tumor	  angiogenesis	  
extremely	   intricate	   to	   target	   as	   vascularization-­‐inducing	   tumor	   cells,	   depending	   on	   the	  








3.7 Zebrafish	  trunk	  angiogenesis	  	  
	  
3.7.1 Primary	  and	  secondary	  sprouting	  
	  
The	   simple	   zebrafish	   trunk	   vasculature	   is	   formed	   by	   two	   subsequent	   sprouting	   events,	  
termed	  primary	  or	  arterial	   and	   secondary	  or	   venous	   sprouting	   (Isogai	  et	   al.	   2003).	  Vegfaa	  
expressed	  in	  somites	  drives	  dorsal	  arterial	  sprouting	  from	  the	  DA,	  a	  process	  termed	  primary	  
sprouting	  (Isogai	  et	  al.	  2001;	  Isogai	  et	  al.	  2003;	  Ellertsdóttir	  et	  al.	  2010).	  Arterial	  sprouts	  form	  
a	  T-­‐structure	  at	  the	  most	  dorsal	  region	  of	  the	  trunk	  and	  anastomose	  with	  adjacent	  sprouts	  
forming	  the	  left	  and	  right	  dorsal	  longitudinal	  anastomotic	  vessel	  (DLAV)	  (Isogai	  et	  al.	  2001).	  
In	  a	  second	  wave	  of	  sprouting,	  venous	  sprouts	  emanate	  from	  the	  PCV	  and	  migrate	  dorsally	  
in	  a	  Vegfc-­‐dependent	  manner	  starting	  at	  32	  hpf	  (Isogai	  et	  al.	  2003;	  Ellertsdóttir	  et	  al.	  2010).	  
Vegfc	   expressed	   in	   the	   hypochord	   activates	   Flt4	   signaling	   in	   some	   venous	   ECs.	   Venous	  
sprouts	  connect	  with	  aISVs	  at	  the	  level	  between	  the	  DA	  and	  HMS	  to	  form	  the	  vISVs	  (Hogan	  
et	  al.	  2009;	  Küchler	  et	  al.	  2006).	  The	  anastomosis	  of	  a	  venous	  sprout	  with	  an	  aISV	  and	  the	  
immediate	   onset	   of	   flow	   lead	   to	   subsequent	   pruning	   of	   the	   DA	   connection,	   and	   as	   a	  
consequence	  a	  vISV	  is	  formed.	  This	  process	  is	  called	  arteriovenous	  remodeling	  and	  is	  mostly	  
completed	  between	  36-­‐48	  hpf	  (Isogai	  et	  al.	  2003;	  Ellertsdóttir	  et	  al.	  2010).	  	  
	  
Notably,	  only	  50	  %	  of	   the	  venous	  sprouts	  connect	   to	  aISVs.	  The	   remaining	  50%	  of	   sprouts	  
migrate	   to	   the	   HMS	   forming	   together	   with	   later	   appearing	   lymphatic	   sprouts,	   which	  
emanate	   from	   the	   vISVs	   the	   parachordal	   lymphangioblasts	   (PLs)	   at	   the	   level	   of	   the	   HMS	  
(Isogai	  et	  al.	  2003;	  van	   Impel	  et	  al.	  2014).	  PLs	  differentiate	   into	   lymphatic	  endothelial	  cells	  
(LECs)	   and	   form	   the	   lymphatic	   system	   (Küchler	   et	   al.	   2006;	   Yaniv	   et	   al.	   2006;	   Yaniv	   et	   al.	  





Figure	  3-­‐4.	  Primary	  and	  secondary	  sprouting	  in	  the	  zebrafish	  trunk	  
Primary	   arterial	   sprouts	   emanate	   from	   the	  DA	  and	   anastomose	  with	   each	  other	   at	   the	  dorsal	   border	   of	   the	  
trunk	   to	   form	   the	  DLAV.	   Secondary	   sprouts	   appear	   later	   and	  originate	   from	   the	   PCV.	   50%	  of	   the	   secondary	  
sprouts	   connect	   to	   aISVs,	   which	   are	   remodeled	   into	   vISVs	   (light	   blue	   sprout).	   The	   other	   50%	   of	   secondary	  
sprouts	   form	   a	   T-­‐shape	   at	   the	   level	   of	   the	   HMS	   and	   differentiate	   into	   parachordal	   lymphangioblasts	   (green	  
sprout	  depicted	  with	  (I)).	  Parachordal	   lymphangioblasts	  (PLs)	  originate	  also	  from	  the	  vISVs	  at	  the	   level	  of	  the	  
HMS	   building	   a	   second	   pool	   of	   PLs,	   depicted	  with	   (II).	   DA,	   dorsal	   aorta;	   PCV,	   posterior	   cardinal	   vein;	   DLAV,	  
dorsal	   longitudinal	   vessel;	   aISV,	   arterial	   intersegmental	   vessel;	   vISV,	   venous	   intersegmental	   vessel;	   HMS,	  
horizontal	  myoseptum.	  
	  
3.7.2 Decision	  making	  –	  becoming	  vein	  or	  lymphatic?	  
	  
It	   is	   debated	  why	   50%	   of	   venous	   sprouts	   connect	  with	   aISVs	   and	   the	   other	   50%	   become	  
lymphatic	  ECs	   (Isogai	  et	  al.	   2003;	  Koltowska	  et	  al.	   2015).	   There	  are	  at	   least	   three	  possible	  
scenarios.	   The	   lymphatic	   specification	   is	   programmed	   in	   the	   PCV	   (I),	   aISVs	   decide	   which	  
venous	   sprouts	   connect	   and	   which	   form	   lymphatics	   (II)	   or	   a	   mixed	   scenario	   would	   be	  
possible	  (III).	  Accordingly,	  one	  hypothesis	  is	  that	  the	  onset	  of	  flow	  in	  aISVs	  adjacent	  to	  vISVs	  
inhibits	   anastomosis	   formation	  with	   venous	   sprouts	   activating	   lymphatic	   differentiation	   in	  
these	  cells	  (Isogai	  et	  al.	  2003).	  Interestingly,	  loss	  of	  dll4	  leads	  to	  the	  formation	  of	  increased	  
vISV	  numbers	  (Leslie	  et	  al.	  2007).	  In	  these	  mutants	  almost	  all	  aISVs	  are	  remodeled	  into	  vISVs,	  
suggesting	   that	  Notch	   signaling	   could	  be	   involved	   in	   venous	   sprout	  anastomosis	   inhibition	  
and	  could	  thus	  regulate	  venous	  remodeling	  (Leslie	  et	  al.	  2007).	  	  
	  
Since	   Dll4/Notch	   signaling	   is	   restricted	   to	   the	   arterial	   domain,	   this	   scenario	   suggests	   that	  
aISVs	   cell-­‐autonomously	   decide	   which	   secondary	   sprouts	   connect	   and	   which	   do	   not.	  
Contradictory,	  recent	  findings	  suggest	  that	  venous	  PCV	  cells	  already	  adopt	  a	  lymphatic	  fate	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prior	   to	   secondary	   sprout	   formation	   by	   prox1	   upregulation	   (Koltowska	   et	   al.	   2015).	   This	  
suggests	  that	  Prox1,	  by	  an	  unknown	  mechanism,	  prevents	  lymphatic	  cells	  from	  anastomosis	  
and	   vISV	   formation	   (Koltowska	   et	   al.	   2015).	   However,	   there	   is	   no	   known	  mechanism	   that	  
could	  randomly	  assign	  every	  other	  sprout	  lymphatic	  or	  venous	  fate.	  Therefore	  the	  regulation	  
of	  arteriovenous	  ISV-­‐remodeling	  by	  flow	  remains	  tempting.	  	  
	  
By	   48	   hpf,	   the	   major	   trunk	   vessels	   carry	   flow	   and	   supply	   the	   somites	   and	   neurons	   with	  
nutrients	  (Isogai	  et	  al.	  2001).	  At	  3dpf	  the	  vertebral	  artery	  forms	  between	  the	  floor	  plate	  and	  
the	   notochord,	   just	   below	   the	   neural	   tube,	   interconnecting	   the	   ISVs	   with	   the	   hindbrain	  
vasculature	  (Kimura	  et	  al.	  2015).	  	  
	  
3.7.3 Bmp	  signaling	  drives	  caudal	  vein	  plexus	  formation	  
	  
The	  caudal	  vein	  plexus	   (CVP),	  which	   is	   formed	  from	  32	  hpf	  onwards	  at	  the	  posterioventral	  
part	  of	  the	  zebrafish	  tail,	  is	  a	  honeycomb-­‐like	  network	  of	  vessels,	  composed	  of	  a	  dorsal	  and	  a	  
ventral	  vein	   interconnected	  by	  vessels	  (Isogai	  et	  al.	  2001;	  Wiley	  et	  al.	  2011).	  Strikingly,	  the	  
CVP	  is	  formed	  in	  a	  Vegfaa-­‐	  and	  Vegfc-­‐	  independent	  manner	  and	  is	  rather	  regulated	  by	  Bmp	  
signaling	  (Wiley	  et	  al.	  2011).	  Mechanistically,	  bmp2b	  is	  expressed	  in	  the	  posterioventral	  tail	  
region	  and	  is	  sensed	  by	  venous	  ECs	  of	  the	  PCV	  with	  the	  Bmpr2a/b	  and	  Alk2/Alk3	  receptors	  
activating	  ventral	  venous	  sprouting	  angiogenesis	  and	  CVP	  formation.	  This	  is	  in	  contrast	  to	  all	  
other	  sprouting	  processes	  in	  the	  zebrafish	  being	  either	  Vegfaa-­‐Kdrl	  or	  Vegfc-­‐Flt4	  dependent	  
(L.	  D.	  Covassin	  et	  al.	  2006;	  Hogan	  et	  al.	  2009;	  B.	  Hogan	  et	  al.	  2009).	  	  
	  
In	   conclusion,	   the	   simple	   zebrafish	   trunk	  vasculature	  composed	  of	  DA,	  PCV,	  CVP,	   ISVs	  and	  
DLAV	   is	   formed	   by	   at	   least	   three	   signaling	   pathways	   unequivocally	   demonstrating	   EC-­‐
heterogeneity	  during	  development.	   It	  will	   be	   interesting	   in	   the	   future	   to	   investigate	  other	  
organ-­‐specific	  vasculatures	  to	  presumably	  identify	  other	  signaling	  pathways	  involved	  in	  their	  
maturation.	   The	   EC	   heterogeneity	   clearly	   shows	   that	   there	   will	   be	   no	   single	   concept	   or	  
targeting	  mechanism	  for	  the	  clinics	  instead	  depending	  on	  the	  origin	  of	  tumors	  or	  the	  tumor	  
bed	   many	   different	   pathways	   have	   to	   be	   targeted.	   On	   the	   other	   hand	   pro-­‐angiogenic	  
therapies	  could	  be	  fine-­‐tuned	  for	  ECs	  of	  a	  specific	  organ’s	  vasculature	  preventing	  side	  effects	  
in	  other	  organs.	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3.7.4 Directional	  migration	  of	  angiogenic	  sprouts	  
	  
After	  selection	  of	  endothelial	  tip	  cells	  they	  extend	  filopodia	  to	  sense	  their	  environment	  for	  
guidance	  cues	  (Gerhardt	  et	  al.	  2003;	  De	  Smet	  et	  al.	  2009).	  Tip	  cells	  are	  thought	  to	  migrate	  
against	  a	  growth	  factor	  gradient	  in	  the	  direction	  of	  the	  highest	  growth	  factor	  concentration,	  
extending	  and	  retracting	  filopodia	  in	  a	  saltatory	  manner	  (Carmeliet	  &	  Tessier-­‐Lavigne	  2005).	  
Interestingly,	   Phng	   and	   coworkers	   recently	   showed	   that	   certain	   zebrafish	   ECs	   can	   sprout	  
even	  in	  the	  absence	  of	  filopodia,	  albeit	  at	  a	  lower	  speed,	  implicating	  that	  filopodia	  increase	  
the	  guidance	  efficacy	  and	  speed	  but	  are	  in	  principle	  dispensable	  for	  guided	  sprouting	  (Phng	  
et	  al.	  2013).	  The	  source	  of	  guidance	  cues	  such	  as	  VEGF	  can	  be	  developmental	  structures	  or	  
oxygen-­‐deprived	   tissue	   such	   as	   wounds,	   ischemic	   tissues	   or	   tumors	   (Ferrara	   2005;	   Haigh	  
2008).	   VEGF	   is	   thought	   to	   be	   upregulated	   in	   these	   tissues	   to	   recruit	   vessels	   until	   supply	  
meets	  demand	  (Carmeliet	  2003).	  	  
	  
However,	   it	  has	  never	  been	  physically	   shown	   that	  VEGFs	   form	  a	  gradient	  or	   that	  different	  
VEGF	  isoforms	  form	  different	  gradients,	  which	  combine	  then	  into	  a	  comprehensive	  gradient.	  
It	  was	   recently	   shown	   that	   blood	   flow	   is	   necessary	   for	   the	   formation	   of	   some	  but	   not	   all	  
sprouts	  in	  zebrafish	  (Watson	  et	  al.	  2013).	  These	  sprouting	  events	  are	  most	  likely	  activated	  by	  
two	  factors,	  namely	  Vegfa	  and	  blood	  flow.	  Similarly	  sprouting	  could	  also	  be	  induced	  by	  shear	  
stress	  using	  in	  vitro	  systems	  (Galie	  et	  al.	  2014).	  Thus,	  sprout	  elongation	  seems	  to	  be	  in	  most	  
cases	   blood	   flow	   and	   growth	   factor	   dependent.	   Apart	   from	   Vegfa	   sources	   and	   gradients,	  
blood	   flow	  could	  also	  provide	   sprouts	  with	   some	  degree	  of	  directionality	  perpendicular	   to	  
the	  direction	  of	  flow	  of	  the	  parent	  vessel.	  Whether	  the	  presumed	  Vegfa	  gradient	  directs	  or	  
only	  activates	  and	  maintains	  sprouting	  angiogenesis	  remains	  elusive.	  
3.7.4.1 Common	  guidance	  factors	  of	  vessels	  and	  nerves	  –	  same	  patterns	  same	  cues?	  
	  
Recent	   evidence	   suggests	   that	   well-­‐known	   nerve	   repellents	   and	   attractants	   can	   also	   be	  
utilized	   by	   vessels	   to	   prevent	   invasion	   into	   certain	   tissue	   regions,	   such	   as	   somites	   during	  
development	   (Torres-­‐Vázquez	   et	   al.	   2004;	   Zygmunt	   et	   al.	   2011).	   Semaphorins	   and	   their	  
Neuropilin	   and	   Plexin	   receptors	   are	   known	   as	   nerve	   repellents	   but	   are	   also	   expressed	   in	  
endothelial	   cells.	   Sema3a	   (the	   mouse	   and	   human	   Sema3E	   homolog)	   is	   expressed	   in	   the	  
somites	   of	   the	   developing	   zebrafish	   embryo,	   whereas	   the	   Sema3a	   receptor	   Plxnd1	   is	  
expressed	   in	   primary	   arteries,	   sprouting	   dorsally	   in	   between	   the	   somites	   at	   the	   somite	  
Introduction 
29	  
boundaries.	   In	  plxnd1um7	  mutants	   or	   in	   sema3a	   knockdown	   scenarios	   primary	   sprouts	   are	  
not	  restricted	  anymore	  to	  the	  region	  close	  to	  the	  somite	  boundaries	  as	  observed	  in	  wild	  type	  
embryos	  but	  sprout	  in	  a	  chaotic	  fashion	  at	  all	  levels	  of	  the	  trunk	  (Torres-­‐Vázquez	  et	  al.	  2004).	  
It	   has	   been	   suggested	   that	   Sema3a-­‐Plxnd1-­‐mediated	   upregulation	   of	   sflt1	   in	   ECs	   prevents	  
sprouting	  at	  the	  level	  of	  the	  somites	  in	  a	  cell-­‐autonomous	  manner	  and	  allows	  only	  sprouting	  
close	   to	   the	   somite	  boundaries	   (Gay	  et	   al.	   2011;	   Torres-­‐Vázquez	  et	   al.	   2004).	   Thus,	   it	  was	  
concluded	  that	  the	  Sema3a-­‐PlxnD1	  signaling	  pathway	  has	  similar	  repellent	  functions	   in	  the	  
vasculature	  and	  in	  neurons	  (Winberg	  et	  al.	  1998).	  	  
	  
Another	  example	  are	  the	  Ephrins	  and	  the	  Eph	  receptors,	  which	  can	  be	  negative	  or	  positive	  
nerve	  guidance	  cues	  (Kania	  &	  Klein	  2016).	  In	  ECs,	  EphrinB2	  and	  EphB4	  were	  the	  first	  markers	  
found	  to	  be	  specifically	  expressed	  in	  arteries	  or	  veins,	  respectively	  (Wang	  et	  al.	  1998).	  They	  
are	   critical	   for	   artery-­‐venous	   differentiation	   early	   in	   development	   and	   are	   important	   for	  
VEGFR-­‐2	  internalization	  and	  signaling	  capacity	  in	  angiogenesis	  (Wang	  et	  al.	  1998;	  Wang	  et	  al.	  
2010;	  Sawamiphak	  et	  al.	  2010).	  Hence,	  Ephrins	  and	  their	  receptors	  have	  different	  functions	  
in	   endothelial	   cells	   acting	   as	   repellents	   similar	   to	   their	   nerve	   function,	   but	   also	   as	  
coreceptors	  enhancing	  angiogenesis.	  The	  connection	  between	  these	  controversial	  functions	  
is	  poorly	  understood.	  
	  
In	  summary,	  sprouting	  angiogenesis	   is	  typically	  non-­‐stereotyped	  and	   is	  activated	  according	  
to	  demand,	  which	  is	  regulated	  by	  growth	  factors	  such	  as	  VEGF.	  In	  contrast	  to	  axon	  guidance,	  
angiogenesis	   can	   only	   span	   short	   distances,	   which	   are	   normally	   guided	   by	   growth	   factor	  
gradients.	   This	   is	   very	   similar	   to	   axonal	   terminal	   arborization	   in	   terms	   of	   guidance	   and	  
survival	   of	   only	   physiologically	   relevant	   connections	   (Carmeliet	   2005).	   Recent	   evidence	  
suggests	  that	  tissues	  under	  some	  circumstances	  may	  utilize	  well-­‐known	  neuronal	  guidance	  
factors	  to	  determine	  vascular	  patterning,	  but	  the	  relevance	  for	  development	  or	  guidance	  of	  
sprouting	  angiogenesis	  during	  wound	  healing	  or	  disease	  remains	  elusive	  (Adams	  &	  Eichmann	  
2010).	  Of	   note,	   several	   of	   the	   neurovascular	   factors	   described	   to	   be	   relevant	   for	   vascular	  
guidance	   were	   investigated	   or	   substantiated	   using	   morpholino-­‐mediated	   knockdown	  
experiments	  in	  zebrafish	  (Carmeliet	  &	  Tessier-­‐Lavigne	  2005).	  Morpholinos	  are	  known	  to	  be	  
good	   agents	   for	   gene	   silencing	   in	   zebrafish	   but	   can	   induce	   unspecific	   side	   effects	   limiting	  
their	   use	   to	   situations	  where	   a	   reference	   such	   as	   a	  mutant	   is	   available	   (Kok	   et	   al.	   2014).	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These	   early	   investigations	   on	   neurovascular	   guidance	   cues	   were	   performed	   solely	   with	  
morpholinos	  and	  may	  thus	  be	  misleading.	  Guidance	  cues	  utilized	  from	  the	  nervous	  system	  
could	   have	   been	   evolutionarily	   evolved	   to	   prevent	   sprout	   penetration	   and	   tissue	   or	   cell	  
differentiation	   damage	   during	   embryonic	   development.	   For	   non-­‐developmental	   sprouting	  
angiogenesis	  sprout	  penetration	  could	  also	  be	  harmful	  and	  could	  for	  instance	  oxygenize	  and	  
hence	  damage	  hypoxic	  stem	  cell	  niches	  (Eliasson	  &	  Jönsson	  2010).	  	  
	  
3.8 The	  zebrafish	  spinal	  cord	  –	  development	  and	  function	  
	  
Upon	  specification	  of	  the	  neuroectoderm	  the	  neural	  plate	  is	  formed.	  In	  zebrafish	  the	  neural	  
plate	  does	  not	   fold	   into	   the	  neural	   tube	   (NT)	  as	  observed	   in	  other	  vertebrates,	  but	   rather	  
forms	  a	  rod-­‐like	  structure,	  which	  is	  only	  secondarily	  infiltrated	  to	  form	  the	  NT	  (Nyholm	  et	  al.	  
2009).	  The	  final	  structure	  of	  the	  zebrafish	  NT	   is	  comparable	  with	  that	  of	  other	  vertebrates	  
(Lewis	  &	  Eisen	  2003;	  Nyholm	  et	  al.	  2009;	  Goulding	  2009;	  Schmidt	  et	  al.	  2013).	  	  
	  
The	   neuroepithelium	   in	   the	   NT	   is	   divided	   into	   three	   zones,	   namely	   the	   ventricular	   zone	  
(source	   of	   neurons	   and	   glia),	   which	   is	   in	   contact	   with	   the	   cerebrospinal	   fluid,	   the	  
intermediate	  zone	  and	  the	  marginal	  zone	  (Goulding	  2009).	  The	  neuroepithelium	  is	  polarized	  
with	  an	  apical	  (luminal	  side)	  and	  a	  basal	  side.	  Proliferating	  progenitors	  move	  from	  the	  apical	  
side	   to	   the	  basal	   side	   to	  differentiate	   (Lewis	  &	  Eisen	  2003;	  Goulding	  2009).	  This	  process	   is	  
known	  as	  interkinetic	  nuclear	  migration	  (Del	  Bene	  2011;	  Spear	  &	  Erickson	  2012;	  Strzyz	  et	  al.	  
2015).	  Thus,	  neuroepithelial	  cells	  (stem	  cells)	  are	  connected	  to	  the	  apical	  and	  the	  basal	  side	  
forming	  a	  neuroepithelium.	  These	  cells	  asymmetrically	  divide,	  whereby	  one	  daughter	   cells	  
remains	  attached	  to	  the	  apical	  surface	  whereas	  the	  other	  detaches	  and	  differentiates	  at	  the	  
basal	  side	  into	  a	  mature	  neuron	  (Strzyz	  et	  al.	  2015).	  As	  the	  neural	  tube	  matures,	  stem	  cells	  
differentiate	  into	  radial	  glia	  cells	  (RGCs)	  (Goulding	  2009).	  	  
RGCs	  have	  a	  similar	  orientation	  as	  neuroepithelial	  cells	  (radial	  from	  apical	  to	  basal)	  and	  give	  
rise	  to	  mature	  neurons	  (stained	  by	  the	  xla.tubb	  promoter),	  oligodendrocytes	  and	  astrocytes	  
and	  are	  the	  main	  source	  of	  neurons	  during	  development	  (Noctor	  et	  al.	  2001;	  Götz	  &	  Huttner	  
2005).	  Neurons	   further	  differentiate	   into	  motor	  neurons	   (mnx	  promoter	  domain),	   sensory	  
neurons,	   interneurons	   or	   other	   types	   of	   neurons.	   The	   xenopus	   beta-­‐tubulin	   promoter	  
(xla.tubb)	  is	  specifically	  active	  in	  mature	  neurons,	  whereas	  the	  huc	  promoter	  (also	  known	  as	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elavl3)	   is	   considered	   to	  be	   a	  pan-­‐neuronal	   promoter	   in	   zebrafish	   (Park	   et	   al.	   2000;	   Peri	  &	  
Nüsslein-­‐Volhard	   2008).	  Motor	   neurons	   are	   formed	   at	   the	   ventrolateral	  margin	   of	   the	  NT	  
whereas	  sensory	  neurons	  and	  interneurons	  are	  located	  dorsally	  (Eisen	  1991;	  Goulding	  2009).	  
Mechanistically,	   Shh,	   which	   is	   secreted	   from	   the	   notochord	   and	   floorplate,	   drives	   motor	  
neuron	  differentiation,	  whereas	  Bmps	  secreted	  from	  the	  dorsal	  ectoderm	  drive	  sensory	  and	  
interneuron	  differentiation	  resulting	  in	  a	  distinct	  dorsoventral	  neuronal	  pattern	  (Nguyen	  et	  
al.	  2000;	  Wilson	  &	  Maden	  2005).	  
	  
3.9 A	  late	  friendship	  –	  neurovascular	  development	  
	  
In	   contrast	   to	   other	   organs	   the	   central	   nervous	   system	   does	   not	   produce	   vascular	  
progenitors	  and	  therefore	  blood	  vessel	  ingression	  into	  the	  developing	  nervous	  system	  has	  to	  
occur	  continuously	   from	  adjacent	  tissues	  (Ruhrberg	  &	  Bautch	  2013).	  Vascularization	  of	  the	  
CNS	  is	  one	  of	  the	  most	  studied	  and	  therefore	  one	  of	  the	  best-­‐understood	  vascular	  processes.	  	  
	  
During	  development,	  angioblasts	  migrate	  to	  the	  CNS	  to	  form	  a	  PNVP	  (Bautch	  &	  James	  2009).	  
The	   brain	   and	   the	   spinal	   cord	   are	   vascularized	   from	   the	   surrounding	   PNVP	   by	   angiogenic	  
sprouting.	   Noteworthy,	   the	   delicate	   neuronal	   architecture	   is	   not	   perturbed	   upon	  
vascularization	  by	  penetrating	   angiogenic	   sprouts	   showing	   the	   remarkable	   communication	  
between	  ECs	  and	  their	  target	  tissue	  (Ruhrberg	  &	  Bautch	  2013;	  Tata	  et	  al.	  2015).	  	  
	  
In	  the	  mouse	  embryonic	  skin,	  nerves	  guide	  the	  patterning	  of	  vascular	  remodeling	  resulting	  in	  
neurovascular	   congruence	   (Mukouyama	   et	   al.	   2002).	   Mechanistically,	   VEGF	   provided	   by	  
nerves	   was	   shown	   to	   promote	   artery	   marker	   expression	   but	   to	   be	   not	   necessary	   for	  
alignment	   and	   arteriogenesis	   (Mukouyama	  et	   al.	   2005).	  Mutant	  mice	   lacking	   nerves	   show	  
defective	   patterning	   of	   vascular	   remodeling.	   However,	   the	   underlying	   mechanism	   is	   still	  
unknown	  (Mukouyama	  et	  al.	  2002;	  Mukouyama	  et	  al.	  2005).	  The	  most	  tempting	  assumption	  
is	   the	   secretion	   of	   guidance	   factors	   by	   nerves	   to	   direct	   vessel	   migration,	   however	   the	  
somewhat	   less	   spectacular	   guidance	   along	   morphological	   structures	   such	   as	   nerves	  
themselves	   should	  not	  be	  disregarded.	   In	  other	   cases,	  neurovascular	   congruence	  could	  be	  




Vice	  versa,	  blood	  vessels	  guiding	  motoneurons	  have	  also	  been	  reported	  (Kwon	  et	  al.	  2013).	  
The	  zebrafish	  DA	  was	  shown	  to	  guide	  motorneuron	  development	  and	  alignment	  with	  the	  DA	  
in	   a	   Vegfc-­‐Flt4	   dependent	   manner	   (Kwon	   et	   al.	   2013).	   Another	   example	   is	   the	   external	  
carotid	  artery,	  which	  acts	  as	  an	  intermediate	  target	  for	  sympathetic	  nerves	  to	  find	  their	  final	  
target,	  such	  as	  salivary	  glands.	  In	  this	  guidance	  process,	  Endothelin	  secreted	  by	  the	  carotid	  
artery	  guides	  the	  axons	  towards	  their	  final	  target,	  serving	  as	  a	  gateway	  (Makita	  et	  al.	  2008).	  	  
	  
In	  these	  examples	  nerves	  or	  vessels	  secrete	  factors	  to	  support	  growth	  and	  alignment	  of	  the	  
other.	  However,	   in	  many	   instances	  nerve	  and	  vessel	  development	  proceed	   independently.	  
For	  instance,	  dorsal	  root	  ganglia	  development	  in	  zebrafish	  as	  well	  as	  hindbrain	  development	  
proceed	  normally	   in	   the	  absence	  of	   vessels	   in	   cloche	  mutants	   (a	   vessel-­‐depleted	   zebrafish	  
mutant),	   suggesting	   that	  blood	  vessels	  are	  dispensable	   for	   some	  early	  CNS	  developmental	  
processes	  and	  necessary	  for	  others	  (Miller	  et	  al.	  2010;	  Ulrich	  et	  al.	  2011).	  Another	  tempting	  
explanation	  for	  close	  anatomical	  positioning	  of	  vessels	  and	  nerves	  is	  that	  nerves	  and	  vessels	  
share	  the	  same	  guidance	  cues	  and	  are	  thus	  guided	  to	  the	  same	  tracks	  (Carmeliet	  &	  Tessier-­‐
Lavigne	  2005).	  
	  
In	  summary,	  nerve	  and	  blood	  vessel	  alignment	  can	  be	  a	  phenomenon	  of	  mutual	  or	  common	  
guidance	   or	   proceed	   altogether	   independently.	   However,	   if	   and	   how	   modulation	   of	  
neurovascular	  guidance	  cues	  can	  be	  used	  as	  new	  therapeutic	   target	  remains	   to	  be	  shown.	  
Due	  to	  their	  dual	  functions	  in	  vessels	  and	  nerves	  it	  remains	  unclear	  whether	  they	  could	  be	  
used	  as	  therapeutic	  targets	  without	  affecting	  neuronal	  integrity	  (Piper	  et	  al.	  2002;	  Furne	  et	  
al.	  2008;	  Ben-­‐Zvi	  et	  al.	  2008).	  
	  
3.9.1 VEGF	  receptors	  	  
	  
3.10 The	  master	  regulators	  of	  angiogenesis	  –	  VEGF	  receptors	  
	  
The	   class	   of	   VEGF	   receptors	   (VEGFRs)	   belongs	   to	   the	   RTK	   superfamily	   consisting	   of	   three	  
VEGFRs.	   The	   VEGFR-­‐1	   (Flt1),	   VEGFR-­‐2	   (Kdr/Kdrl)	   and	   VEGFR3	   (Flt4)	   have	   been	   described	  
(Olsson	   et	   al.	   2006).	   VEGFRs	   are	   single	   pass	   transmembrane	   proteins	   with	   characteristic	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seven	  immunoglobulin	  (Ig)	  domains	  in	  the	  extracellular	  part	  together	  with	  a	  split-­‐kinase	  and	  
a	  C-­‐terminal	  domain	  in	  the	  intracellular	  part	  of	  the	  receptors	  (Herbert	  &	  Stainier	  2011).	  The	  
5th	  Ig	  domain	  of	  the	  VEGFR3	  is	  replaced	  with	  a	  disulfide	  bridge.	  Ig	  domains	  2	  and	  3	  bind	  to	  
the	  VEGF	  ligands	  whereas	  the	  function	  of	  the	  domains	  4	  to	  7	  is	  poorly	  understood	  (Brozzo	  et	  
al.	  2012).	  	  
	  
	  
Figure	  3-­‐6.	  VEGFRs	  and	  their	  ligands	  
Vascular	  endothelial	   growth	   factors	   (VEGFs)	  bind	  homo-­‐	  and	  heterodimers	  of	   three	  VEGF	   receptors.	  VEGFR1	  
(FLT1)	   has	   at	   least	   two	   isoforms	   (depending	   on	   the	   organism),	   a	   soluble	   (sVEGFR1/sFlt1)	   and	   a	   membrane	  
bound	   (VEGFR1/mFlt1)	   binding	   three	   ligands,	   PLGF,	   VEGFA	   and	   VEGFB.	   VEGFR2	   binds	   to	   VEGFA,	   processed	  
VEGFC	   and	   VEGFD.	   The	   lymphatic	   VEGFR3	   binds	   to	   VEGFC	   and	   VEGFD.	   Modified	   from	   (Herbert	   &	   Stainier	  
2011).	  
	  
Ligand-­‐induced	   VEGFR	   homo-­‐	   or	   heterodimerization	   leads	   to	   conformational	   changes	  
inducing	   receptor-­‐kinase	   activity	   and	   autophosphorylation	   of	   defined	   tyrosine	   residues	   of	  
the	  receptors	  (Olsson	  et	  al.	  2006).	  Interacting	  proteins	  are	  recruited	  to	  the	  phosphorylated	  
receptors	   activating	   downstream	   signaling	   (Olsson	   et	   al.	   2006;	   Herbert	   &	   Stainier	   2011).	  
VEGFR-­‐1	   (Flt1)	   is	   thought	   to	   act	   mainly	   as	   a	   VEGF-­‐A	   decoy	   receptor	   limiting	   VEGFR-­‐2	  
signaling	   and	   thus	   functions	   as	   a	   negative	   regulator	   of	   angiogenesis.	   VEGFR-­‐1	   binds	   to	   its	  
ligands	  VEGF-­‐A,	  PlGF	  and	  VEGF-­‐B.	  The	  VEGFR-­‐2	  is	  the	  key	  regulator	  in	  vascular	  biology	  and	  
regulates	   EC	   functions	   as	   diverse	   as	   EC	   survival,	   proliferation,	   vessel	   permeability,	  
vasculogenesis	   and	   angiogenesis.	   VEGFR-­‐2	   (Kdr/Kdrl)	   binds	   to	   VEGF-­‐A	   and	   the	   processed	  
forms	  of	  VEGF-­‐C	  and	  VEGF-­‐D	   (Joukov	  et	  al.	  1997;	  Leppänen	  et	  al.	  2013).	  The	   third	  VEGFR,	  
VEGFR-­‐3	  (Flt4)	  binds	  to	  VEGF-­‐C	  and	  VEGF-­‐D	  and	  regulates	  lymphangiogenesis	  and	  early	  vein	  
formation	  (Küchler	  et	  al.	  2006;	  Adams	  &	  Alitalo	  2007)	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3.10.1 	  Expression	  and	  Regulation	  of	  VEGFRs	  	  
	  
The	  VEGFRs	  were	  originally	  identified	  in	  the	  vascular	  domain	  (Fong	  et	  al.	  1995;	  Shalaby	  et	  al.	  
1995;	   Dumont	   et	   al.	   1998).	   Notably,	   recent	   findings	   showed	   that	   VEGFR-­‐1,	   VEGFR-­‐2	   and	  
VEGFR-­‐3	  are	  also	  expressed	   in	   some	  neuronal	  populations	   (Kwon	  et	  al.	  2013;	  Okabe	  et	  al.	  
2014;	  Selvaraj	  et	  al.	  2015).	  	  
	  
VEGFR-­‐2	   is	  expressed	  both	   in	  blood	  endothelial	   cells	  and	   in	   the	   lymphatic	   system	   in	  mice,	  
but	   is	   restricted	   to	   the	   blood	   endothelial	   cells	   in	   zebrafish	   (Adams	  &	  Alitalo	   2007).	   Flt1	   is	  
known	  as	  an	  arterial	  marker	  and	  is	  expressed	  at	  higher	  levels	  in	  arteries	  compared	  to	  veins	  
(Cui	   et	   al.	   2015;	   Krueger	   et	   al.	   2011;	   Hogan	   et	   al.	   2009).	   In	   zebrafish	   flt1	   is	   even	   barely	  
detectable	  in	  the	  venous	  domain	  (Hogan	  et	  al.	  2009;	  Bussmann	  et	  al.	  2010).	  VEGFR-­‐1	  is	  also	  
expressed	   in	  myeloid	   cells	   and	   trophoblasts	   of	   the	   placenta	   (Stefater	   et	   al.	   2011).	   During	  
early	   development,	   Vegfr-­‐3	   (Flt4)	   is	   expressed	   in	   arterial	   and	   venous	   ECs	   and	   may	   be	  
enriched	  in	  the	  tip	  cells	  of	  angiogenic	  sprouts	  (Siekmann	  &	  Lawson	  2007;	  Hogan	  et	  al.	  2009).	  
By	  26	  hpf,	   flt4	   expression	   is	   restricted	   to	   venous	  ECs	  and	   LECs	   (Bussmann	  et	   al.	   2007).	  At	  
later	  developmental	  stages	  and	  in	  adults,	  VEGFR-­‐3	  is	  restricted	  to	  the	  lymphatic	  system	  and	  
is	  mostly	  downregulated	   in	   venous	  endothelium	   (Adams	  &	  Alitalo	  2007).	   The	  only	  mature	  
blood	  vessels	  expressing	  flt4	  are	  fenestrated	  capillaries	  and	  angiogenic	  vessels	  (Saharinen	  et	  
al.	  2004).	  	  
	  
3.10.2 	  VEGFR-­‐1	  (FLT1,	  Flt1)	  function	  and	  signaling	  	  
	  
The	  VEGFR-­‐1	  (FLT1/Flt1)	  is	  a	  high	  affinity	  receptor	  for	  VEGF,	  PlGF	  and	  VEGF-­‐B	  (Autiero	  et	  al.	  
2003;	   Olsson	   et	   al.	   2006).	   As	   the	   VEGFR-­‐2	   is	   the	   focal	   point	   in	   EC	   biology,	   its	   signaling	  
capacity	  has	  to	  be	  tightly	  controlled.	  Flt1	  mainly	  acts	  as	  a	  decoy	  receptor	  scavenging	  VEGF-­‐A	  
and	   thereby	   limiting	   VEGFR-­‐2	   signaling	   (Fong	   et	   al.	   1995;	   Carmeliet	   2003;	   Krueger	   et	   al.	  
2011).	  
	  
3.10.2.1 Flt1	  is	  alternatively	  spliced	  
	  
The	  Flt1	  gene	  (mouse	  Flt1,	  human	  FLT1,	  zebrafish	  flt1)	  of	  all	  vertebrates	  so	  far	  investigated	  
Introduction 
35	  
codes	   for	   at	   least	   two	   alternative	   isoforms,	   a	   membrane-­‐bound	   receptor	   (mFlt1)	   and	   a	  
shorter	  secreted,	  soluble	  receptor	  (sFlt1)	  produced	  by	  alternative	  splicing	  (Sela	  et	  al.	  2008;	  
Krueger	  et	  al.	  2011).	   In	  humans,	  at	   least	  three	  soluble	   isoforms	  exist,	  which	  are	  formed	  by	  
alternative	  splicing	  or	  alternative	  3’UTR	  processing.	  In	  zebrafish,	  only	  one	  membrane-­‐bound	  
and	   one	   soluble	   isoform	  have	   been	   described,	  which	   are	   produced	   by	   alternative	   splicing	  
(Krueger	  et	  al.	  2011).	  The	  zebrafish	  sflt1	  is	  spliced	  further	  upstream	  compared	  to	  the	  human	  
sFlt1	  isoforms	  and	  contains	  only	  Ig1-­‐5	  (Krueger	  et	  al.	  2011).	  	  
Alternative	  splicing	  may	  be	  regulated	  by	  the	  protein	  hydroxylase	  Jumonji	  domain-­‐containing	  
protein	  6	  (jmjd6)	  (Boeckel	  et	  al.	  2011).	  Jmjd6	  is	  thought	  to	  hydroxylate	  U2AF65	  at	  normoxic	  
conditions,	   thereby	   shifting	   the	   alternative	   splicing	   equilibrium	   towards	   mFlt1.	   Under	  
hypoxic	  conditions	  this	  regulation	   is	   relieved	  and	  sFlt1	  production	   is	   favored	  (Webby	  et	  al.	  
2009;	  Boeckel	  et	  al.	  2011).	  This	  regulation	  is	  in	  contrast	  to	  the	  expectations	  since	  hypoxia	  is	  a	  
condition	  under	  which	  vessel	  recruitment	  is	  normally	  favored,	  thus	  the	  upregulation	  of	  the	  
highly	  anti-­‐angiogenic	  factor	  sFlt1	  is	  elusive.	  Accordingly,	  another	  research	  group	  identified	  
that	   in	   contrast	   to	   HUVECs	   that	  were	   used	   by	   Boeckel	   and	   colleagues,	  microvascular	   ECs	  
downregulate	  sFlt1	  under	  hypoxic	  conditions	  to	  induce	  vascularization	  (Ikeda	  et	  al.	  2011).	  In	  
conclusion,	  reports	  on	  the	  regulation	  of	  Flt1	  splicing	  and	  the	  correlation	  with	  hypoxia	  appear	  
inconsistent,	  but	  could	  be	   the	   result	  of	  differing	   regulatory	  mechanisms	  depending	  on	   the	  
subtype	   of	   endothelia.	   Moreover,	   Flt1	   splicing	   was	   only	   investigated	   in	   ECs,	   but	   may	   be	  
different	  in	  other	  cell	  types	  such	  as	  neurons.	  
3.10.2.2 Flt1	  protein	  structure	  
	  
Flt1	   is	  a	   receptor	   tyrosine	  kinase	  and	  shares	  structural	   similarities	  with	   the	   fms	   family	  and	  
was	   therefore	   originally	   described	   as	   fms-­‐like	   tyrosine	   kinase	   1	   (Shibuya	   et	   al.	   1990).	  
Structurally	  the	  VEGFR-­‐1	  is	  organized	  into	  seven	  extracellular	  immunoglobulin-­‐like	  domains	  
followed	   by	   a	   transmembrane	   domain.	   The	   intracellular	   part	   is	   composed	   of	   a	  
juxtamembrane	   domain,	   a	   split	   tyrosine-­‐kinase	   domain	   and	   a	   C-­‐terminal	   tail.	   The	   kinase	  
insert	   domain	   has	   ~70	   amino	   acids	  with	   unknown	   function	   (Olsson	   et	   al.	   2006),	   a	   typical	  
feature	   of	   the	   VEGFR	   class	   of	   receptors.	   Crystal	   structures	   and	   deletion	   analyses	   have	  
revealed	   that	   the	   Ig2	   domain	   is	   most	   relevant	   for	   VEGF	   binding	   (Wiesmann	   et	   al.	   1997;	  
Christinger	  et	  al.	  2004).	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3.10.2.3 Is	  Flt1	  a	  negative	  or	  a	  positive	  regulator	  of	  angiogenesis?	  
	  
Flt1	  has	  been	  conversely	  described	  as	  a	  positive	  and	  negative	  regulator	  of	  angiogenesis	  and	  
has	  been	  implicated	  in	  the	  regulation	  of	  monocyte	  and	  macrophage	  migration	  (Clauss	  et	  al.	  
1996;	   Tchaikovski	   et	   al.	   2008;	   Hiratsuka	   et	   al.	   1998;	   Chappell	   et	   al.	   2009).	   Flt1	   loss-­‐of-­‐
function	  scenarios	  can	  lead	  to	  vascular	  overgrowth	  with	  unproductive	  angiogenesis	  or	  vessel	  
fusion	  and	  thus	  decreased	  perfusion.	  These	  findings	  prompted	  some	  investigators	  to	  define	  
Flt1	  as	  a	  positive	  modulator	  of	  angiogenesis	  (Kearney	  et	  al.	  2004;	  Chappell	  et	  al.	  2016).	  Most	  
other	  studies	  classify	  Flt1	  as	  a	  negative	  regulator	  of	  angiogenesis	  which	  will	  be	  discussed	  in	  
the	  next	  chapters	  (Fong	  et	  al.	  1995;	  Chappell	  et	  al.	  2009).	  	  
	  
3.10.2.4 Flt1	  and	  its	  tyrosine	  kinase	  domain	  function	  in	  angioblast	  differentiation	  
	  
In	  monocytes	  and	  macrophages	  Flt1	  may	  act	  as	  a	  signaling	  receptor,	  activating	  downstream	  
signaling	  pathways	  such	  as	  MAPK	  and	  PI3K/Akt	  (Stefater	  et	  al.	  2011).	  Apart	  from	  this,	  Flt1	  is	  
thought	  to	  act	  mainly	  as	  a	  VEGF	  decoy	  receptor	  limiting	  VEGFR-­‐2	  signaling	  (Fong	  et	  al.	  1995;	  
Krueger	   et	   al.	   2011).	   In	   Flt1	   knock-­‐out	  mice	   (Flt1-­‐/-­‐)	   increased	  hemangioblast	   commitment	  
can	  be	  observed,	  which	  results	  in	  the	  formation	  of	  a	  disorganized	  vascular	  plexus	  and	  early	  
embryonic	   lethality	   (Fong	   et	   al.	   1995;	   Fong	   et	   al.	   1999).	   Interestingly,	   the	   intracellular	  
domain	   and	   thus	   Flt1	   signaling	   capacity	   seems	   to	   be	   dispensable	   and	   its	   depletion	   is	  
compatible	  with	  life	  (Hiratsuka	  et	  al.	  2001).	  Protein	  domain	  deletion	  experiments	  show	  that	  
mice	  lacking	  the	  entire	  Flt1	  intracellular	  domain	  are	  phenotypically	  normal	  (Hiratsuka	  et	  al.	  
2001).	  Only	  if	  the	  transmembrane	  domain	  is	  deleted,	  causing	  mFlt1	  conversion	  into	  a	  soluble	  
Flt1	  form,	  mice	  show	  decreased	  EC	  numbers	  and	  survival	  (Hiratsuka	  et	  al.	  2001;	  Hiratsuka	  et	  
al.	  2005).	  	  
In	   summary,	   Flt1	   tyrosine	   kinase	   activity	   seems	   to	   be	   dispensable	   but	   mFlt1	   membrane	  
fixation	   is	   important	   to	   ensure	   proper	   sFlt1	   levels.	   It	   is	   unknown	   whether	   the	   additional	  
decoy	  capacity	  of	  mFlt1	  is	  required	  for	  normal	  development,	  as	  mFlt1	  splicing	  deficient	  mice	  




3.10.2.5 Is	  FLT1	  function	  compatible	  with	  its	  prominent	  role	  in	  the	  tip	  cell	  concept?	  
	  
Conducting	  morula	  transplantation	  experiments,	  Fong	  and	  colleagues	  could	  show	  that	  FLT1	  
is	  necessary	  to	  restrict	  hemangioblast	  commitment,	  but	  is	  not	  required	  for	  vascular	  growth	  
in	  general	  (Fong	  et	  al.	  1999).	  Flt1-­‐depleted,	  transplanted	  endothelial	  cells	  were	  able	  to	  form	  
normal	  vascular	  networks,	  suggesting	  that	  after	  the	  completion	  of	  vasculogenesis	  FLT1	  may	  
have	  only	  minor	  functions	  in	  vascular	  growth	  in	  mice	  (Fong	  et	  al.	  1996).	  However,	  from	  this	  
experiment	   it	   cannot	   be	   concluded	   to	   what	   extent	   non-­‐vascular	   FLT1	   regulates	   murine	  
angiogenesis.	  Moreover,	   inducible	  FLT1	  depletion	  experiments	   in	   the	  mouse	   retinal	  plexus	  
or	   ubiquitously	   in	   postnatal	   mice	   induce	   only	   mild	   phenotypes	   with	   increased	   filopodial	  
numbers,	   suggesting	  a	  minor	   role	   for	   FLT1	   in	  angiogenesis	   (Chappell	   et	   al.	   2009;	  Ho	  et	   al.	  
2012).	   Chappell	   and	   Ho	   are	   claiming	   an	   important	   function	   of	   FLT1	   in	   retinal	   sprouting	  
angiogenesis	   as	  well	   as	   in	  other	   vascular	  beds,	   however	   the	  observed	  effects	   appear	  mild	  
compared	   to	   the	   extremely	   potent	   function	   of	   the	   FLT1	   protein	   (Yamaguchi	   et	   al.	   2002).	  
Additionally,	  the	  differences	  in	  tip	  cell	  numbers	  reported	  by	  Ho	  and	  coworkers	  in	  postnatal	  
mice	   with	   inducibly	   depleted	   Flt1	   are	   very	   subtle.	   It	   is	   remarkable	   that	   up	   to	   now	   the	  
inducible	  Flt1flox/flox	  mouse	  used	  by	  Chappell	  and	  Ho	  has	  not	  been	  published	  in	  combination	  
with	   a	   vascular	   Cre	   driver	   line.	   One	   could	   speculate	   that	   postnatal	   vascular	   Flt1	   loss-­‐of-­‐
function	   phenotypes	   observed	   after	   angioblast	   differentiation	   and	   plexus	   formation	   are	  
even	   milder	   than	   ubiquitous	   Flt1	   depletion,	   questioning	   its	   important	   role	   in	   angiogenic	  
processes	   such	   as	   tip	   cell	   formation.	   Another	   possibility	   is	   that	   embryonically	   produced	  
vascular	   Flt1	   is	   sufficient	   to	   prevent	   hypersprouting	   in	   postnatal	   Flt1-­‐depleted	   mice.	  
Therefore,	   in	   order	   to	   understand	   the	   diverse	   functions	   of	   FLT1	   it	   is	   important	   to	   study	  
neuronal	   or	   vascular	   tissue-­‐specific	   Flt1	   loss-­‐of-­‐function	   models	   after	   angioblast	  
differentiation.	  
Contradictory	   to	   these	   findings,	   which	   imply	   a	   collateral	   role	   of	   vascular	   FLT1	   in	  
angiogenesis,	   FLT1	   is	   widely	   seen	   as	   an	   important	   component	   of	   the	   “tip	   cell	   concept”	  
(Herbert	   &	   Stainier	   2011;	   Siekmann	   et	   al.	   2013).	   In	   this	   model	   DLL4-­‐NOTCH	   signaling	   is	  
considered	   to	   upregulate	   Flt1	   in	   stalk	   cells	   limiting	   VEGFR-­‐2	   signaling	   in	   the	  
microenvironment	  of	  the	  stalk	  cells	  and	  thus	  preventing	  tip	  cell	  formation	  (Funahashi	  et	  al.	  
2010;	  Herbert	  &	  Stainier	  2011).	  In	  addition,	  Chappell	  and	  coworkers	  hypothesized	  that	  FLT1	  
is	   necessary	   to	   prevent	   “backsprouting”	   of	   a	   newly	   forming	   vascular	   sprout	   and	   its	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reconnection	   with	   the	   parent	   vessel	   (Chappell	   et	   al.	   2009).	   In	   this	   model,	   sFLT1	   was	  
suggested	  to	  form	  a	  corridor	  guiding	  the	  nascent	  spout	  away	  from	  its	  origin	  (Chappell	  et	  al.	  
2009).	  Similarly,	  a	  recent	  publication	  conducted	  in	  zebrafish,	  suggests	  that	  sFlt1	  acts	  in	  a	  cell-­‐
autonomous	  manner	  downstream	  of	  Sema3a-­‐PlxnD1	  signaling	  guiding	  the	  sprout	  away	  from	  
sema3a	  expressing	  cells,	  such	  as	  zebrafish	  somites	  (Zygmunt	  et	  al.	  2011).	  	  
Noteworthy,	  both	  concepts	   imply	  a	  cell-­‐autonomous	  FLT1	  function	  and	  are	  not	  compatible	  
with	  the	  transplantation	  experiments	  performed	  by	  Fong	  and	  colleagues	  (Fong	  et	  al.	  1996;	  
Fong	   et	   al.	   1999).	   In	   addition,	   the	   effects	   observed	   in	   Flt1	   inducible	   knockout	   scenarios	  
appear	  extremely	  mild	  if	  compared	  with	  Dll4	  loss-­‐of-­‐function	  scenarios	  which	  are	  supposed	  
to	  be	  upstream	  of	  Flt1,	  with	  FLT1	  being	  one	  important	  effector	  of	  the	  DLL4/NOTCH	  pathway	  
to	   prevent	   tip	   cell	   formation	   (Suchting	   et	   al.	   2007;	  Hellström	   et	   al.	   2007).	   Therefore,	   it	   is	  
important	  to	  carefully	  analyze	  data	  and	  put	  the	  effects	  into	  relation	  to	  previous	  publications.	  
This	  is	  extremely	  important	  since	  many	  authors	  claim	  small	  but	  statistically	  consistent	  results	  
to	  be	  physiologically	  relevant	  but	  may	  be	  frequently	  misguided	  by	  the	  wish	  to	  publish	  their	  
results.	   In	   doing	   so	   it	   may	   be	   easier	   to	   substantiate	   the	   current	   opinion	   than	   publishing	  
against	  it.	  	  
	  
3.10.2.6 Non-­‐vascular	  flt1	  –	  the	  overseen	  regulator?	  
	  
Flt1	   is	   mainly	   expressed	   in	   arterial	   endothelial	   cells,	   but	   it	   is	   also	   found	   in	   trophoblasts,	  
myeloid	   cells,	   monocytes	   and	   hematopoietic	   stem	   cells	   and	   certain	   neuronal	   populations	  
(Sawano	   et	   al.	   2001;	   Stefater	   et	   al.	   2011;	   Selvaraj	   et	   al.	   2015).	   sFLT1	   secreted	   by	  
trophoblasts	   is	   known	   for	   its	   prominent	   role	   in	   pre-­‐eclampsia,	   a	   disease	   associated	   with	  
pregnancy,	  which	  manifests	   in	  widespread	  endothelial	   dysfunction	   (Hirashima	  et	   al.	   2003;	  
Sawano	   et	   al.	   2001;	   Stefater	   et	   al.	   2011).	   More	   recently,	   expression	   of	   Flt1	   has	   been	  
detected	  in	  various	  neuronal	  cell	  populations,	  such	  as	  motor	  neurons,	  sensory	  neurons	  and	  
dorsal	   root	   ganglia	   (Poesen	   et	   al.	   2008;	   Storkebaum	   et	   al.	   2005;	   Selvaraj	   et	   al.	   2015).	   In	  
neuronal	   cells,	   Flt1	   was	   found	   to	   have	   neuronal	   cell	   autonomous	   functions	   including	  
induction	  of	  cancer	  pain	  in	  sensory	  neurons	  or	  neurodegenerative	  functions	  in	  motoneurons	  
(Storkebaum	  et	  al.	  2005;	  Selvaraj	  et	  al.	  2015).	  Robciuc	  and	  colleagues	  recently	  showed	  that	  
VEGF-­‐B	   gain-­‐of-­‐function	   or	   Flt1	   knockdown	   prevents	   VEGFR-­‐1/VEGFR-­‐2	   heterodimer	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formation	   and	   thus	   favored	   VEGFR-­‐2	   homodimer	   formation,	   which	   have	   higher	   signaling	  
capacity	  (Robciuc	  et	  al.	  2016).	  This	  study	  shows	  that	  FLT1	  cannot	  exclusively	  act	  as	  a	  decoy	  
receptor	   but	   can	   also	   negatively	   modulate	   angiogenesis	   by	   heterodimer	   formation	   with	  
VEGFR-­‐2,	  which	  reduces	  angiogenic	  potential	  (Robciuc	  et	  al.	  2016).	  Since	  mice	  with	  deleted	  
Flt1	   intracellular	   domain	   are	   phenotypically	   normal,	   this	   result	   suggests	   that	   the	  
transmembrane,	  and	  the	  extracellular	  domain	  of	  FLT1	  are	  sufficient	  for	  VEGFR-­‐2	  interaction.	  
In	  conclusion,	  loss	  of	  Flt1	  has	  tremendous	  effects	  on	  early	  vasculogenesis	  but	  its	  function	  in	  
angiogenesis	   is	   less	  well	  understood.	  Remarkably,	  FLT1	   is	  seen	  as	  a	  prominent	  regulator	   in	  
sprouting	   models,	   disagreeing	   with	   its	   known	   in	   vivo	   functions.	   Recently,	   FLT1	   has	   been	  
shown	   to	  have	   cell-­‐autonomous	   functions	   in	  neuronal	   cells,	  monocytes	   and	  macrophages.	  
Whether	  non-­‐vascular	  FLT1	  can	  also	  act	  non-­‐cell	  autonomously	  and	  affect	  vascular	  growth	  is	  
currently	  unknown.	  
	  
3.10.3 	  Clinical	  implications	  of	  angiogenesis	  and	  Flt1	  
	  
VEGF	   levels	   are	   critical	   for	   various	   physiological	   processes,	   including	   vasculogenesis,	  
angiogenesis,	  EC	  barrier	  formation,	  survival	  as	  well	  as	  glomeruli	  filter	  function	  (Senger	  et	  al.	  
1993;	   Carmeliet	   2003;	   Lee	   et	   al.	   2007).	   Increased	   vascular	   growth	   is	   involved	   in	  
tumorigenesis	   and	   ocular	   disease	   and	   can	   be	   regulated	   by	   FLT1	   (Carmeliet	   2003;	   Lange,	  
Storkebaum,	   et	   al.	   2016).	  Moreover,	   FLT1	   is	   expressed	   in	   various	   tumors,	   such	   as	   breast,	  
prostate	   and	   colon	   cancer,	   pulmonary	   adenocarcinoma,	   hepatocellular	   carcinoma,	  
glioblastoma	   and	   lung	   cancer,	   albeit	   with	   unknown	   function	   (Yao	   et	   al.	   2011).	   In	   healthy	  
conditions,	   sFLT1	   expression	   in	   the	   cornea	   of	   the	   eye	  maintains	   it	   avascular	   to	   safeguard	  
optimal	  vision.	  Without	  sFlt1	  expression,	  VEGF	  expressed	  in	  the	  cornea	  recruits	  vessels	  from	  
the	  directly	  adjacent	  vascularized	  tissues,	  which	  impairs	  vision	  (Ambati	  et	  al.	  2006).	  	  
	  
Flt1	  was	  recently	  implicated	  in	  the	  phenomenon	  of	  cancer	  pain	  (Selvaraj	  et	  al.	  2015).	  Here,	  
Flt1	  expressed	  by	  sensory	  neurons	  can	  be	  activated	  by	  its	  ligands	  VEGF-­‐A,	  PlGF	  and	  VEGF-­‐B,	  
which	   are	   released	   by	   tumors.	   As	   a	   result,	   Flt1	   signaling	   in	   sensory	   neurons	   alters	   them	  
structurally	   and	   functionally.	  Mechanistically,	   activation	   of	   Flt1	   downstream	   kinases	   PLCy,	  
PI3K	   and	   Src	   kinase	   sensitizes	   sensory	   transducers	   such	   as	   TRPV1	   and	   thereby	   produces	  




Pre-­‐eclampsia,	   a	   disorder	   of	   pregnancy	   is	   characterized	   by	   hypertension	   and	   proteinuria	  
(Young	  et	  al.	  2010).	  This	  disease	   is	  caused	  by	  endothelial	  dysfunction,	  which	   is	   induced	  by	  
elevated	  circulating	  sFLT1	  levels	  and	  other	  factors	  such	  as	  PLGF	  and	  soluble	  Endoglin	  (Young	  
et	  al.	  2010;	  Agarwal	  &	  Karumanchi	  2011).	   It	   is	  speculated	  that	  pre-­‐eclampsia	   is	   induced	  by	  
abnormal	   placentation	   leading	   to	   hypoxia	   and	   sFLT1	   release	   into	   the	   circulation	   by	  
trophoblasts	  of	  the	  placenta.	  On	  the	  molecular	  level,	  sFLT1	  could	  be	  shown	  to	  impair	  eNOS	  
phosphorylation	   and	   thus	   nitric	   oxide	   (NO)	   production	   in	   ECs,	   thereby	   preventing	  
vasodilation	   and	   blood	   pressure	   reduction	   (Burke	   et	   al.	   2016).	   Proteinuria	   is	   most	   likely	  
caused	  by	  a	  decreased	  bioavailability	  of	  VEGF	   in	  podocytes	  of	  the	  kidney	  glomeruli	  caused	  
by	   elevated	   circulating	   sFLT1	   levels	   evoking	   podocyte	   and	   fenestrated-­‐EC	   dysfunction	  
(Eremina	  et	  al.	  2003).	  	  
	  
3.10.4 	  VEGFR-­‐2	  (Kdr/Kdrl)	  –	  the	  focal	  point	  of	  vascular	  biology	  
	  
The	  VEGFR-­‐2	  is	  implicated	  in	  all	  facets	  of	  endothelial	  cell	  biology	  and	  has	  a	  critical	  role	  during	  
development	  (Shalaby	  et	  al.	  1995;	  Carmeliet	  2003;	  Olsson	  et	  al.	  2006).	  The	  prominent	  role	  of	  
VEGFR-­‐2	   has	   been	   highlighted	   in	   Vegfr-­‐2	   KO	  mice,	  which	   do	   not	   show	   any	   signs	   of	   blood	  
islands	  or	  blood	  vessel	  formation	  (Shalaby	  et	  al.	  1995).	  In	  addition,	  haploinsufficiency	  of	  the	  
VEGFR-­‐2	   ligand	   VEGF	   and	   the	   absence	   of	   blood	   vessels	   in	   these	   mice	   substantiates	   the	  
crucial	  role	  of	  VEGFR-­‐2	  during	  development	  (Ferrara	  et	  al.	  1996;	  Carmeliet	  et	  al.	  1996).	  	  
	  
In	  the	  zebrafish	  two	  VEGFR-­‐2	  homologs	  exist,	  Kdr	  (Kdrb)	  and	  Kdrl	  (Kdra).	  Kdr	  is	  orthologous	  
to	   mammalian	   KDR,	   whereas	   kdrl	   is	   a	   fourth	   VEGFR,	   which	   was	   secondarily	   lost	   in	   the	  
eutherian	  lineage	  (Bussmann	  et	  al.	  2008).	  In	  zebrafish	  Kdrl,	  although	  not	  orthologous	  to	  the	  
mammalian	   KDR,	   is	   the	   major	   Vegf	   receptor	   as	   substantiated	   by	   loss-­‐of-­‐function	  
experiments.	  On	   the	   other	   hand,	   Kdr	   is	   dispensable	   for	   normal	   vascular	   development	   but	  
retained	  some	  residual	  function	  in	  genetically	  sensitized	  backgrounds	  (Bussmann	  et	  al.	  2008;	  
L.	  D.	  Covassin	  et	  al.	  2006;	  Covassin	  et	  al.	  2009).	  	  
Ephrin-­‐B2	  mediated	   VEGFR-­‐2	   internalization	   was	   shown	   to	   be	   important	   for	   full	   VEGFR-­‐2	  
signaling	  capacity	  (Wang	  et	  al.	  2010;	  Sawamiphak	  et	  al.	  2010).	  However,	  whether	  all	  VEGFR-­‐
2	   signaling	   modes	   are	   affected	   by	   VEGFR-­‐2	   internalization	   and	   whether	   VEGFR-­‐2	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internalization	   is	   needed	   for	   signal	   integration	   with	   other	   parallel	   signaling	   pathways,	  
remains	  to	  be	  determined.	  	  
	  
Complex	  signaling	  cascades	  activated	  by	  VEGFR-­‐2	  and	  modulated	  at	  various	  levels	  facilitate	  
the	  tight	  coordination	  of	  a	  vast	  diversity	  of	  cellular	  responses	  activated	  by	  VEGFR-­‐2	  signaling.	  	  
	  
3.10.4.1 VEGFR-­‐2	  mediated	  EC-­‐migration	  
	  
Migration	   of	   ECs	   is	   a	   complex	   process,	   since	   ECs	   are	   organized	   in	   tight	   association	   and	  
covered	  with	  a	  basement	  membrane	  (Adams	  &	  Alitalo	  2007;	  Herbert	  &	  Stainier	  2011).	  Thus,	  
ECs	   have	   to	   dissociate	   from	   the	   EC	  monolayer	   and	   to	   degrade	   the	   basement	  membrane,	  
without	   compromising	   the	   integrity	   of	   the	   vessel.	   VEGF-­‐VEGFR-­‐2	   activation	   leads	   to	  
autophosphorylation	   of	   several	   VEGFR-­‐2	   tyrosine	   residues	   involved	   in	   the	   regulation	   of	  
migration	   (Olsson	   et	   al.	   2006).	   VEGF	   induced	   phosphorylation	   of	   Y951,	   Y1175	   and	   Y1214	  
activates	  downstream	  signaling	  resulting	  in	  actin	  polymerization	  at	  the	  leading	  tip	  and	  focal	  
adhesion	  turnover	  (Koch	  &	  Claesson-­‐Welsh	  2012).	  	  
	  
In	   order	   for	   sprout	   induction	   to	   be	   initiated,	   the	   basement	   membrane	   surrounding	   the	  
vessel	  has	  to	  be	  degraded	  (Adams	  &	  Alitalo	  2007).	  Subsequently,	  actin	  is	  polymerized	  at	  the	  
leading	   edge	   to	   push	   the	   tip	   forward,	   thereby	   forming	   a	   protrusion.	   PI3K	   activation	   and	  
production	  of	  phosphatidylinositol	  (3,4,5)-­‐trisphosphate	  (PIP3)	  at	  the	  leading	  edge	  of	  the	  cell	  
leads	   to	   Rho	   activation	   and	   actin	   polymerization	   (Holmqvist	   et	   al.	   2003).	   Low	   levels	   of	  
phosphatase	  and	  tensin	  homolog	  (PTEN)	  at	  the	  cellular	  front	  and	  high	   levels	  at	  the	  rear	  of	  
the	  cell	  are	  considered	   to	  substantiate	   the	  concentrated	  actin	  polymerization	  at	   the	   tip	  of	  
the	   cell	   (Iijima	   et	   al.	   2002).	   In	   zebrafish	   ptena−/−;ptenb−/−	   double	   mutants	   show	   a	   strong	  
vascular	   phenotype	   with	   hypersprouting	   occurring	   at	   the	   level	   of	   the	   spinal	   cord,	  
emphasizing	   the	   importance	  of	  PI3K	   signaling	   for	  EC	   function	   (Choorapoikayil	   et	   al.	   2013).	  
Notably,	   polarization	   in	   the	   ptena−/−;ptenb−/−	   depleted	   migrating	   ECs	   is	   not	   affected	  
suggesting	   that	   at	   least	   in	   zebrafish,	   Pten	   function	   is	   not	   necessary	   for	   proper	   migration	  
(Choorapoikayil	   et	   al.	   2013).	  Moreover,	   the	  hypersprouting	  phenotype	   in	  ptena−/−;ptenb−/−	  




As	  a	  consequence	  of	  PIP3	  accumulation	  at	  the	  leading	  edge,	  small	  GTPases	  of	  the	  Rho	  family	  
become	  activated	  and	  induce	  actin	  polymerization.	  The	  small	  GTPase	  CDC42	  is	  an	  important	  
regulator	  of	  polarization	  regulating	  lamellipodia	  formation	  as	  well	  as	  Golgi	  and	  microtubule	  
organizing	  center	  (MTOC)	  positioning	  in	  front	  of	  the	  nucleus	  (Gundersen	  &	  Worman	  2013).	  
Thus,	   all	   organelles	   are	   oriented	   towards	   the	   side	   of	   migration.	   Although	   it	   is	   clear	   that	  
nuclear	   positioning	   is	   important	   for	   cell	   migration,	   its	   function	   is	   poorly	   understood	  
(Gundersen	   &	   Worman	   2013).	   As	   many	   proteins	   and	   membrane	   lipids	   have	   to	   be	  
transported	  to	  the	  leading	  migrational	  edge	  it	  seems	  reasonable	  to	  orient	  the	  entire	  cellular	  
machinery	   such	   as	   nucleus,	   ER	   and	  Golgi	   in	   the	   direction	   of	  migration	   to	   enable	   fast	   and	  
efficient	   migrational	   behavior.	   However,	   how	   this	   is	   achieved	   mechanistically	   remains	  
elusive.	  	  
	  
Besides	   EC-­‐migration,	   VEGF	   also	   regulates	   EC-­‐proliferation,	   survival	   and	   vascular	  
permeability.	   How	   one	   receptor	   can	   regulate	   such	   a	   remarkable	   diversity	   of	   functions	   is	  
poorly	   understood.	   Mice	   specifically	   lacking	   vascular	   VEGF	   expression	   show	   endothelial	  
degeneration	   and	   sudden	   death.	   Since	   paracrine	   VEGF	   cannot	   compensate	   for	   autocrine	  
VEGF,	  endothelial	  VEGF	  is	  thought	  to	  be	  necessary	  for	  EC	  survival	  (Lee	  et	  al.	  2007).	  	  
	  
In	   order	   to	   make	   a	   sprout	   the	   entire	   repertoire	   of	   VEGF-­‐induced	   functions	   have	   to	   be	  
activated	   in	   a	   coordinated	   manner.	   ECs	   have	   to	   migrate,	   proliferate	   and	   increase	   their	  
permeability	  to	  dissociate	  from	  the	  tight	  endothelial	  cell	  sheet.	  Thus,	  it	  appears	  reasonable	  
that	  one	  factor,	  namely	  VEGF	  can	  activate	  such	  a	  wealth	  of	  cellular	  functions.	  However,	  how	  
such	   a	   factor	   can	   activate	   the	   spatially	   and	   timely	   coordinated	   activation	   of	   all	   these	  
processes	  resulting	  in	  sprout	  formation	  and	  eventually	  perfusion	  is	  an	  impressive	  miracle	  of	  
nature.	  	  
	  
3.10.5 	  VEGFR-­‐3	  (FLT4,Flt4)	  function	  in	  vascular	  biology	  
	  
VEGFR-­‐3	  (FLT4,	  Flt4)	  is	  indispensible	  for	  venous	  angiogenesis	  and	  lymphangiogenesis	  during	  
early	   development,	   and	   blockade	   of	   FLT4	   or	   its	   ligand	  VEGF-­‐C	   inhibits	   vein	   and	   lymphatic	  
vessel	  formation	  (Dumont	  et	  al.	  1998;	  Küchler	  et	  al.	  2006;	  Hogan	  et	  al.	  2009).	  Adults	  express	  
Flt4	  in	  angiogenic	  blood	  vessels,	  in	  some	  fenestrated	  endothelia	  and	  in	  the	  lymphatic	  system	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where	   it	   is	   required	   for	   lymphangiogenesis	   and	   lymphatic	   maintenance.	   (Zarkada	   et	   al.	  
2015).	   Similar	   to	   VEGFR-­‐2,	   FLT4	   receptor	   internalization	   and	   signaling	   is	   regulated	   by	  
EphrinB2,	   DAB2	   and	   PAR-­‐3	   (Nakayama	   et	   al.	   2013;	   Wang	   et	   al.	   2010).	   Interestingly,	   in	  
zebrafish	  efnb2	  and	  dab2	  are	  almost	  exclusively	  expressed	  in	  arteries	  and	  veins,	  respectively.	  
Thus,	  the	  regulation	  of	  Flt4	   internalization	   in	  zebrafish	  does	  possibly	  not	  require	  Ephrin-­‐B2	  
(L.	  Covassin	  et	  al.	  2006;	  Wang	  et	  al.	  1998).	  	  
	  
Flt4	  is	  expressed	  in	  arteries	  and	  veins	  during	  early	  development.	  It	  has	  been	  speculated	  that	  
Vegfc	   responsiveness	   of	   arteries	   is	   inhibited	   by	   Dll4	   (Hogan	   et	   al.	   2009).	   Hogan	   and	  
colleagues	   reported	   that	   depletion	   of	   Flt4	   rescues	   the	   hypersprouting	   phenotype	   in	   dll4	  
morphants	   and	   concluded	   that	   Dll4	   represses	   Flt4	   function	   in	   aISVs	   (Hogan	   et	   al.	   2009).	  
However,	   this	   interpretation	  does	  not	   take	   into	   account	   that	   in	  dll4	  morphants,	   aISVs	   are	  
almost	  completely	  absent	  and	  thus	  the	  hypersprouting	  observed	   in	   these	  morphants	  most	  
likely	   occurs	   from	   the	   venous	   domain.	   Furthermore,	   flt4	   depletion	   does	   not	   only	   prevent	  
signaling	   in	   ISVs	  but	  also	  prevents	  vISV	  formation,	  which	  could	   influence	  the	  results	  of	  this	  
experiment.	  
	  
Benedito	   and	   colleagues	   showed	   that	   VEGFR-­‐2	   function	   in	   postnatal	   angiogenesis	   can	   be	  
completely	  sustained	  by	  FLT4	  and	  that	  FLT4	  not	  VEGFR-­‐2	  is	  upregulated	  by	  NOTCH	  signaling,	  
which	  is	  contradictory	  to	  the	  tip	  cell	  concept	  (Benedito	  et	  al.	  2012).	  In	  contrast,	  Zarkada	  et	  
al.	   recently	   published	   that	   VEGFR-­‐2	   has	   non-­‐redundant	   functions,	   which	   could	   not	   be	  
compensated	  by	  FLT4	  in	  postnatal	  retinal	  angiogenesis	  (Zarkada	  et	  al.	  2015).	  	  
	  
Remarkably,	   primary	   sprouting	   in	   zebrafish	   is	   sustained	   in	   flt4hu4602	   mutants,	   whereas	  
secondary	  sprouting	  and	  venous	  remodeling	  is	  blocked.	  These	  findings	  substantiate	  that	  Flt4	  
is	   not	   generally	   required	   for	   sprout	   formation	   but	  most	   likely	   of	   particular	   importance	   in	  
venous	  angiogenesis.	  	  
	  
3.10.6 	  VEGF	  ligands	  
	  
In	  mammals,	  the	  VEGF	  family	  consists	  of	  five	  VEGF	  ligands:	  VEGF-­‐A,	  VEGF-­‐B,	  VEGF-­‐C,	  VEGF-­‐D	  
and	   the	  placental	   growth	   factor	  PlGF.	   In	   snake	  venoms	  and	   in	  parapoxviruses,	   structurally	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related	  proteins	  named	  VEGF-­‐E	  and	  VEGF-­‐F	  have	  been	  identified	  (Olsson	  et	  al.	  2006;	  Suto	  et	  
al.	  2005;	  Takahashi	  &	  Shibuya	  2005).	  In	  zebrafish	  more	  vegf	  isoforms	  exist	  due	  to	  the	  teleost	  
genome	  duplication,	  namely	  vegfaa,	  vegfab,	  vegfba,	  vegfbb,	  vegfc,	  vegfd	  and	  plgf	  (Liang	  et	  
al.	   2001;	   Glasauer	   &	   Neuhauss	   2014;	   Jensen	   et	   al.	   2015).	   VEGFs	   are	   secreted,	   disulfide-­‐
linked,	   homodimeric	   glycoproteins	   of	   approximately	   40	   kDa	   and	   dimerization	   occurs	   in	   a	  
head-­‐to-­‐tail	  fashion	  (Muller	  et	  al.	  1997;	  Shibuya	  2001).	  	  
	  
3.10.6.1 	  VEGF	  function	  and	  gradient	  formation	  
	  
Alternative	   splicing	   generates	   multiple	   isoforms	   of	   VEGF-­‐A,	   with	   decreasing	   diffusibility.	  
VEGFA189	   (VEGFA188	   in	  mice)	   contains	   two	   heparin-­‐binding	   domains,	   VEGFA165	   (VEGFA	  
164	   in	   mice)	   only	   one	   and	   VEGFA121	   (VEGFA164	   in	   mice)	   lacks	   both	   heparin-­‐binding	  
domains	   (Ruhrberg	   et	   al.	   2002).	   VEGFs	   and	   other	   growth	   factors	   are	   thought	   to	   bind	  
heparane	  sulfate	  proteoglycans	  (HSPGs)	  in	  the	  ECM	  and	  thereby	  forming	  a	  gradient	  (Cohen	  
et	  al.	  1995;	  Ruhrberg	  et	  al.	  2002;	  Zhao	  et	  al.	  2012).	  This	  gradient	  is	  thought	  to	  be	  formed	  by	  
secretion	  and	  extracellular	  degradation	  but	  to	  be	  also	  dependent	  on	  the	  differing	  diffusibility	  
of	  the	  various	  VEGF	  isoforms	  (Ruhrberg	  et	  al.	  2002;	  Ruiz	  de	  Almodovar	  et	  al.	  2009).	  VEGF189	  
generates	   very	   steep	   and	   short	   gradients,	   whereas	   VEGFA165	   forms	   intermediate	   and	  
VEGFA121	   long	   shallow	   gradients.	   However,	   under	   which	   conditions	   these	   different	  
gradients	  are	  needed	  is	  still	  discussed.	  Interestingly,	  VEGF164/164	  knock-­‐in	  mice	  expressing	  
only	   the	   intermediate	   form	   and	   VEGF120/188	   expressing	   the	   short	   and	   the	   long	   distance	  
isoform	   show	   no	   phenotype	   (Ruhrberg	   et	   al.	   2002).	   Thus,	   there	   seems	   to	   be	   no	   strict	  
necessity	  for	  neither	  of	  the	  VEGF	  isoforms	  (Ruhrberg	  et	  al.	  2002).	  	  
	  
ECM-­‐bound	   VEGF	   can	   be	   released	   by	   matrix	   metalloproteinases	   (MMPs),	   which	   can	  
potentially	   alter	   the	  gradient.	   In	  addition,	   it	  has	  been	  put	   forward	   that	   cleaved	  VEGF	  may	  
have	   different	   VEGFR-­‐2-­‐signaling	   outcomes	   (Lee	   et	   al.	   2005).	   VEGF	   gradients	   are	   believed	  
not	   only	   to	   activate	   angiogenic	   processes	   but	   also	   to	   guide	   them	   (Gerhardt	   et	   al.	   2003).	  
However,	  the	  mechanism	  of	  guidance	  and	  which	  VEGF	  isoforms	  are	  involved	  remains	  elusive	  
(Ruhrberg	  et	  al.	  2002).	  Recent	  evidence	  suggests	  that	  not	  only	  VEGF	  gradients	  but	  also	  other	  
signaling	  pathways	  such	  as	  NETRIN-­‐UNC,	  SLIT-­‐ROBO	  and	  SEMA3-­‐NRP1/PLXND1	  are	  involved	  
in	   sprout	   guidance,	   analogous	   to	   the	   growth	   cone	   in	   migrating	   axons	   (Carmeliet	   2005;	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Adams	  &	   Eichmann	   2010).	   Interestingly,	   in	   contrast	   to	   all	   other	   VEGF	   isoforms,	   the	   splice	  
isoform	  VEGF165b	  has	  been	  proposed	  to	  negatively	  regulate	  VEGFR	  function	  (Woolard	  et	  al.	  
2004).	  
	  
3.10.7 	  Expression	  and	  regulation	  of	  VEGFs	  	  
	  
During	  early	  development,	  vegfaa	  is	  expressed	  in	  the	  somites	  of	  developing	  zebrafish	  and	  in	  
a	  bilateral	   fashion	   in	   the	  hindbrain	  at	   the	  origin	  of	   central	  arteries	   (Bussmann	  et	  al.	  2011;	  
Stahlhut	  et	  al.	  2012).	  Vegfab	   is	  expressed	  in	  the	  axial	  vessels	  of	  zebrafish	  larvae	  and	  in	  the	  
midline	  of	  the	  developing	  hindbrain	  driving	  hindbrain	  vascularization	  (Bussmann	  et	  al.	  2011).	  
Vegfaa	   and	   Vegfab	   activate	   ISV	   formation,	   since	   vegfaa	   loss-­‐of-­‐function	   completely	  
abolishes	   ISV	   formation	   (L.	   D.	   Covassin	   et	   al.	   2006).	   Strikingly,	   vegfaa	   gain-­‐of-­‐function	   in	  
miRNA-­‐1	   and	  miRNA-­‐6	  morphants	   does	   not	   change	   ISV	   patterning	   (Stahlhut	   et	   al.	   2012),	  
thus	  primary	  sprouting	  appears	  to	  be	  rather	  resilient	  to	  changes	  in	  vegfaa	  expression.	  	  
	  
In	  the	  early	  zebrafish	  embryo,	  vegfc	   is	  expressed	  in	  the	  hypochord	  and	  becomes	  restricted	  
to	  the	  DA	  and	  ISVs	  at	  ~24	  hpf	  (L.	  D.	  Covassin	  et	  al.	  2006;	  Gore	  et	  al.	  2011).	  Vegfc	  activates	  
secondary	   sprouting	   in	   the	   venous	   ECs	   of	   the	   PCV	   which	   are	   needed	   for	   venous	   ISV	  
remodeling	   (Isogai	  et	  al.	  2003).	  The	  expression	  patterns	  of	  vegfb,	  vegfd	  and	  plgf	  and	   their	  
function	  in	  zebrafish	  are	  poorly	  understood.	  Mutants	  such	  as	  vhlhu2117	  and	  ptena−/−;ptenb−/−	  
were	   shown	   to	   globally	   upregulate	   vegfaa	   in	   zebrafish	   larvae	   by	   3	   dpf,	  which	   results	   in	   a	  
hypervascularization	  phenotype	  at	   the	   level	  of	   the	  spinal	   cord	   (Choorapoikayil	  et	  al.	  2013;	  
van	  Rooijen	  et	  al.	  2011).	  	  
	  
In	   mice,	   VEGF	   is	   expressed	   in	   various	   tissues.	   The	   nerves	   in	   the	   skin	   produce	   VEGF	   to	  
regulate	  arterial	  differentiation	  (Mukouyama	  et	  al.	  2002;	  Mukouyama	  et	  al.	  2005)	  and	  VEGF	  
secreted	  by	   retinal	  astrocytes	  has	  been	  shown	   to	  activate	  postnatal	   retinal	   vascularization	  
(Ruhrberg	   et	   al.	   2002;	   Gerhardt	   et	   al.	   2003).	   Non-­‐developmentally	   expressed	   VEGF	   is	  
considered	   to	   be	   activated	   by	   HIF1α	   in	   an	   oxygen-­‐dependent	   manner	   (Pugh	   &	   Ratcliffe	  
2003).	  HIF1α	   is	   constantly	   hydroxylated	   by	   prolyl	   hydroxylase	   domain-­‐containing	   enzymes	  
(PHDs)	  under	  normoxic	  conditions,	  and	  the	  E3	  ubiquitin	   ligase	  pVHL	  binds	   to	  hydroxylated	  
HIF1α,	   ubiquitinylates	   it	   and	   thereby	   targets	   it	   for	   degradation	   (Carmeliet	   et	   al.	   1998;	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Weidemann	  &	  Johnson	  2008).	  Under	  hypoxic	  conditions,	  Hif1α	  cannot	  be	  hydroxylated	  and	  
is	   therefore	   stabilized.	   Stabilized	   HIF1α	   translocates	   to	   the	   nucleus	   and	   activates	  
transcription	   of	   genes	   bearing	   a	   hypoxia	   response	   element	   (HRE)	   in	   their	   regulatory	  
sequences	  (Carmeliet	  et	  al.	  1998;	  Kimura	  et	  al.	  2000).	  The	  major	  HIF1α	  target	  gene	  is	  VEGF,	  
which	   is	   dramatically	   upregulated	  upon	  oxygen	  depletion	   (Liu	   et	   al.	   1995;	  Carmeliet	   et	   al.	  
1998).	  The	  exact	  role	  of	  the	  hypoxia-­‐HIF1α	  -­‐VEGF	  pathway	  is	  debated,	  since	  mice	  lacking	  the	  
HREs	   in	   the	   VEGF	   gene	   (Vegf∂/∂)	   suffer	   from	  motor	   neuron	   degeneration,	   but	   remarkably	  
lack	   major	   vascular	   defects	   (Oosthuyse	   et	   al.	   2001).	   Chronic	   hypoperfusion	   and	   resulting	  
ischemia	  in	  the	  spinal	  cord	  was	  suggested	  to	  be	  the	  reason	  for	  the	  motorneuron	  degradation	  
in	   the	   (Vegf∂/∂)	  mice	   (Oosthuyse	   et	   al.	   2001).	  Other	   authors	   suggest	   a	  HIF1α-­‐independent	  
VEGF	   regulation	   by	   PGC-­‐1α	   and	   ERR-­‐α	   under	   hypoxic	   conditions	   (Arany	   et	   al.	   2008).	   This	  
would	  explain	  the	  rather	  subtle	  phenotype	  in	  the	  (Vegf∂/∂)	  mice	  	  
	  
Taken	  together,	   it	   is	  clear	   that	  hypoxia	  can	  regulate	  VEGF,	  but	  how	  this	   is	  accomplished	   is	  
not	  fully	  understood	  yet.	  	  
3.11 Dll4-­‐Notch	  signaling	  
	  
The	  Dll4-­‐Notch	  pathway	  is	  of	  ample	  importance	  for	  both,	  AVD	  and	  angiogenesis	  (Lawson	  et	  
al.	  2001;	  Siekmann	  &	  Lawson	  2007;	  Suchting	  et	  al.	  2007;	  Herbert	  &	  Stainier	  2011).	  Notch1	  
and	   its	   ligand	  dll4	   are	  predominantly	  expressed	   in	   arterial	   ECs	   in	   the	  developing	   zebrafish	  
and	  Notch	  signaling	   is	   strictly	   restricted	   to	   the	  arterial	  domain	   (Siekmann	  &	  Lawson	  2007;	  
Quillien	  et	  al.	  2014;	  Lawson	  et	  al.	  2001;	  Leslie	  et	  al.	  2007).	  	  
	  
3.11.1 	  Notch	  signaling	  in	  AVD	  
	  
The	   arterial	   Notch	   restriction	   is	   highlighted	   by	   the	   observation	   that	   following	   venous	  
remodeling	  in	  zebrafish,	  where	  notch1a-­‐expressing	  aISVs	  are	  converted	  into	  vISVs,	  notch1a	  
expression	   and	   signaling	   in	   remodeled	   segments	   is	   rapidly	   lost	   (Quillien	   et	   al.	   2014).	  
Moreover,	  NOTCH	  signaling	  was	  recently	  shown	  to	  be	  dependent	  on	  mechanical	  force,	  e.g.	  
blood	   flow,	  which	  could	  be	  an	  explanation	   for	   the	   rapid	   loss	  of	   signaling	  under	  decreased	  
force	  conditions	  with	  less	  shear	  stress	  in	  veins	  (Gordon	  et	  al.	  2015).	  Other	  authors	  indicate	  
that	  Notch	  is	  expressed	  in	  a	  pan-­‐endothelial	  manner	  and	  becomes	  only	  restricted	  to	  arteries	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after	  the	  onset	  of	  flow	  (Jahnsen	  et	  al.	  2015).	  After	  activation	  of	  Notch	  in	  arterial	  ECs,	  efnb2,	  
hey/hes	  and	  other	  arterial	  markers	  are	  activated	  (Siekmann	  &	  Lawson	  2007).	  Of	  note,	  in	  dll4	  
depleted	   zebrafish,	   venous	   remodeling	   is	   greatly	   favored	   suggesting	   that	   Notch	   signaling	  
inhibits	  venous	  remodeling	  in	  zebrafish	  (Leslie	  et	  al.	  2007).	  	  
	  
In	  summary,	  Notch	  is	  an	  arterial	  marker,	  which	  activates	  arterial	  differentiation	  in	  ECs.	  Notch	  
expression	   can	   be	   genetically	   hardwired	   or	   reprogrammed	   in	   response	   to	   hemodynamic	  
forces.	  
	  
3.11.2 	  The	  role	  of	  Notch	  in	  angiogenesis	  
	  
Besides	   determining	   arterial	   fate,	   NOTCH	   is	   widely	   seen	   as	   an	   important	   regulator	   of	  
angiogenesis	  with	  mainly	  anti-­‐angiogenic	  functions	  (Suchting	  et	  al.	  2007;	  Herbert	  &	  Stainier	  
2011;	  Siekmann	  et	  al.	  2013).	  This	  is	  illustrated	  since	  loss	  of	  Notch	  or	  Dll4	  leads	  to	  a	  massive	  
increase	  in	  tip	  cell	  and	  sprout	  formation	  (Suchting	  et	  al.	  2007;	  Thurston	  et	  al.	  2007;	  Noguera-­‐
Troise	  et	  al.	  2006).	  NOTCH	  anti-­‐angiogenic	  function	  is	  attributed	  to	  Flt1	  upregulation	  and/or	  
blockade	   of	   VEGFR-­‐2	   signaling	   (Krueger	   et	   al.	   2011;	   Funahashi	   et	   al.	   2010;	   Chappell	   et	   al.	  
2013;	  Bentley	  et	  al.	  2014).	  FLT1	  is	  thought	  to	  limit	  VEGFR-­‐2	  signaling	  by	  decreasing	  the	  VEGF	  
bioavailability	   in	   the	   immediate	   microenvironment	   of	   stalk	   cells	   (Funahashi	   et	   al.	   2010).	  
Blockade	  of	  VEGFR-­‐2	  signaling	  via	  FLT1	  or	  directly	  via	  NICD	  was	  also	  suggested	  to	  prevent	  EC	  
dissociation	   from	   the	   endothelial	   sheet	   and	   thus	   formation	   of	   angiogenic	   sprouts	   and	  
shuffling	  (Bentley	  et	  al.	  2014).	  Furthermore,	  it	  is	  known	  for	  more	  than	  a	  decade	  that	  Notch	  
depletion	   leads	   to	   more	   tip	   cells	   and	   non-­‐productive	   angiogenesis	   and	   therefore	  
paradoxically	   to	   less	   tumor	   growth	   (Noguera-­‐Troise	   et	   al.	   2006;	   Thurston	   et	   al.	   2007).	  
Interestingly,	   in	   contrast	   to	   all	   other	   tissues,	   in	   bone	   ECs	   NOTCH	   has	   pro-­‐angiogenic	  
functions	  and	  supports	  sprouting	  angiogenesis	  (Ramasamy	  et	  al.	  2014).	  	  
	  
The	   functions	   of	   NOTCH	   in	   AVD	   and	   angiogenesis	   are	   regarded	   as	   separate	   processes.	  
NOTCH	  activates	  arterial	  fate	  and	  restricts	  angiogenesis.	  Possibly,	  both	  processes	  are	  linked	  




3.12 Anastomosis	  and	  lumen	  formation	  
	  
In	  order	  to	  form	  a	  patent	  vessel	  an	  angiogenic	  sprout	  has	  to	  connect	  to	  another	  sprout	  or	  to	  
an	  already	  lumenized	  vessel,	  establishing	  a	  functional	  loop	  (Herwig	  et	  al.	  2011;	  Lenard	  et	  al.	  
2013).	   A	   vascular	   anastomosis	   is	   the	   connection	   of	   two	   sprouts	   that	   form	   a	   lumenized	  
continuum.	   Tissue	   macrophages	   may	   support	   vascular	   anastomosis	   formation	   acting	   as	  
chaperons	  by	  bringing	  two	  angiogenic	  sprouts	  into	  close	  physical	  contact	  (Fantin	  et	  al.	  2010).	  
How	  macrophages	  mechanistically	  detect	  nascent	  sprouts	  and	  bring	  them	  together	  is	  poorly	  
understood	  (Fantin	  et	  al.	  2010).	  	  
	  
3.12.1 	  Vascular	  lumen	  formation	  	  
	  
There	   are	   mainly	   two	   models	   for	   vascular	   lumen	   formation	   currently	   debated.	   Lumen	  
formation	   was	   first	   suggested	   to	   proceed	   by	   pinocytosis	   and	   vacuole	   formation.	   These	  
vacuoles	  were	   reported	   to	  eventually	   fuse	  and	   form	  an	   intracellular	  and	   then	   intercellular	  
lumen	   (Folkman	   &	   Haudenschild	   1980;	   Davis	   &	   Camarillo	   1996;	   Kamei	   et	   al.	   2006;	  
Sigurbjörnsdóttir	   et	   al.	   2014).	   Recently,	   Gebala	   and	   colleagues	   reported	   that	   lumen	  
formation	   in	   zebrafish	  primary	   sprouts	   involves	   inverse	  membrane	  blebbing	   (Gebala	  et	   al.	  
2016).	   It	  may	  be	   that	  different	   vessels	  have	   varying	  mechanisms	   for	   lumen	   formation,	   for	  
instance	   depending	   on	   whether	   the	   lumen	   is	   de	   novo	   formed	   or	   expanded	   from	   a	   pre-­‐
existing	  lumen.	  
	  
Taken	   together,	   sprouting	   angiogenesis	   is	   completed	   by	   anastomosis	   formation	   with	  
adjacent	   sprouts	   or	   lumenized	   vessels	   and	   subsequent	   lumen	   formation	   by	   inverse	  
membrane	   blebbing	   or	   vacuole	   formation	   and	   fusion	   mechanisms.	   After	   the	   lumen	   is	  
formed	  the	  vessel	  is	  perfused	  and	  becomes	  stabilized.	  
	  
3.13 Endothelial	  cell	  junctions	  
	  
The	   endothelial	   cell	  monolayer	   lining	   the	   inner	   vessel	  wall	   is	   interconnected	   by	   adherens	  
junctions,	   tight	   junctions	   and	   gap	   junctions	   (Bazzoni	  &	  Dejana	   2004;	   Dejana	   2004).	   These	  
junctions	  are	  important	  for	  vascular	  integrity,	  vascular	  permeability,	  sprouting	  angiogenesis	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and	  extravasation	  of	   leucocytes	  (Dejana	  et	  al.	  2009).	  Junctions	  are	  constituted	  of	  adhesion	  
proteins	   that	   are	   linked	   to	   the	   intracellular	   cytoskeletal	   network	   and	   signaling	  molecules.	  
The	   junctions	   are	   not	   only	   rigid	   structures	   maintaining	   vascular	   integrity,	   but	   they	   are	  
necessary	  to	  sense	  cell	  position	  and	  to	  form	  tubular	  structures	  (Wallez	  &	  Huber	  2008).	  Post-­‐
capillary	   venules	   have	   less	   complex	   adherens	   and	   tight	   junctions	   and	   are	   therefore	   the	  
major	  extravasation	  sites	   for	   leukocytes	   (Wallez	  &	  Huber	  2008;	  Dejana	  2004;	  Dejana	  et	  al.	  
2009).	   Similarly,	   tumor	   vascularization	   arises	   from	   capillaries	   and	   post-­‐capillary	   venules	  
which	   are	   vessels	   with	   weak	   cell	   junctions	   (Bergers	   &	   Benjamin	   2003).	   During	   sprouting	  
angiogenesis,	   junctions	   have	   to	   be	   loosened	   to	   allow	   cell	   rearrangements.	   A	   recent	  
publication	   suggests	   that	   this	   is	   achieved	   via	   differential	   VE-­‐cadherin	   endocytosis	   in	   a	  
NOTCH-­‐dependent	  manner	  (Bentley	  et	  al.	  2014).	  	  
In	   summary	   these	   findings	   suggest	   that	   cell	   junctions	   do	   not	   only	   connect	   ECs	   but	   also	  
constitute	   a	  major	   determinator	   of	   the	   angiogenic	   potential	   of	   ECs,	   possibly	   regulated	   by	  
NOTCH	  signaling.	  	  
	  
3.14 Morpholinos	  –	  friend	  or	  foe?	  
 
Morpholinos	   are	   known	   to	   be	   great	   tools	   for	   gene	   silencing	   in	   zebrafish	   if	   used	   carefully	  
(Eisen	  &	  Smith	  2008).	  They	  can	  either	  be	  used	  to	  sterically	  block	  the	  start	  codon	  and	  thus	  the	  
translation	  of	  an	  mRNA	  or	  to	  block	  an	  splice	  site	  of	  the	  pre-­‐mRNA	  to	  prevent	  splicing	  (Bill	  et	  
al.	  2009).	  Depending	  on	  the	  morpholino,	  the	  knockdown	  achieved	  can	  be	  almost	  complete	  
and	   therefore	   constitutes	   a	   very	   robust	   and	   fast	   tool	   to	   examine	   gene	   function.	   The	  
downside	  of	  morpholino	  use	  is	  the	  subjectiveness	  of	  the	  approach.	  Morpholinos	  need	  to	  be	  
titrated	  for	  optimal	  usage.	  Depending	  on	  their	  RNA	  binding	  characteristics	  and	  equilibrium	  
binding	  constant	  they	  need	  distinct	  injection	  amounts	  for	  optimal	  effects.	  This	  poses	  the	  risk	  
that	   dosages	   are	   increased	   until	   the	   expected/desired	   phenotype	   is	   observed.	   This	  
phenotype	  can	  be	  correct	  or	  the	  result	  of	  side	  effects	  which	  cannot	  be	  clearly	  distinguished.	  
Researchers	   normally	   do	   various	   controls	   to	   safeguard	   the	   specificity	   of	   the	   knockdown.	  
Rescue	  experiments,	  where	  the	  mRNA	  of	  the	  morpholino-­‐knockdowned	  gene	  is	  injected	  into	  
morphants	  to	  verify	  complementation	  and	  rescue	  of	  the	  phenotype.	  This	  approach	  again	  is	  
subjective	   and	   therefore	   error-­‐prone.	   With	   the	   use	   of	   CRISPR/Cas	   and	   TALENs	   many	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morpholino	   results	   were	   questioned	   because	   the	   generated	   mutants	   did	   not	   display	   the	  
expected	  morpholino	   phenotype	   or	   no	   phenotype	   at	   all	   (Schulte-­‐Merker	  &	   Stainier	   2014;	  
Kok	   et	   al.	   2014).	   Therefore,	   the	   generation	   of	   CRISPR/Cas	   mutants	   to	   verify	   the	   specific	  
morpholino	  dosage	  was	  suggested	  as	  a	  gold	  standard	  (Kok	  et	  al.	  2014;	  Stainier	  et	  al.	  2015).	  
This	   is	   controversially	   discussed,	   since	   mutant	   generation	   is	   time-­‐consuming	   and	   comes	  
along	  with	  higher	  space	  requirements	  for	  fish	  tanks	  or	  can	  even	  ban	  certain	  organisms	  from	  
developmental	  biology	  research	  for	  lack	  of	  alternatives	  (Blum	  et	  al.	  2015).	  	  
	  
In	   conclusion,	   the	   usage	   of	   morpholinos	   is	   safe	   if	   a	   reference	   mutant	   is	   available	   for	  
comparison	  and	  would	  also	  be	  safe	  if	  controls	  would	  be	  used	  stringently,	  which	  is	  not	  always	  
the	  case	  as	  revealed	  by	  the	  numerous	  bad	  examples	  in	  the	  past.	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3.15 Aim	  of	  the	  work	  
	  
VEGFR-­‐1	  (Flt1)	  has	  been	  reported	  to	  limit	  tip	  cell	  formation	  as	  well	  as	  being	  a	  critical	  player	  
in	  shaping	  Vegf	  microgradients	  to	  direct	  sprout	  migration.	  Despite	  two	  decades	  of	  intensive	  
research	  on	  Flt1,	  its	  function	  in	  forming	  vascular	  networks	  and	  the	  role	  of	  neuronal	  Flt1	  and	  
other	  cellular	  sources	  is	  still	  controversially	  discussed.	  Flt1	  is	  a	  Vegf	  scavenger	  limiting	  Vegf	  
bioavailability	   and	   Kdrl	   signaling.	   Vegf	   has	   been	   shown	   to	   influence	   neurodegenerative	  
processes	  since	  adequate	  vascular	  supply	   is	  critical	   for	  neuronal	   function	  and	  survival.	  The	  
role	  of	   the	  soluble	  and	  membrane	  bound	  Flt1	   in	  neurons	  and	  their	   function	   in	  endothelial	  
cells	  remains	  elusive.	  
The	  aim	  of	  this	  study	  is	  therefore	  to	  dissect	  the	  distinct	  physiological	  functions	  of	  neuronal	  
and	  vascular	  Flt1	  and	   its	  different	   isoforms	   sFlt1	  and	  mFlt1.	   In	  order	   to	  elucidate	   the	  cell-­‐
autonomous	  and	  non-­‐cell	  autonomous	  functions	  of	  Flt1	  in	  vessels	  and	  nerves,	  an	  extensive	  
set	   of	   isoform-­‐specific,	   and	   tissue-­‐specific	   zebrafish	   mutants,	   cell	   transplantation	  
experiments	   as	  well	   as	   a	   variety	   of	   sFlt1	   and	   Vegfaa	   gain-­‐of-­‐function	   transgenic	   zebrafish	  
were	  generated	  and	  analyzed.	  FACS	  analysis,	  real-­‐time	  PCR	  evaluation	  and	  RNA	  sequencing	  











4.1 Loss	  of	  Flt1	  induces	  massive	  hypervascularization	  of	  the	  spinal	  cord	  
	  
To	  study	  the	  role	  of	  Flt1	  in	  neurovascular	  development,	  we	  used	  the	  zebrafish	  model	  since	  
vascular	  development	  can	  be	  dynamically	  tracked	  in	  various	  vascular	  and	  neuronal	  reporter	  
lines	  (Isogai	  et	  al.	  2003;	  Kamei	  &	  Weinstein	  2005).	  In	  addition,	  owing	  to	  recent	  advances	  in	  
genomic	   engineering,	   the	   genome	   can	   be	   easily	   modified	   using	   CRISPR/Cas	   or	   TALENs	  
(Hwang	  et	  al.	  2013;	  Auer	  &	  Bene	  2014).	  Two	  flt1	  mutants	  were	  generated	  utilizing	  the	  novel	  
CRISPR/Cas	   technique.	   The	   zebrafish	   flt1	   gene	   consists	   of	   34	   exons	   encoding	  membrane-­‐
bound	  mFlt1	  and	  at	  least	  one	  soluble	  form,	  which	  are	  formed	  by	  alternative	  splicing	  at	  the	  
exon	  10-­‐intron	  10	  boundary	  (Krueger	  et	  al.	  2011).	  In	  order	  to	  dissect	  the	  roles	  of	  membrane-­‐
bound	  and	  soluble	  Flt1,	  a	  mutant	  targeting	  both	  isoforms	  (full	  mutant)	  and	  an	  mFlt1-­‐specific	  
mutant	  were	  generated.	  	  
	  
4.1.1 Generation	  of	  flt1	  full	  mutants	  
	  
To	   obtain	   flt1	   full	   mutants,	   flt1	   exon	   3	   was	   targeted	   with	   a	   small	   guide	   RNA	   (sgRNA),	  
designed	  to	  target	  exon	  3	  (Figure	  4-­‐1).	  As	  exon	  3	  codes	  for	  the	  first	  Ig1	  domain,	  all	  frameshift	  
mutants	   obtained	   generate	   an	   early	   premature	   stop	   codon	   that	   produces	   a	   truncated	  
protein	  lacking	  the	  Ig2	  domain	  that	  is	  essential	  for	  VEGF-­‐binding	  (Figure.	  4-­‐1a)	  (Herley	  et	  al.	  
1999).	  Four	   independent	  full	  flt1	  mutant	  founder	  fish	  were	  recovered	  and	  outcrossed.	  The	  
lines	  were	  annotated	  according	  to	  the	  ZFIN	  zebrafish	  nomenclature	  using	  the	  Karlsruhe	  (KIT)	  
lab	  designation	  ‘ka’	  (Figure	  4-­‐1d).	  Mutant	  lines	  flt1ka601	  (-­‐1nt),	  flt1ka602	  (-­‐5nt),	  flt1ka603	  (+5nt)	  
and	   flt1ka604	   (-­‐14nt)	   were	   crossed	   to	   the	   reporter	   lines	   Tg(Xla.Tubb:DsRed)zf148,	  
Tg(kdrl:EGFP)s843,	   Tg(kdrl:hsa.-­‐HRAS-­‐mcherry)s916	   and	   Tg(fli1a:nGFP)y7	   to	   allow	   phenotypic	  
analysis	  of	   the	  mutants.	   To	  evaluate	   if	   the	   flt1	  mRNA	   is	  degraded	  by	  non-­‐sense	  mediated	  
decay	  (NMD),	  the	  reads	  of	  an	  RNAseq	  experiment	  performed	  with	  flt1ka601	  mutants	  and	  WT	  
siblings	   were	   mapped	   to	   the	   flt1	   mRNA	   depicted	   in	   a	   Sashimi-­‐plot.	   Comparison	   of	   read	  
numbers	   covering	   the	   exons	   revealed	   that	   flt1	   mRNA	   levels	   are	   unchanged	   in	   flt1ka601,	  




Figure	  4-­‐1.	  CRISPR/Cas	  approach	  for	  generating	  flt1	  mutants	  and	  mflt1	  mutants.	  
(a)	   Flt1	   exon	   structure	   and	   splice	   sites	   for	   zebrafish	   sflt1	   and	  mflt1.	   Schematic	   protein	   structure	   and	   IgG	  
domains	  of	  sFlt1	  and	  mFlt1	  for	  comparison.	  Domains	  targeted	  by	  sgRNA	  in	  exon	  3	  (full	  flt1	  mutants	  flt1	  ka601-­‐604,	  
targeting	  both	  sflt1,	  mflt1)	  and	  exon	  11b	  (targeting	  only	  mflt1,	  flt1	  ka605-­‐608)	  are	  indicated.	  (b).	  Position	  of	  guide	  
sequence,	  Flt1	  exon	  3	   forward	  and	  reverse	  primers	  and	  expected	  PCR	  band	  size	  after	  T7EI	  cleavage.	   (c)	  T7EI	  
assay	  and	  quantification	  of	  sgRNAflt1E3	  (targeting	  exon	  3)	  efficiency	  (d)	  Structure	  and	  DNA	  sequence	  of	  flt1ka601	  
(-­‐1nt),	   flt1ka602	   (-­‐5nt),	   flt1ka603	   (+5nt)	   mutant	   alleles.	   PTC,	   premature	   termination	   codon;	   PAM,	   protospacer	  





Figure	  4-­‐2.	  flt1	  mRNA	  NMD	  does	  not	  occur	  in	  flt1ka601	  mutants.	  
(a)	  Sashimi-­‐plot	  showing	  number	  of	  reads	  mapped	  to	  the	  flt1	  genomic	  locus	  in	  WT	  and	  flt1ka601	  mutants.	  Note	  
that	  the	  number	  of	  reads	  in	  shared	  exons	  (1-­‐10),	  sFlt1	  unique	  exons	  (11a)	  and	  in	  mflt1	  unique	  exons	  (11b-­‐30)	  
are	  comparable.	  	  
	  
Flt1	   KO	   mice	   exhibit	   a	   severe	   angioblast	   over-­‐commitment	   phenotype	   resulting	   in	   a	  
disorganized	   vascular	   plexus	   and	   early	   lethality	   (Fong	   et	   al.	   1995;	   Fong	   et	   al.	   1999).	  
Accordingly,	  an	  early	  phenotype	  affecting	  the	  first	  angiogenic	  processes	  was	  also	  expected	  in	  
zebrafish	   deficient	   for	   flt1.	   Surprisingly,	   primary	   sprouting	   and	   secondary	   sprouting	   in	   the	  




Figure	  4-­‐3.	  Primary	  and	  secondary	  sprouting	  are	  not	  affected	  in	  flt1ka601	  mutants.	  
(a-­‐a’’’)	  Trunk	  vascular	  network	  in	  WT	  embryos	  at	   indicated	  time	  points.	  (b-­‐b’’’)	  Trunk	  vasculature	  in	  flt1ka601/+	  
embryos	   at	   indicated	   time	   points.	   (c-­‐c’’’)	   Trunk	   vasculature	   in	   flt1ka601	   embryos	   at	   indicated	   time	   points.	  
Arrowheads	  indicate	  ectopic	  branches.	  dpf,	  days	  post	  fertilization.	  Scale	  bar,	  50μm	  in	  a’-­‐c’,	  a’’’-­‐c’’’;	  25μm	  in	  a-­‐c,	  
a’’-­‐c’’.	  
	  
At	  slightly	  later	  stages,	  flt1ka601	  mutants	  displayed	  severe	  hyperbranching	  at	  the	  level	  of	  the	  
neural	   tube	   starting	  at	   ~2.5dpf	   (Figure	  4-­‐3	  and	  4-­‐4).	   flt1ka601	   (-­‐1nt),	   flt1ka602	   (-­‐5nt),	   flt1ka603	  
(+5nt)	   and	   flt1ka604	   (-­‐14nt)	   mutant	   lines	   were	   phenotypically	   undistinguishable,	   therefore	  




Figure	   4-­‐4.	   Flt1	   mutants	   develop	   hyperbranched	   vascular	   networks	   at	   the	   level	   of	   the	  
neural	  tube.	  	  
(a)	   Trunk	   vasculature	   in	   4dpf	  WT	   sibling,	   (b)	   trunk	   vasculature	   in	   4dpf	   flt1ka601	   mutant,	   in	   Tg(kdrl:EGFP)s843	  
background.	   Perfused	   aISVs	   with	   red	   arrow,	   veins	   with	   blue	   arrow.	   Note	   the	   extensive	   amount	   of	  
hyperbranching	   (dotted	  box)	  at	   the	   level	  of	   the	  neural	   tube.	   (c)	  Schematic	   representation	  of	  hyperbranching	  
phenotype	  along	  the	  neural	  tube;	  ectopic	  vessels	  make	  anastomosis	  between	  vISV	  (blue)	  with	  aISVs	  (red).	  (d)	  
Hyperbranching	   (dotted	   box)	   is	   also	   observed	   in	   flt1ka602	   and	   (e)	   flt1ka603	   mutants.	   (f)	   Quantification	   of	  
hyperbranching	  for	  indicated	  mutant	  alleles.	  Mean	  ±	  s.e.m,	  n=10.	  DA,	  dorsal	  aorta;	  PCV,	  posterior	  cardinal	  vein;	  
DLAV,	   dorsal	   longitudinal	   anastomotic	   vessel;	   NT,	   neural	   tube;	   hpf,	   hours	   post	   fertilization;	   dpf,	   days	   post	  
fertilization.	  Scale	  bar,	  50μm.	  
	  
To	   substantiate	   the	   specificity	   of	   the	   flt1ka601	  mutants	   and	   to	   exclude	   that	   residual	   Flt1	  
protein	  is	  produced	  in	  the	  flt1ka601	  mutant,	  the	  phenotype	  was	  compared	  with	  morpholino-­‐
mediated	   knockdown.	   At	   low	   flt1-­‐ATG	  morpholino	   dosages	   (1ng)	   ectopic	   sprouting	   at	   the	  
level	  of	   the	  neural	   tube	  starting	  at	  2.5dpf	  as	  observed	   in	   flt1ka601	  mutants	  could	  be	  exactly	  






Figure	  4-­‐5.	  Low	  dosage	  morpholino	  injection	  phenocopies	  flt1ka601	  mutants.	  
(a,b)	  Vascular	  pattern	  in	  Tg(kdrl:EGFP)s843	  embryos	  injected	  with	  control	  MO	  (a),	  and	  1ng	  flt1	  targeting	  MO	  (b).	  
(c)	  Quantification	  of	  a,b;	  mean	  ±	   s.e.m,	  n=10.	  Note	  hyperbranching	  equal	   to	   flt1ka601.	  MO,	  morpholino.	  Scale	  
bar,	  50µm.	  
	  
Nevertheless,	   high	   morpholino	   dosages	   (3ng)	   induced	   excessive	   primary	   sprouting	   and	  
increased	  tip	  cell	  numbers	  as	  previously	  reported	  (Krueger	  et	  al.	  2011).	  Morpholino	  injection	  
into	   a	   flt1ka601	   mutant	   background	   did	   also	   result	   in	   hypersprouting	   suggesting	   that	  
unspecific	  morpholino	   effects	   and	   not	  molecular	   compensations	   induce	   this	   early	   arterial	  
hypersprouting	   phenotype	   (Figure	   4-­‐6)	   (Rossi	   et	   al.	   2015).	   Strikingly,	   all	   flt1ka601	   mutants	  
shown	   in	   this	   manuscript	   are	   maternal	   zygotic	   flt1ka601	   mutants	   (flt1ka601	   	   X	   	   flt1ka601	  
breeding),	   which	   are	   phenotypically	   identical	   to	   homozygous	   flt1ka601	   mutants	   from	  
heterozygous	  parents	  (not	  shown).	  Hence,	  contribution	  of	  maternally	  deposited	  Flt1	  protein	  
or	  flt1	  mRNA	  can	  be	  excluded.	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Figure	  4-­‐6.	  High	  dosage	  
morpholino	  injections	  
induce	  unspecific	  early	  
vascular	  phenotypes.	  
(a-­‐d)	   flt1ka601	   with	   1ng	   (c)	   and	  
3ng	   (d)	   flt1	   targeting	   MO	  
injected.	  	  
Note:	   the	   3ng	   dosage	   causes	  
arterial	   branching	   defects	  
(arrowheads)	   not	   observed	   in	  
flt1ka601	   mutants.	   MO,	  






During	  zebrafish	  vascular	  development,	  secondary	  sprouts	  emanating	  from	  the	  PCV	  connect	  
in	   roughly	   ~50	  %	   of	   the	   cases	   to	   aISV	   forming	   a	   vISV	   (venous	   remodeling)	   and	   the	   other	  
~50%	  of	  the	  secondary	  sprout	  migrate	  along	  the	  aISV	  and	  split	  at	  the	  level	  of	  the	  horizontal	  
myoseptum	   (HMS)	   to	   form	   the	  parachrodal	   lymphangioblasts	   (PL	   cells)	   and	  eventually	   the	  
lymphatic	  system	  (Isogai	  et	  al.	  2003).	  Careful	  inspection	  of	  the	  flt1	  mutants	  revealed	  that	  the	  
lymphatic	   secondary	   sprouts	   migrated	   along	   the	   aISV	   as	   observed	   in	   WT	   but	   rather	  
connected	  to	  the	  aISV	  at	  the	  level	  of	  the	  HMS	  forming	  an	  arteriovenous	  shunt	  (Figure	  4-­‐7b).	  	  




Figure	  4-­‐7.	  Arteriovenous	  shunt	  formation	  in	  flt1ka601	  mutants.	  
(a)	  Representative	   image	  of	   the	  ventral	  aspect	  of	  aISV	   in	  WT	  zebrafish	  at	  4dpf.	  Note	   that	   secondary	   sprouts	  
differentiated	   into	   lymphatic	   ECs	   and	   downregulated	   kdrl	  and	   are	   therefore	   not	   visible	   in	   these	   images.	   (b)	  
Ventral	  aspect	  of	  the	  aISV	  of	  a	  flt1ka601	  mutant.	  Note	  that	  the	  secondary	  sprout	  connected	  to	  the	  aISV	  forming	  
an	   arteriovenous	   shunt,	   blue	   arrow.	   (c)	  Quantification	   of	   shunt	   formation	   in	   flt1ka601	  mutants.	   ss,	   secondary	  
sprout.	  Scale	  bar,	  10µm.	  
	  
This	   pathological	   behavior	   remained	   unobtrusive,	   most	   likely	   because	   parachordal	  
lymphangioblasts	   are	   also	   formed	   from	   vISVs	   at	   the	   level	   of	   the	   HMS.	   These	   cells	   can	  
possibly	   compensate	   for	   the	   loss	  of	  direct	   secondary	   sprout	   contribution	   to	   the	   lymphatic	  
system.	  Analysis	  of	  other	  vascular	  beds	  in	  flt1ka601	  mutants	  revealed	  that	  vascular	  density	  is	  
also	   affected	   in	   other	   tissues.	   For	   instance	   flt1ka601	   mutants	   display	   a	   hypersprouting	  
phenotype	  in	  the	  hyaloid	  vascular	  plexus	  of	  the	  retina	  (see	  Figure	  4-­‐8).	  	  
	  
	  
Figure	  4-­‐8.	  flt1ka601	  mutants	  display	  increased	  vascular	  hyaloid	  plexus	  density	  in	  the	  eye.	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(a)	  Representative	  image	  of	  the	  vascular	  hyaloid	  plexus	  in	  the	  eye	  of	  a	  WT	  sibling	  (b)	  and	  a	  flt1ka601	  mutant	  at	  
4.5dpf.	   (c)	  Quantification	  of	   vascular	  plexus	  density	   in	   the	  eye.	  Dense	  was	  defined	  as	  more	   than	  50%	  of	   the	  
retina	  area	  covered	  by	  ECs.	  Scale	  bar,	  15µm.	  
	  
Flt1	   KO	   mice	   display	   a	   serve	   angioblast	   over-­‐commitment	   phenotype	   resulting	   in	   early	  
lethality.	   Surprisingly,	   flt1ka601	   mutants	   display	   no	   early	   vascular	   defects.	   To	   ascertain	  
whether	   angioblast	   commitment	   and	   proliferation	   are	   affected	   in	   flt1ka601	   mutants	   EC	  
numbers	   were	   counted	   using	   Tg(Fli1a:nGFP)y7	   reporter	   fish	   staining	   the	   nuclei	   of	   ECs.	  
Interestingly	   angioblast	   formation	   and	   proliferation	   appeared	   normal	   in	   flt1ka601	   zebrafish	  
mutants	  (Figure	  4-­‐9).	  	  
	  
Figure	  4-­‐9.	  Angioblast	  numbers	  are	  
not	  affected	  in	  flt1ka601	  mutants.	  
(a)	   Graphical	   illustration	   of	   angioblast	  
localization	   and	   quantification	   area	   in	  
zebrafish	   embryos.	   (b,c)	   Imaging	   of	  
endothelial	  nuclei	  in	  17hpf	  WT	  and	  flt1ka601	  
embryos.	   EC	   numbers	   were	   counted	  
between	   somite	   7-­‐9	   (a).	   (d)	  Quantification	  
of	  angioblasts	  at	  17hpf	  shows	  no	  difference	  
in	   angioblast	   numbers.	   Angioblasts	   were	  
counted	   using	   ImageJ	   plugin	   3D	   object	  
counter,	   mean	   ±	   s.e.m,	   n=4.	   Scale	   bar,	  
10μm.	  
	  
Similarly,	   primary	   sprouting	   and	   venous	   remodeling	   were	   not	   altered	   in	   flt1ka601	   mutants	  
(Figure	  4-­‐10).	  Rottbauer	  and	  colleagues	  reported	  that	  VEGF	  controls	  cardiac	  contractility	   in	  
mice	  and	  rats	  via	  Flt1	  receptor	  signaling.	  As	  opposed	  to	  this,	  in	  flt1ka601	  mutants	  we	  could	  not	  
find	  changes	  in	  contractility	  as	  depicted	  in	  Figure	  4-­‐11	  (Rottbauer	  et	  al.	  2005).	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Figure	   4-­‐10.	   Primary	  
arterial	   sprouting	   is	  
not	   affected	   in	  
flt1ka601	  mutants	  and	  
other	   Vegfaa	   gain-­‐
of-­‐function	  
scenarios.	  
(a-­‐a’’’)	   Confocal	   images	  
of	   primary	   arterial	  
segmental	   vessel	  
sprouting	   in	   WT	   (a),	  
flt1ka601	  (a’),	  vhlhu2114	  (a’’),	  
and	   flt1ka601;vhlhu2114	  
double	  mutants	  (a’’’).	  (b,c)	  Quantification	  of	  filopodia	  characteristics	  for	  indicated	  genotypes.	  Note	  that	  there	  
are	  no	  differences	  in	  sprouting	  or	  filopodia	  between	  indicated	  mutants	  and	  WT,	  mean	  ±	  s.e.m,	  n=27	  (b),	  mean	  
±	  s.e.m,	  n=9	  (c).	  Double,	  flt1ka601;vhlhu2114	  double	  mutants;	  hpf,	  hours	  post	  fertilization.	  Scale	  bar,	  10µm.	  
	  
Figure	   4-­‐11.	   The	   heart	   rate	   in	   flt1ka601	   mutants	   is	  
normal.	  






Strikingly,	  the	  brain	  and	  hindbrain	  vasculature,	  which	  are	  
–	  similar	   to	   the	   ISVs	  –	   in	  close	  contact	   to	  CNS	  neurons,	  
are	  not	  affected	  in	  flt1ka601	  mutants,	  although	  sprouting	  
in	   vhlhu2117	   mutants,	   a	   well-­‐known	   vegfaa	   gain-­‐of-­‐function	   zebrafish	   line,	   is	   significantly	  
augmented	  (Figure	  4-­‐12).	  This	  indicates	  that	  either	  the	  brain	  vessels	  do	  not	  express	  flt1	  and	  
therefore	   do	   not	   respond	   in	   flt1	   loss-­‐of-­‐function	   scenarios	   or	   the	   brain	   does	   not	   produce	  





Figure	  4-­‐12.	  Formation	  of	  the	  hindbrain	  vasculature	  is	  not	  affected	  in	  flt1ka601	  mutants.	  
(a-­‐c)	  Representative	  images	  of	  the	  hindbrain	  vasculature	  at	  4dpf	  in	  (a)	  WT,	  (b)	  flt1ka601	  mutants,	  and	  (c)	  vhlhu2117	  
mutants.	   CtAs	   are	   indicated	   with	   red	   arrowheads.	   (d)	   Graphical	   illustration	   of	   a	   stereotypical	   hindbrain	  
vasculature	  with	  indicated	  branch	  points	  as	  quantified	  in	  (e).	  (e)	  Quantification	  of	  branch	  points	  in	  WT	  siblings,	  
flt1ka601	  and	  vhlhu2117	  mutants,	  mean	  ±	  s.e.m,	  n=8.	  PHBC,	  primordial	  hindbrain	  channel;	  BA,	  basilar	  artery;	  CtA,	  
central	  artery;	  dpf,	  days	  post	  fertilization.	  Scale	  bar,	  10µm.	  
	  
Noteworthy,	  despite	  of	  their	  numerous	  vascular	  phenotypes	  flt1ka601	  mutants	  were	  viable	  as	  
adults	  and	  did	  not	  show	  any	  signs	  of	  abnormality.	  Careful	  analysis	  of	  the	  literature	  revealed	  
that	  ptena−/−;ptenb−/−	  double	  mutants	  and	  vhlhu2117	  mutants	  exhibit	  a	  comparable	  spinal	  cord	  
hypersprouting	   phenotype	   as	   flt1ka601	   mutants	   (Rooijen	   et	   al.	   2009;	   Choorapoikayil	   et	   al.	  
2013).	  Notably,	   in	  these	  mutants,	  vegfaa	  was	  reported	  to	  be	  ubiquitously	  upregulated	  at	  3	  






4.1.2 Generation	  of	  mflt1-­‐specific	  mutants	  
	  
To	  obtain	  mflt1-­‐specific	  mutants,	  the	  first	  mflt1-­‐specific	  exon	  (exon	  11b)	  was	  targeted	  using	  
a	  CRISPR/Cas	  approach.	  Analysis	  of	  four	  independently	  generated	  mutant	  lines	  (flt1ka605-­‐608)	  
did	   not	   show	   any	   obvious	   vascular	   malformations	   or	   prominent	   defects	   during	   early	  
development	   (Figure	   4-­‐13).	   These	   observations	   are	   compatible	   with	   the	   lack	   of	   obvious	  
vascular	   malformations	   found	   in	   murine	   mFlt1TK-­‐/-­‐	   mutants,	   which	   are	   mFlt1	   signaling	  
deficient	   (Takahashi	   &	   Shibuya	   2005).	   These	   results	   indicate	   that	   sFlt1,	   but	   not	   mFlt1	  
regulates	  vascular	  patterning	  in	  zebrafish.	  
	  
	  
Figure	  4-­‐13.	  Generation	  of	  mflt1	  mutants	  using	  CRISPR/Cas.	  
(a,b)	   Membrane-­‐bound	   flt1	   mutant	   (flt1ka605)	   without	   vascular	   phenotype	   (compare	   dotted	   box	   in	   b,	   with	  
control	  in	  (a).	  (c)	  Structure	  and	  DNA	  sequence	  of	  mflt1	  mutants,	  flt1ka605	  (+28nt),	  flt1ka606	  (+20nt),	  flt1ka607	  (-­‐1nt)	  
and	  flt1ka608	  (-­‐1nt,1MM).	  MM,	  mismatch;	  PTC,	  premature	  termination	  codon;	  PAM,	  protospacer	  adjacent	  motif;	  
sgRNA,	  small	  guide	  RNA;	   Indel,	   insertion/deletion,	  dpf,	  days	  post	   fertilization.	  Scale	  bar,	  50µm.	  Design	  of	   the	  




4.2 Spinal	  cord	  neurons	  express	  Flt1	  and	  Vegfaa	  
	  
The	   severe	   hyperbranching	   phenotype	   at	   the	   level	   of	   the	   neural	   tube	   was	   the	   most	  
prominent	  phenotype	  in	  flt1ka601	  mutants	  and	  therefore	  this	  work	  is	  focused	  on	  the	  analysis	  
of	  the	  trunk	  hypervascularization	  phenotype.	  Interestingly,	  the	  ectopic	  vascular	  network	  was	  
formed	  in	  close	  proximity	  to	  the	  trunk	  spinal	  cord.	  In	  addition,	  flt1	  is	  expressed	  in	  aISVs,	  the	  
dorsal	  part	  of	  vISVs	  and	  some	  neuronal	  subpopulations	  of	  the	  zebrafish	  trunk	  (Figure	  4-­‐14).	  
This	  suggests	  that	  neuronal	  Flt1	  may	  contribute	  to	  the	  formation	  of	  the	  flt1	  loss-­‐of-­‐function	  
phenotype.	  
	  
Figure	  4-­‐14.	  Expression	  of	  Vegf	  receptors	  and	  ligands	  at	  the	  neurovascular	  interface.	  
(a,b)	  Double	  transgenic	  embryos	  TgBAC(flt1:YFP)hu4624;	  Tg(kdrl:hsa.HRAS-­‐mcherry)916	  at	  30hpf	  and	  3dpf	  shows	  
flt1	   expression	   (green)	   in	   dorsal	   aorta,	   arterial	   ISV	   and	   dorsal	   aspect	   of	   venous	   ISV	   (3dpf),	   and	   neurons	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(arrowheads).	   (c)	   3D-­‐rendered	   view	   of	   vessels	   (green),	   and	   nerves	   (purple)	   in	  
Tg(kdrl:EGFP)s843;Tg(XIa.Tubb:DsRed)zf148	   embryos	   highlighting	   dorsal	   aspect	   of	   ISVs	   (arrowheads)	   in	   close	  
contact	   to	   the	   neural	   tube	   (NT).	   (d)	   Transverse	   section	   of	   the	   trunk	   of	  
TgBAC(flt1:YFP)hu4624;Tg(XIa.Tubb:DsRed)zf148	  embryos	  shows	  that	  ISVs	  (green,	  arrowhead)	  and	  neural	  tube	  (NT,	  
red)	  are	  in	  close	  contact.	  The	  white	  dotted	  line	  demarcates	  the	  embryo	  boundaries,	  dorsal	  is	  up.	  (e)	  Magnified	  
view	  of	  purple-­‐boxed	  area	  in	  (d),	  showing	  direct	  contact	  of	  vessels	  with	  nerves	  at	  the	  neurovascular	  interface	  
(blue	   arrowheads)	   and	   flt1	   expressing	   neurons	   with	   long	   axonal	   extensions	   in	   the	   neural	   tube	   (white	  
arrowheads).	   (f)	  Magnified	  view	  of	  blue-­‐boxed	  area	   in	   (d)	  showing	   flt1	  expressing	  neurons	   (arrowheads)	  and	  
their	  axons	  inside	  neural	  tube	  (red).	  (g)	  Lateral	  view	  of	  TgBAC(flt1:YFP)hu4624;	  Tg(Xla.Tubb:DsRed)zf148	  at	  the	  level	  
of	  the	  neural	  tube	  showing	  flt1	  expressing	  neurons	  (arrowheads)	  in	  neural	  tube.	  ISV,	  intersegmental	  vessel;	  DA,	  
dorsal	   aorta;	   PCV,	   posterior	   cardinal	   vein;	   DLAV,	   dorsal	   longitudinal	   anastomotic	   vessel;	   NC,	   notochord;	  NT,	  
neural	  tube;	  hpf,	  hours	  post	  fertilization;	  dpf,	  days	  post	  fertilization.	  Scale	  bar,	  30μm	  in	  a,	  b,	  c,	  d,	  g;	  10μm	  in	  e,	  
f.	  
	  
Careful	  analysis	  of	  the	  spinal	  cord	  neurons	  using	  an	  imageJ	  count	  algorithm	  revealed	  that	  6-­‐
8%	  of	  the	  neurons	  are	  TgBAC(flt1:YFP)	  positive	  (not	  shown).	  As	  neurons	  extend	  long	  axons	  
and	  dendritic	  branches,	  the	  entire	  spinal	  cord	  appeared	  penetrated	  by	  neuronal	  extensions	  
presumably	  secreting	  sFlt1	  (Figure	  4-­‐14d-­‐f).	  sflt1	  production	  in	  neurons	  could	  also	  be	  shown	  
using	  real-­‐time	  PCR	  expression	  analysis	  (data	  not	  shown).	  Analysis	  of	  3D-­‐projections	  showed	  
that	   ISVs	   are	   indenting	   the	   neural	   tube,	   indicating	   close	   contact	   and	   suggesting	   a	   tight	  
neurovascular	   interface	  between	  the	  spinal	  cord	  neurons	  and	  ISVs	  with	  possible	  functional	  
implications	   (Figure	  4-­‐14c).	  Real-­‐time	  PCR	  analysis	  of	   FAC-­‐sorted	  neuronal	   cells	  uncovered	  
that	  not	  only	  flt1	  but	  also	  other	  vascular	  markers	  such	  as	  kdr,	  kdrl	  and	  flt4	  as	  well	  as	  their	  
ligands	  vegfaa,	  vegfab	  and	  plgf	  are	  expressed	  in	  neurons	  at	  similar	  levels	  as	  known	  neuronal	  
markers	   such	   as	   sema3a	   and	   unc5b	   indicative	   of	   a	   functional	   relevance	   for	   the	   genes	   in	  
neurons	   (data	  not	   shown,	   experiments	  performed	  by	   Janna	  Krüger).	  As	  neuronal	   Flt4	  was	  
shown	   to	   have	   functional	   relevance	   in	   axonal	   guidance,	   the	   comparably	   high	   expression	  
levels	  of	  mflt1	  and	  sflt1	  are	  highly	  suggestive	  of	  a	  functional	  relevance	  of	  neuronal	  Flt1	  (data	  
not	  shown,	  Janna	  Krüger).	  In	  zebrafish,	  two	  vegfa	  isoforms	  exist,	  namely	  vegfaa	  and	  vegfab.	  
Real-­‐time	   PCR	   analysis	   of	   isolated	   zebrafish	   trunks	   at	   various	   time	   points	   revealed	   that	  
vegfaa	  is	  predominantly	  expressed	  in	  the	  trunk	  and	  that	  vegfaa	  upregulation	  in	  the	  zebrafish	  
trunk	   occurs	   just	   prior	   to	   the	   appearance	   of	   the	   first	   ectopic	   flt1ka601	   sprouts,	   starting	   at	  
2.5dpf	  (Figure	  4-­‐15a).	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Figure	  4-­‐15.	  vegfaa	  
is	  the	  major	  
isoform	  expressed	  
in	  the	  trunk	  and	  is	  
upregulated	  just	  
prior	  to	  flt1ka601	  
hypersprouting.	  
(a)	   mRNA	   expression	  
levels	   of	   vegfaa	   and	  
vegfab	  in	  the	  trunks	  of	  zebrafish	  embryos	  at	  indicated	  time	  points.	  Note	  that	  vegfaa	  is	  upregulated	  at	  2dpf,	  just	  
prior	   to	   sprout	  emergence	   in	   flt1ka601	  mutants.	   (b)	  RNA	  used	   in	   (a)	  was	   isolated	   from	  the	   trunks	  of	  embryos,	  
severed	  behind	  the	  yolk	  sac.	  	  
	  
Vegfab	  in	  contrast	  was	  only	  expressed	  at	  very	  low	  levels	  in	  the	  zebrafish	  trunk.	  To	  elucidate	  
which	  cells	  in	  the	  trunk	  express	  vegfaa,	  real-­‐time	  PCR	  analysis	  was	  performed	  on	  FAC-­‐sorted	  
neuronal	   cells	   of	   3dpf	   old	   zebrafish	   larvae	   (schematic	   see	   Figure	   4-­‐16a).	   Real-­‐time	  
expression	   data	   conclusively	   show	   that	   vegfaa	   expression	   in	   neurons	   is	   more	   than	   20x	  
higher	   than	   in	  non-­‐neuronal	   cells	   at	   3dpf,	   substantiating	   that	   at	   3dpf	   the	  major	   source	  of	  
vegfaa	  are	  not	  the	  somites,	  as	  during	  early	  development,	  but	  indeed	  the	  spinal	  cord	  neurons	  
(Liang	  et	  al.	  2001).	  This	  clearly	  illustrates	  that	  hypersprouting	  is	  restricted	  to	  the	  spinal	  cord	  




Figure	  4-­‐16.	  Neuronal	  cells	  are	  the	  major	  source	  of	  Vegfaa	  and	  vhl	  loss-­‐of-­‐function	  triggers	  
predominantly	  neuronal	  Vegfaa	  upregulation.	  
(a)	   FACS	   procedure	   for	   obtaining	   neuronal	   cells	   in	   control	   and	   vhl	   morphants	   using	   Tg(Xla.Tubb:DsRed)zf148	  
neuronal	   reporter	   embryos	   at	   3dpf.	   (b)	   Quantification	   of	   vegfaa	   expression	   using	   real-­‐time	   qPCR	   in	   FACS-­‐
sorted	  cell	  populations.	  Note	  that	  neuronal	  cells	  expressed	  significantly	  more	  vegfaa	  than	  non-­‐neuronal	  cells.	  
Loss	  of	  vhl	  promoted	  neuronal	  vegfaa	  expression	  predominantly	  in	  neuronal	  cells.	  Mean	  ±	  s.e.m,	  n=3	  separate	  
experiments	   in	   triplicate	   (two-­‐way	   ANOVA).	   (c,c’)	   Neuronal	   cells	   were	   isolated	   from	   Tg(Xla.Tubb:DsRed)zf148	  
embryos	   at	   3dpf	   by	   FACS	  with	   indicated	   gating	   settings.	   About	   12%	  of	   all	   intact	   cells	  were	  DsRed+	   neurons	  
prior	   to	   sorting	   (Pre-­‐sort)	   (c’).	   (d,d’)	   Post-­‐sorting	   analysis	   showed	   that	   sorted	   neuronal	   cells	   are	   enriched	   to	  
51%	   neuronal	   DsRed+	   cells.	   DsRed-­‐	   cells	   contained	   less	   than	   1.7	   %	   DsRed+	   cells	   (d’).	   NC,	   neuronal	   cell;	   KD,	  
knockdown;	  MO,	  morpholino.	  FACS	  sorting	  was	  performed	  in	  collaboration	  with	  Yuya	  Hayashi.	  
	  
It	   is	  well-­‐known	  that	   in	  vhlhu2117	  mutants,	  vegfaa	   is	  upreglated	  due	  to	  stabilization	  of	  Hif1α	  
(Rooijen	  et	  al.	  2009;	  van	  Rooijen	  et	  al.	  2010).	  However,	  the	  exact	  source	  of	  vegfaa	  remains	  
elusive	   as	   in	   situ	   hybridizations	   only	   show	   a	   blurred	   staining	   with	   low	   resolution	   of	  
expression	  (van	  Rooijen	  et	  al.	  2011).	  To	   identify	   the	  cell	  population	  upregulating	  vegfaa	   in	  
vhlhu2117	   loss-­‐of-­‐function	   scenarios,	   vhl	  was	   knocked	   down	   using	   a	   morpholino	   approach.	  
Subsequently,	  neuronal	  cells	  were	  FAC-­‐sorted	  for	  further	  analysis.	  Real-­‐time	  PCR	  analysis	  of	  
vegfaa	   expression	   in	   vhl	   morphant-­‐neuronal	   cells	   (NCs)	   showed	   that	   vegfaa	   is	   globally	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upregulated	  in	  NCs	  and	  in	  non-­‐NCs,	  but	  that	  the	  expression	  in	  NCs	  is	  almost	  10x	  higher	  in	  vhl	  
morphants	   (Figure	  4-­‐16b).	  These	   results	   suggest	   that	   (I)	   the	   spinal	   cord	   is	   a	   rich	   source	  of	  
vegfaa	  and	  (II)	  neuronal	  vegfaa	  is	  the	  major	  driver	  of	  hypersprouting	  in	  vhl	  morphants.	  
	  
4.2.1 Analysis	  of	  flt1ka601;	  vhlhu2117	  double	  mutants	  
	  
Flt1	  and	  pVhl	  are	  involved	  in	  different	  layers	  of	  VEGF	  biology.	  Whereas	  pVhl	  regulates	  Hif1α	  
turnover	  and	  thus	  vegfaa	   transcriptional	  regulation,	  Flt1	  regulates	  Vegfaa	  bioavailability	  of	  
secreted	  Vegfaa	  protein	  (see	  schematic	  illustration	  in	  Figure	  4-­‐17a)	  (van	  Rooijen	  et	  al.	  2011).	  
Therefore,	   it	   can	   be	   assumed	   that	   loss	   of	   both	   tiers	   of	   regulation	   enhances	   the	   vascular	  
phenotype.	  Indeed,	  in	  flt1ka601;	  vhlhu2117	  homozygous	  double	  mutants	  sprouting	  angiogenesis	  
was	   dramatically	   augmented.	   Remarkably,	   hypersprouting	   was	   restricted	   to	   the	   dorsal	  
region	  of	  the	  trunk	  at	  the	  level	  of	  the	  spinal	  cord	  similar	  to	  flt1ka601	  mutants	  (Figure	  4-­‐17b).	  
As	   expected,	   the	   observed	   ectopic	   vascular	   network	   in	   flt1ka601;	   vhlhu2117	   double	   mutants	  
exhibited	  a	  higher	  vascular	  density	  than	  single	  flt1ka601,	  vhlhu2117	  or	  ptena−/−;ptenb−/−	  mutants.	  
Interestingly,	   using	   Y-­‐Z	   projections	   it	   could	   be	   shown	   that	   ectopic	   sprouts	   did	   not	   only	  
laterally	  vascularize	  the	  spinal	  cord,	  but	  also	  invaded	  into	  the	  spinal	  cord	  in	  flt1ka601;	  vhlhu2117	  
double	  mutants	  (Figure	  4-­‐17d-­‐e).	  This	  invasive	  sprouting	  behavior	  did	  not	  occur	  in	  any	  other	  
single	  mutant	   investigated.	  The	   finding	   further	  substantiates	   that	   indeed	  the	  spinal	  cord	   is	  
the	   source	   of	   Vegfaa	   and	   that	   the	   spinal	   cord	   neurons	   are	   the	   major	   source	   of	   Hif1α	  
















Figure	   4-­‐17.	   Massive	   vegfaa	   upregulation	   in	  
flt1ka601;vhlhu2114	  double	  mutants	  induces	  spinal	  cord	  
sprout	  invasion.	  
(a)	   Schematic	   representation:	   loss	   of	   vhl	   augments	   vegfaa	  
transcription,	   loss	   of	   flt1	   augments	   Vegfaa	   bioavailability;	  
combining	  both	  mutants	  augments	  Vegfaa	  bioavailability	  above	  
single	   mutant	   level.	   (b)	   Trunk	   vasculature	   in	   flt1ka601;vhlhu2114	  
double	  mutants	  at	  4dpf.	  Note	  the	  severe	  hyperbranching	  at	  the	  
level	  of	  the	  neural	  tube.	  (c)	  Schematic	  representation	  of	  optical	  
section	  (shown	  in	  d’-­‐d’’)	  through	  the	  neural	  tube	  and	  associated	  
trunk	  vasculature.	  (d’-­‐d’’)	  Dorsal	  view	  on	  optical	  section	  through	  
WT	   (d),	   flt1ka601	   (d’),	   and	   flt1ka601;vhlhu2114	   double	  mutants	   (d’’).	  
Note	  invasion	  of	  sprouts	  into	  the	  neural	  tube	  in	  mutants	  (arrowheads	  in	  d’,	  d’’).	  Red	  circle	  indicates	  position	  of	  
ISV,	   dotted	   line	   neural	   tube	   boundary.	   (e)	   Transverse	   3D-­‐rendered	   view	   of	   vasculature	   (green)	   through	   the	  
trunk	  in	  WT	  (left	  panel)	  and	  flt1ka601;vhlhu2114	  double	  mutants	  (right	  panel);	  note	  vessels	  penetrating	  the	  neural	  
tube	   in	  mutant	   (compare	   vessel	   in	   dotted	   circle	   right	   panel,	   arrowhead;	   such	   vessels	   are	   absent	   in	  WT	   left	  
panel).	   DA,	   dorsal	   aorta;	   PCV,	   posterior	   cardinal	   vein;	   NT,	   neural	   tube;	   f.c.	   fold	   change.	   Mutants	   are	   in	  





4.3 Ectopic	   neurovascular	   networks	   in	   flt1ka601	   and	   other	   Vegfaa	   gain-­‐of-­‐function	  
scenarios	  originate	  from	  venous	  ISVs	  
	  
The	   vascular	   spinal	   cord	   phenotype	   emerged	   around	   2.5dpf	   with	   sprouts	   emanating	  
exclusively	  from	  venous	  ISVs	  (Figure	  4-­‐18a,a’).	  Ectopic	  sprouts	  originating	  from	  arterial	  ISVs	  
were	   never	   observed	   in	   flt1ka601	   mutants	   (Figure	   4-­‐18a’,b).	   Similarly,	   in	   vhlhu2117	   and	  
ptena−/−;ptenb−/−	   mutants	   almost	   exclusively	   venous	   sprouts	   were	   observed	   (Figure	   4-­‐
18a’’,a’’’).	  PTEN	   is	  a	   tumor	  suppressor	  gene	  acting	  as	  PI3K/AKT	  signaling	  attenuator	  and	   is	  
linked	  to	  the	  progression	  of	  many	  tumors	  involving	  VEGF-­‐A	  (Choorapoikayil	  et	  al.	  2013).	  	  
To	   test	   if	   aISVs	   are	   generally	   responsive	   to	   Vegfaa,	   the	   trunk	   ISVs	   were	   exposed	   to	   high	  
Vegfaa	   levels	  using	  either	   flt1ka601;	  vhlhu2117	   double	  mutants	  or	   inducible	  overexpression	  of	  
vegfaa	   in	   neurons	   using	   a	   tamoxifen/endoxifen	   inducible	   Gal4ERt2/UAS	   system	   driven	   by	  
the	  pan-­‐neuronal	  promoter	  huc	  (also	  known	  as	  elavl3)	  (Figure	  4-­‐18b).	  The	  inducible	  system	  
was	   used	   because	   early	   expression	   of	   sFlt1	   or	   Vegfaa	   resulted	   in	   massive	   disturbance	   of	  
vascular	   development	   and	   lethality.	   To	   make	   mosaic	   overexpression	   visible	   without	  
disrupting	  Vegfaa	   function,	   the	  p2A	  peptide	  was	  used	   to	   co-­‐express	  Vegfaa165	  and	  eGFP.	  
The	  expression	  was	  induced	  at	  52	  hpf,	  right	  after	  the	  vascular	  trunk	  network	  is	  formed.	  This	  
time	   point	  was	   chosen	   to	   allow	   formation	   of	   an	   intersegmental	   network	  with	   venous	   ISV	  
present	  and	  to	  recapitulate	  the	  endogenous	  vegfaa	  upregulation	  observed	  at	  a	  similar	  time	  
point	   (see	   Figure	   4-­‐15a	   for	   endogenous	   expression	   of	   vegfaa	   and	   Figure	   4-­‐33a,e	   for	  
schematic	   illustration	  of	   the	  Gal4ERt2/UAS	  system).	  Using	  neuronal	  vegfaa	  overexpression	  
few	  arterial	  ectopic	  sprouts	  could	  be	  observed,	  although	  venous	  sprout	  numbers	  remained	  
more	   than	   three	   fold	   higher	   (Figure	   4-­‐18b).	   These	   experiments	   illustrate	   that	   aISVs	   are	  
generally	   responsive	   to	   Vegfaa	   but	   have	   a	   severely	   decreased	   angiogenic	   potential	  




Figure	   4-­‐18.	   flt1ka601	   mutants	   and	   vegfaa	   gain-­‐of-­‐function	   scenarios	   promote	   ectopic	  
venous	  sprouting.	  
(a-­‐a’’’)	  Trunk	  vasculature	  at	  3dpf	  in	  WT	  (a),	  flt1ka601	  (a’),	  vhlhu2114	  (a’’)	  and	  ptena-­‐/-­‐;ptenb-­‐/-­‐	  double	  mutants	  (a’’’)	  
in	  Tg(kdrl:EGFP)s843	  background.	  Note	  ectopic	  sprouts	  originate	  from	  vISVs	  (blue	  arrowheads)	  in	  mutants.	  aISVs	  
indicated	   in	   red,	   vISVs	   in	   blue.	   (b)	   Quantification	   of	   ectopic	   sprouting	   in	   indicated	   mutants	   and	   inducible	  
neuronal	  specific	  vegfaa	  gain-­‐of-­‐function.	  In	  all	  models	  ectopic	  sprouting	  preferentially	  occurs	  in	  veins,	  mean	  ±	  
s.e.m,	   n=13.	   (c-­‐c’)	   flt1ka601	   mutants	   show	   hyperbranching	   and	   knockdown	   of	   flt4	   in	   flt1ka601	   mutant	   rescues	  
hyperbranching.	  MO,	  morpholino;	  vISV,	  intersegmental	  vein;	  aISV,	  intersegmental	  artery.	  Scale	  bar,	  30μm	  in	  a-­‐
a’’’,	  50µm	  in	  c-­‐c’.	  
	  
To	   verify	   if	   venous	   ISVs	   are	   necessary	   for	   hypersprouting	   in	   flt1ka601	   mutants,	   venous	   ISV	  
formation	   was	   blocked	   using	   a	   flt4	   morpholino	   knockdown	   approach.	   The	   Vegfc/Flt4	  
pathway	  drives	  venous	  sprouting	  and	  thus	  vISV	  formation	  is	  Vegfc/Flt4-­‐dependent	  (Küchler	  
et	  al.	  2006;	  Hogan	  et	  al.	  2009).	  Inhibiting	  either	  Vegfc	  or	  Flt4	  leads	  to	  a	  phenotype	  displaying	  
few	  or	  no	  vISVs,	  but	  with	  circulation	  mostly	  present	  up	  to	  5dpf	  (Figure	  4-­‐19a).	  Depleting	  Flt4	  
in	  flt1ka601	  mutants	  fully	  rescued	  the	  hypersprouting	  phenotype,	  stressing	  the	  imperative	  for	  




Figure	   4-­‐19.	   Venous	   ISV	   formation	   is	  
required	  for	  flt1ka601	  hypersprouting.	  
(a)	   Characterization	   of	   intersegmental	   blood	   flow	  
characteristics	   in	   flt1ka601	   (top	   panel)	   and	   flt1ka601	  
injected	  with	  flt4	  targeting	  morpholino	  (bottom	  panel).	  
In	   flt1ka601	   mutant	   ISVs	   carry	   both	   arterial	   (red	   arrow	  
up)	   and	   venous	   (blue	   arrow	   down)	   flow	   and	   the	  
artery/vein	  ratio	  is	  about	  1.	  Upon	  loss	  of	  flt4,	  almost	  all	  
investigated	  ISVs	  carry	  arterial	  flow	  consistent	  with	  flt4	  






Accordingly,	  when	  the	  same	  experiment	  was	  repeated	   in	   flt1ka601;	  vhlhu2117	  double	  mutants	  
flt4MO-­‐mediated	  blockade	  of	  vein	  formation	  rescued	  only	  venous	  sprouting	  but	  not	  the	  few	  
arterial	  sprouts	  present	  in	  flt1ka601;	  vhlhu2117	  double	  mutants	  (Figure	  4-­‐20a-­‐c).	  	  





Figure	   4-­‐20.	   Arterial	   sprouting	   does	   occur	   only	   at	  
extreme	  Vegfaa	  levels.	  
(a,b)	  Knockdown	  of	   flt4	   in	   flt1ka601;	  vhlhu2114	  double	  mutants	   rescues	  
hyperbranching;	  compare	  yellow	  dotted	  box	  in	  a	  and	  b.	  The	  position	  
of	  vessels	  is	  color-­‐coded.	  (c)	  Quantification	  of	  a,b.	  Mean	  ±	  s.e.m,	  n=4	  
animals/group.	   (d)	   Semi-­‐automated	   vascular	   network	   analysis	   was	  
performed	   using	   ImageJ	   plugins	   indicated,	   also	   in	   other	   Figures	   of	  
this	  manuscript	  displaying	  segment	  number,	  branch	  point	  number	  or	  
total	   branch	   length	   analysis.	   MO,	   morpholino;	   dpf,	   days	   post	  








4.4 Ectopic	  sprouts	  in	  flt1ka601	  mutants	  display	  distinctive	  angiogenic	  cell	  behaviors	  	  
	  
Hyperactive	  ECs	  in	  the	  dorsal	  aspect	  of	  venous	  ISVs	  in	  flt1ka601	  mutants	  extended	  sprouts,	  of	  
which	   only	   ~55%	   generated	   patent	   connections	   whereas	   the	   remaining	   ~45%	   retracted	  
(Figure	   4-­‐21c).	   From	   the	   population	   of	   patent	   ectopic	   venous	   sprouts	   ~95%	   formed	   an	  




Figure	  4-­‐21.	  Sprouting	  kinetics	   in	  
flt1ka601	  hypersprouts.	  
(a)	   Time	   lapse	   imaging	   of	   sprout	  
initiation	   and	   anastomosis	   formation	   in	  
flt1ka601	   mutant.	   Sprout	   initiation	  
(60.0hpf),	   elongation	   (65.2hpf)	   and	  
connection-­‐anastomoses	   (72.5hpf)	   with	  
adjacent	  aISV.	   (b)	  Time	   lapse	   imaging	  of	  
sprout	   initiation	   and	   retraction	   in	  
flt1ka601	   mutant.	   ECs	   are	   hyperactive,	  
produce	   filopodia	   (68.8hpf),	   extend	   a	  
sprout	   (71.6hpf),	   which	   subsequently	  
retracts	   (80.8hpf).	   	   (c)	   Quantification	   of	  
data	   in	   a	   and	   b	   showing	   %	   of	   sprouts	  
retracting	   (top	   part)	   or	   connecting	  
(bottom	  part)	  to	  either	  aISV	  (red)	  or	  vISV	  
(blue).	   In	   45%	   of	   all	   sprouting	   events	  
detected,	  filopodia	  formation	  and	  sprout	  
initiation	   were	   followed	   by	   sprout	  
retraction;	   in	   55%	   of	   cases	   the	   sprout	  
initiation	   was	   followed	   by	   sprout	  
extension	   and	   connection	   with	   an	  
adjacent	   ISV.	   From	   all	   these	   patent	  
venous	   sprouts	   95%	  made	  a	   connection	  
with	   aISVs,	   whereas	   only	   5%	   made	   a	  
connection	   with	   vISVs.	   Sprouting	  
behavior	   was	   analyzed	   in	   time-­‐lapse	  
confocal	   movies,	   n=20	   embryos.	   A,	  
artery;	  V,	  vein;	  EC,	  endothelial	  cell.	  Scale	  bar,	  30μm.	  
	  
The	  clear	  preference	  for	  aISVs	  may	  have	  physiological	  relevance,	  since	  only	  connections	  with	  
a	  blood	  pressure	  gradient	  promote	  blood	  flow	  perfusion.	  As	  the	  arteriovenous	  ratio	  in	  ISVs	  is	  
roughly	   ~50%	   the	   likelihood	   that	   two	   veins	   are	   adjacent	   is	   ~25%	   thus	   the	   expected	   ratio	  
would	  be	  ~25%	  venous	  anastomosis	  and	  ~75%	  arterial	   anastomosis	   (Isogai	  et	  al.	  2003).	   In	  
conclusion,	   venous	   anastomosis	   is	   greatly	   underrepresented	   suggesting	   a	   mechanism	  
whereby	   angiogenic	   sprouts	   detect	   the	   pressure	   gradient,	   e.g.	   utilizing	   thin	   filopodia	  
Results 
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interacting	  with	  adjacent	  vessels,	  enabling	  them	  to	  sense	  pressure	  gradients.	  The	  observed	  
sprout	   filopodia-­‐length	   ranged	   from	   1-­‐20µm	   and	   projected	   at	   an	   angle	   between	   90°-­‐120°	  
with	   respect	   to	   the	   venous	   ISV,	   compatible	  with	  arterial	   anastomosis	   formation	   (Figure	  4-­‐
22).	  Current	  models	  posit	   that	  sFlt1	  secreted	  by	  sprouts	   forms	  a	  corridor	   to	  prevent	  back-­‐
sprouting	   and	   reconnection	  with	   their	   parent	   vessel	   (Chappell	   et	   al.	   2009).	   Contradictory,	  
flt1	  depleted	  sprouts	  retain	  their	  directionality	  and	  migrate	  away	  from	  their	  sprout	  initiation	  
point	  (Figure	  4-­‐22c).	  	  
	  
Figure	  4-­‐22.	  Flt1	  is	  
dispensable	  for	  sprout	  
directionality.	  
(a-­‐c)	   Filopodia	   directionality	  
and	  length	  in	  flt1ka601	  mutants	  
(n=10	   embryos,	   n=920	  
filopodia).	  Note	  that	   filopodia	  
are	   oriented	   away	   from	   the	   sprout	   origin	   although	   Flt1	   is	   absent	   (a,b).	   (c)	   Quantification	   of	   filopodia	  
directionality.	  Note	  that	  the	  predominant	  direction	  is	  120°,	  pointing	  to	  the	  ventral	  spinal	  cord	  which	  is	  rich	  in	  
motor	  neurons	  and	  thus	  sFlt1	  splicing	  in	  WT.	  aISV,	  intersegmental	  artery;	  vISV,	  intersegmental	  vein;	  Scale	  bar,	  
10µm	  (a)	  and	  25μm	  (b).	  
	  
4.4.1 Nuclear	  migration	  and	  positioning	  is	  linked	  to	  ectopic	  sprout	  initiation	  
	  
Using	  the	  endothelial	  nuclear	  reporter	  line	  Tg(fli1a:nGFP)y7,	  endothelial	  nuclear	  movements	  
were	   carefully	   analyzed	   in	   flt1ka601	   mutant	   ectopic	   sprouts.	   Remarkably,	   an	   association	  
between	   nuclear	   positioning	   and	   sprout	   initiation	   was	   observed	   (Figure	   4-­‐23a-­‐b).	   Nuclei	  
migrated	  actively	  at	  velocities	  of	  up	  to	  1µm·∙min-­‐1	  towards	  sprout	  initiation	  points	  (SIP)	  and	  
in	  more	  than	  80%	  of	  the	  sprout	  initiations	  studied,	  nuclear	  positioning	  was	  directly	  linked	  to	  
sprout	   initiation	   (linkage	   was	   defined	   as	   nucleus-­‐SIP	   distance	   of	   less	   than	   5µm	   at	   sprout	  
initiation)	   (Figure	   4-­‐23c,d).	   Nuclear	   migration	   is	   most	   studied	   in	   interkinetic	   nuclear	  
migration	  behavior	  in	  neuroepithelia,	  but	  has	  never	  been	  described	  in	  endothelial	  cells	  nor	  
was	   it	   linked	   to	   sprout	   formation	   (Del	   Bene	   2011;	   Strzyz	   et	   al.	   2015).	   Interestingly,	   these	  
observations	  are	  in	  contrast	  to	  rearward	  nuclear	  positioning	  in	  vitro	  (Gundersen	  &	  Worman	  




Figure	  4-­‐23.	  Nuclear	  
positioning	  is	  associated	  
with	  sprout	  initiation.	  
(a’-­‐a’’’)	   Time	   lapse	   imaging	   of	  
endothelial	   nuclei	   in	  
Tg(fli1a:nGFP)y7;Tg(kdrl:hsa.HR
AS-­‐mcherry)s916	   showing	  
association	   between	   nuclear	  
position	  and	  sprouting	  initiation	  
point	   (SIP).	   Note	   that	   sprouts	  
arise	   in	   close	   proximity	   to	   the	  
position	   of	   the	   nucleus.	  
Arrowheads	   indicate	   sprouts;	  
nuclei	   at	   indicated	   time	   points	  
(sprout	   initiation	   with	   actively	  
migrating	  nucleus	  towards	  SIP	  I,	  
II,	   III,	   IV,	   and	   nucleus	   already	  
located	   at	   SIP	   1,2,3,4).	   (b)	  
Schematic	   representation	   of	  
nuclear	  position	  with	  respect	  to	  
SIP.	   (c,d)	   Quantification	   of	  
observations	   in	   a-­‐a’’’.	   Red	   dot	  
indicates	   sprout	   initiation	   time	  
point.	   Note	   that	   sprouting	  
preferentially	   occurs	   when	  
endothelial	   nuclei	   are	   within	  
less	   than	  5μm	  from	  SIP.	  n=5	   (c)	  
and	   n=13	   (d).	   SIP,	   sprout	  
initiation	   point.	   Scale	   bar,	  
10μm.	  
	  
Next,	   the	   proliferation	   rate	   in	   flt1ka601	   mutants	   was	   evaluated.	   The	   cell	   numbers	   were	  





Figure	  4-­‐24.	  Flt1ka601	  mutants	  display	  increased	  nuclear	  numbers.	  
(a,a’)	   Representative	   images	   of	   EC	   nuclei	   in	   vISVs	   of	  WT	   and	   flt1ka601	   embryos	   at	   4dpf.	   (b)	  Quantification	   of	  
nuclei	  #	  in	  vISVs	  displayed	  as	  mean	  ±s.e.m,	  n=21.	  ISV,	  intersegmental	  vessel.	  Scale	  bar	  50μm.	  
	  
4.5 flt1ka601	  ectopic	  sprouts	  are	  blood	  flow	  dependent	  
	  
Primary	  sprouting	  is	  not	  dependent	  on	  blood	  flow,	  as	  blockade	  of	  heartbeat	  and	  blood	  flow	  
does	  not	  prevent	  aISV	  formation	  (Watson	  et	  al.	  2013).	  To	  test	  whether	  flt1ka601	  sprouts	  are	  
also	   resistant	   to	   loss	   of	   blood	   flow,	   the	   heartbeat	   was	   stopped	   using	   2,3-­‐Butanedione	  
monoxime	   (BDM)	   or	   2.5x	   Tricaine	   at	   48hpf	   and	   sprout	   formation	   was	   analyzed	   at	   4dpf.	  
Surprisingly,	   depletion	   of	   blood	   flow	   using	   either	   approach	   completely	   prevented	   ectopic	  
sprout	  formation	  in	  flt1ka601	  mutants	  ((Figure	  4-­‐25).	  	  




Figure	  4-­‐25.	  Flt1ka601	  hypersprouting	  is	  blood	  flow	  dependent.	  
(a)	   Blood	   flow	   blockade	   using	   BDM	   or	   Tricaine	   prevents	   sprout	   formation	   at	   the	   level	   of	   the	   spinal	   cord	   in	  
flt1ka601	  mutants.	  Representative	  images	  of	  the	  dorsal	  part	  of	  ISVs	  at	  4dpf	  (neural	  tube	  level).	  (b)	  Quantification	  
of	   sprout	   formation	  under	   indicated	   conditions	   at	   3dpf.	  Note	   that	   sprout	   formation	   is	   completely	   abolished	  
under	   loss	   of	   flow	   (BDM)	   or	   deceleration	   of	   flow	   (Tricaine)	   conditions.	   ISV,	   intersegmental	   vessel;	   dpf,	   days	  
post	  fertilization;	  BDM,	  2,3-­‐Butanedione	  monoxime.	  Scale	  bar,	  20µm.	  
	  
4.5.1 Ectopic	  flt1ka601	  sprouts	  originate	  from	  remodeled	  arterial	  or	  purely	  venous	  ECs	  
	  
To	   elucidate	   the	   endothelial	   identity	   of	   hyperactive,	   sprout	   initiating	   endothelial	   cells,	  
Tg(flt1enh:tdTomato);	   Tg(flt4:mCitrine)hu7135	   double	   transgenics	   were	   analyzed.	  
Tg(flt1enh:tdTomato)	   is	   specifically	   expressed	   in	   arteries,	   whereas	   Tg(flt4:mCitrine)hu7135	   is	  
enriched	  in	  veins	  but	  is	  also	  expressed	  at	  somewhat	  lower	  levels	  in	  aISVs.	  	  
In	   the	  dorsal	   aspect	   of	   vISVs	   from	   flt1	  morphants,	  Tg(flt1enh:tdTomato)	  positive	   as	  well	   as	  
Tg(flt1enh:tdTomato)	  negative	   hyperactive	   ECs	  were	   identified	   (Figure	   4-­‐26a-­‐c).	   Thus,	   both	  
venularized	   arterial	   ECs	   and	  purely	   venous	   ECs	   (originating	   from	   the	  PCV)	   can	   give	   rise	   to	  
ectopic	  sprouts	  in	  flt1	  loss-­‐of-­‐function	  scenarios.	  This	  suggests,	  that	  not	  the	  EC	  origin	  but	  the	  
position	   and	   exposure	   to	   factors	   differing	   between	   arteries	   and	   veins	   are	   critical	   to	  




The	  finding	  that	  sprouts	  typically	  originate	  at	  the	  dorsal	  aspect	  of	  vISVs	  in	  flt1ka601	  mutants	  is	  
in	  contrast	  to	  the	  current	  opinion	  of	  vISV	  formation	  in	  zebrafish	  (Bussmann	  et	  al.	  2010).	  It	  is	  
widely	   excepted,	   that	   secondary	   sprouts	   connect	   to	   aISV	  which	   are	   eventually	   remodeled	  
into	  vISVs	  resulting	   in	  an	  hybrid	  vessel	  with	  ventral	  venous	  origin	  and	  dorsal	  arterial	  origin	  
(Bussmann	   et	   al.	   2010).	   To	   test	   this	   model,	   a	   photoswitchable	   Tg(kdrl:nlskikGR)hsc7	  
transgenic	   reporter	   line	  was	  utilized.	  Venous	  ECs	  were	   switched	   from	  green-­‐kikGR	   to	   red-­‐
kikGR	  using	  UV	  light	  to	  allow	  cell	  tracking	  of	  venous	  ECs	  from	  the	  PCV.	  Time-­‐lapse	  imaging	  
identified	   that	   photoswitched	   red-­‐kikGR	   venous	   ECs	   form	   secondary	   sprouts,	   anastomose	  
with	  an	  aISV	  forming	  a	  vISV	  and	  subsequently	  migrate	  dorsally,	  proliferate	  and	  displace	  all,	  
most	   or	   some	   of	   the	   venularized	   arterial	   ECs.	   This	   PCV-­‐derived	   EC	   behavior	   explains	   that	  
both	  flt1+	  (venularized	  arterial	  ECs)	  and	  flt1-­‐	  (purely	  venous	  ECs	  from	  the	  PCV)	  sprouts	  can	  be	  
observed	  (Figure	  4-­‐26d-­‐e).	  Noteworthy,	  careful	  tracking	  of	  EC	  migration	  events	  revealed	  that	  
vECsPCV	   migrate	   against	   the	   flow	   direction	   dorsally	   into	   the	   vISVs	   whereas	   vaECsISV	   never	  
migrate	  ventrally	  into	  the	  PCV.	  





Figure	  4-­‐26.	  Flt1ka601	  hypersprouts	  originate	  from	  both,	  venularized	  and	  purely	  venous	  ECs	  
(a-­‐a’’’’)	  Time-­‐lapse	  imaging	  of	  nuclear	  migration	  in	  Tg(kdrl:nlskikGR)hsc7	  after	  photoswitching	  of	  venous	  ECs	   in	  
the	  PCV.	  Venous	  ECs	  in	  the	  PCV	  were	  switched	  at	  30	  hpf	  just	  prior	  to	  secondary	  vein	  formation,	  and	  migration	  
of	  purely	  venous	  PCV	  ECs	  was	  followed	  up	  to	  60hpf.	  Note	  that	  ECs	  with	  PCV	  origin	  migrate	  up	  to	  the	  DLAV	  and	  
that	   the	   dorsal	   venous	   ISV	   has	  mixed	   origin,	   consisting	   of	   purely	   venous	   ECs	   (marked	   with	   letters	   -­‐	   red	   or	  
yellow	  cells)	  and	  venularized	  arterial	  ECs	  (marked	  with	  numbers	  –	  green	  cells).	   (b)	  Schematic	   illustration	  of	  a	  
venous	  ISV	  with	  mixed	  EC	  origin	  at	  the	  dorsal	  aspect.	  Venularized	  arterial	  EC	  in	  blue	  and	  purely	  venous	  ECs	  in	  
red.	   (c)	   Time-­‐lapse	   imaging	   of	   Tg(flt1enh:tdtomato);Tg(flt4:mCitrine)hu7135	   injected	   with	   flt1MO	   showing	   that	  
both	   populations,	   venularized	   arterial	   ECs	   and	   purely	   venous	   ECs	   can	   give	   rise	   to	   ectopic	   sprouts.	   EC,	  
endothelial	   cell;	   PCV,	   posterior	   cardinal	   vein;	   DA,	   dorsal	   aorta;	   hpf,	   hours	   post	   fertilization;	   dpf,	   days	   post	  
fertilization.	  Scale	  bar	  a-­‐a’’’’,	  10µm,	  c.	  
4.5.2 Spinal	  cord	  vascularization	  in	  WT	  larvae	  involves	  venous	  sprouting	  	  
	  
Spinal	   cord	  vascularization	  has	  been	  described	  only	   fragmentary	   in	   zebrafish	   (Okuda	  et	  al.	  
2012).	   Time-­‐lapse	   imaging	   and	   careful	   counting	   of	   sprouts	   showed	   that	   normal	  
vascularization	   occurs	   similarly	   in	   WT	   zebrafish	   larvae	   as	   in	   flt1ka601	   mutants	   but	   at	   a	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considerably	   later	   time	   point.	   From	   12-­‐15dpf	   sprouts	   originate	   mostly	   from	   venous	   ISVs	  
(more	  than	  90%)	  and	  laterally	  vascularize	  the	  spinal	  cord	  without	  invading	  it	  (Figure	  4-­‐27c).	  
This	   vascularization	   is	   completed	   at	   20dpf	   and	   is	   congruent	   with	   the	   flt1ka601	   sprouting	  
behavior	  at	  2.5dpf	   (Figure	  4-­‐3c’’).	  At	   later	  developmental	  stages	  the	  spinal	  cord	   is	  possibly	  
also	  internally	  vascularized	  similar	  to	  spinal	  cord	  neurovascular	  development	  in	  mice	  (James	  
et	  al.	  2009).	  
	  
Figure	  4-­‐27.	  Spinal	  cord	  vascularization	  in	  WT	  larvae	  occurs	  from	  the	  venous	  side.	  
(a)	  The	  spinal	  cord	  is	  laterally	  vascularized	  between	  11-­‐15dpf	  from	  mostly	  venous	  ISVs.	  Spinal	  cord	  neurons	  in	  
red,	  and	  ECs	  in	  green.	  (b)	  WT	  ECs	  lacking	  spinal	  cord	  vasculature	  at	  4dpf.	  WT	  embryos	  do	  not	  show	  spinal	  cord	  
vascularization	  prior	  to	  11	  dpf.	  (c)	  Representative	  image	  of	  the	  trunk	  vasculature	  with	  spinal	  cord	  vasculature	  
marked	  with	   numbers.	   (d)	  Quantification	  of	   spinal	   cord	   vasculature	   sprout	   origin	   in	  WT	   at	   13dpf.	  Note	   that	  
most	   sprouts	   originate	   from	   venous	   ISVs.	   ISV,	   intersegmental	   vessel;	   dpf,	   days	   post	   fertilization.	   Scale	   bar	  
50µm.	  Sprout	  counting	  and	  imaging	  were	  performed	  by	  Alina	  Klems.	  
	  
4.5.3 Notch	  related	  genes	  are	  not	  deregulated	  in	  flt1ka601	  mutants	  	  
	  
Various	   marker	   genes	   enriched	   in	   angiogenic	   tip	   cells	   have	   been	   described	   (Herbert	   &	  
Stainier	  2011).	  Genes	  downstream	  of	  Dll4/Notch1a	  signaling	  are	  strongly	  associated	  with	  tip-­‐	  
and	   stalk	   cell	   identity	   (Leslie	   et	   al.	   2007;	  Herbert	  &	  Stainier	   2011).	  Other	  markers	   such	  as	  
esm1,	  which	  is	  known	  to	  increase	  VEGF	  bioavailability	  and	  angpt2,	  with	  poorly	  characterized	  
tip	   cell	   function,	   are	   known	   tip-­‐cell	  markers	   (del	   Toro	   et	   al.	   2010;	   Rocha	   et	   al.	   2014).	   To	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transcriptionally	   profile	   sprout	   characteristics,	   the	   transcriptome	   of	   flt1ka601	   mutants	   was	  
analyzed	   using	   RNA	   sequencing	   and	   differentially	   regulated	   genes	   were	   identified.	   As	  
expected,	   tip	  cell	  markers	  such	  as	  angpt2a	  and	  esm1	  were	  strongly	  upregulated	  (Figure	  4-­‐
28a-­‐c)	   whereas	   notch	   related	   genes	   such	   as	   dll4,	   notch1a,	   nrarpa/b	   and	   hey/hes	   were	  
surprisingly	   not	   differentially	   regulated	   in	   flt1ka601	  mutants	   (Figure	   4-­‐28b)	   (del	   Toro	   et	   al.	  
2010).	   This	   finding	   is	   in	   line	  with	   the	   observation	   that	   ectopic	   sprouts	   in	   flt1ka601	  mutants	  
originate	   from	   venous	   ECs,	   which	   were	   shown	   to	   have	   low	   or	   absent	   notch	   signaling	  
(Quillien	  et	   al.	   2014).	   The	   secreted	  Esm1	  protein,	   according	   to	   its	   function	   in	  mice,	  would	  
further	   increases	  Vegfaa	   levels	   (Rocha	  et	  al.	  2014).	  This	  positive	   feedback	   loop	  would	  thus	  




Figure	  4-­‐28.	  RNAseq	  analysis	  and	  qPCR	  validation	  of	  flt1ka601	  mutants.	  
(a)	   Heat	   map	   showing	   deregulated	   genes	   defined	   as	   ≥	   2	   fold	   significantly	   regulated	   (P<	   0.05)	   with	   two	  
independent	  methods	  (DEseq	  and	  Cuffdiff)	  from	  three	  independent	  biological	  replicates.	  Upregulated	  genes	  in	  
green,	  downregulated	  genes	  in	  red.	  (b)	  qPCR	  validation	  of	  indicated	  genes	  identified	  as	  differentially	  expressed	  
between	  WT	  and	  flt1ka601	  mutants	  in	  RNAseq	  experiment	  at	  4dpf.	  (c)	  Expression	  of	  known	  regulators	  of	  the	  tip-­‐
stalk	  cell	  identity.	  Note	  that	  expression	  of	  relevant	  genes,	  thought	  to	  be	  involved	  in	  tip	  cell	  formation	  are	  not	  
altered	  in	  flt1ka601	  mutants,	  although	  increased	  number	  of	  tip	  cells	  can	  be	  derived	  from	  elevated	  esm-­‐1	  and	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angpt2a	  levels.	  F.c.,	  fold	  change;	  dpf,	  days	  post	  fertilization;	  FPKM,	  Fragments	  Per	  Kilobase	  of	  exon	  per	  Million	  
fragments	  mapped.	  	  
	  
4.6 Artery-­‐vein	  differences	  in	  Vegfaa	  responsiveness	  can	  be	  explained	  with	  notch	  
	  
One	  major	  difference	  between	  arteries	  and	  veins	  is	  their	  Notch	  signaling	  status.	  NOTCH	  has	  
been	  described	  as	  an	  activator	  or	  repressor	  of	  sprouting	  depending	  on	  the	  organ	  (Suchting	  
et	  al.	  2007;	  Ramasamy	  et	  al.	  2014).	  The	  anti-­‐angiogenic	  actions	  of	  NOTCH	  have	  been	  mostly	  
attributed	   to	   FLT1,	  which	   is	   downstream	  of	  NOTCH	   signaling.	   To	   test	   if	   Notch	   signaling	   is	  
anti-­‐angiogenic	   in	   arterial	   ISVs,	   possibly	   explaining	   the	  discrepancy	   in	   angiogenic	  potential	  
between	   aISVs	   and	   vISVs,	   Notch	   was	   inducibly	   depleted	   specifically	   in	   aISVs	   utilizing	   the	  
dominant	   negative	   truncated	   fusion	   protein	   DN-­‐Maml-­‐GFP	   (Figure	   4-­‐29a-­‐c)	   (Zhao	   et	   al.	  
2014).	  The	   inducible	  gal4ERt2	  was	  driven	  using	  an	  arterial	   specific	   flt1	   enhancer	  promoter	  
construct	   (Bussmann	   et	   al.	   2010).	   Gal4ERt2	   induction	   at	   52hpf	   could	   be	   traced	   with	   the	  
MAML-­‐GFP	   signal	   in	   arterial	   ECs	   in	   flt1ka601	   mutants.	   Remarkably,	   DN-­‐Maml-­‐GFP	   positive	  
arterial	   ISVs,	   which	   have	   blocked	   notch	   signaling,	   emanated	   sprouts	   similar	   to	   vISVs	   in	  
flt1ka601	  mutants,	   albeit,	   at	   four	   fold	   decreased	   levels	   compared	   to	   venous	   ISVs	   (Figure	   4-­‐
29a-­‐c).	  This	  finding	  suggests	  that	  Notch	  is	  a	  strong	  negative	  regulator	  of	  sprout	  formation	  in	  
arteries,	  independent	  of	  Flt1.	  Notably,	  in	  this	  experiment	  Notch	  signaling	  was	  inhibited	  in	  a	  
mosaic	   fashion,	   hence	   incomplete	   Notch	   signaling	   deactivation	   cannot	   be	   excluded.	  
Therefore,	   it	   is	   not	   surprising	   that	   sprouting	   levels	   in	   vISVs	   are	   higher	   than	   in	   aISVs	   even	  
though	  their	  sprouting	  potential	  may	  be	  similar	  under	  notch	  loss-­‐of-­‐function	  conditions.	  It	  is	  
known	  that	  NOTCH	  exhibits	  anti-­‐angiogenic	  effects	  but	  that	  notch	  can	  be	  repressive	  even	  in	  
the	  absence	  of	  its	  major	  effector	  FLT1	  is	  novel	  (Suchting	  et	  al.	  2007;	  Funahashi	  et	  al.	  2010;	  
Jakobsson	   et	   al.	   2010).	  Moreover,	   ectopic	   venous	   sprout	   numbers	   did	   not	   differ	   between	  
flt1ka601	   mutants	   and	   arterial	   DN-­‐Maml	   gain-­‐of-­‐function	   flt1ka601	   mutants	   (Figure	   4-­‐29c),	  




Figure	   4-­‐29.	   Inhibiting	   Notch	   partially	  
restores	  arterial	  sprouting	  	  
(a)	   flt1ka601	   mutants	   show	   ectopic	   venous	   sprouts	  
(blue	   circles),	   but	   no	   arterial	   sprouts.	   (b)	   Inhibiting	  
arterial	   Notch	   by	   endoxifen-­‐induced	   arterial	   ISV	  
specific	   expression	   of	   dominant	   negative	   MAML	  
(Notch	   iΔEC)	   at	   52hpf	   under	   control	   of	   the	   flt1enh	  
promoter	  in	  flt1ka601	  mutant	  results	  in	  the	  emergence	  
of	   ectopic	   arterial	   sprouts	   (red	   circles).	   (c)	  
Quantification	  of	  experiments	   in	  (a,b),	  mean	  ±	  s.e.m,	  
n=7.	   (d,e)	   Comparison	   of	   flt1ka601	   mutant	   (d)	   with	  
flt1ka601	   mutant	   injected	   with	   flt4	   targeting	  
morpholino	   and	   treated	   with	   notch	   inhibitor	   DAPT	  
(e).	  Note	  that	   in	  flt1ka601,	  flt4	  MO	  embryos,	   inhibition	  
of	   notch	   with	   DAPT	   does	   not	   induce	   patent	   sprouts	  
(only	   few	   filopodial	   extensions	   –	   arrowheads	   in	   (e),	  
although	   flt1	   and	   Notch	   signaling	   are	   absent	   in	  
arteries	   (e),	   n=3	   embryos.	   MO,	   morpholino;	   vISV,	  
intersegmental	   vein;	   aISV,	   intersegmental	   artery;	  
Notch	   iΔEC,	   inducible	   ISV	   specific	   loss	   of	   notch;	   A,	  






To	   substantiate	   these	   data	   the	   gamma-­‐
secretase	  inhibitor	  DAPT	  was	  used	  to	  inhibit	  
notch	   signaling	   in	   flt1ka601;	   Flt4MO	   injected	  
embryos	   (Figure	   4-­‐29d,e).	   These	   embryos	  
have	   mostly	   aISVs	   and	   displayed	   even	  
without	   arterial	   Notch	   signaling	   only	   mild	  
filopodia	   and	   ectopic	   sprout	   induction	   with	  
only	   few	   patent	   connections	   formed.	   These	  




4.7 Neuronal	   sFlt1	   and	   Vegfaa	   determine	   angiogenic	   sprouting	   at	   the	   neurovascular	  
interface	  
	  
Flt1	  and	  vegfaa	  are	  expressed	  in	  spinal	  cord	  neurons	  and	  not	  only	  flt1+	  venularized	  arterial	  
ECs	  but	  also	  flt1-­‐	  purely	  venous	  ECs	  contribute	  to	  the	  vascular	  hypersprouting	  (Figure	  4-­‐26).	  
These	   flt1-­‐	  ECs	  never	  expressed	   flt1	  during	  development	  but	  generate	  hypersprouts	  at	   the	  
spinal	   cord	   in	   flt1ka601	   mutants	   (Krueger	   et	   al.	   2011).	   This	   strongly	   suggests	   a	   non-­‐cell	  
autonomous	  neuronal	   Flt1	   function.	   To	  validate	   the	  possibility	   that	   indeed	  not	   the	   lack	  of	  
vascular	   Flt1	   but	   neuronal	   Flt1	   is	   sufficient	   to	   explain	   the	   hypersprouting	   phenotype	   in	  
flt1ka601	  mutants,	  neuronal	  specific	  flt1	  mutants	  (flt1ΔNC)	  were	  generated	  using	  a	  CRISPR/Cas-­‐
mediated	  KO	  approach	  (Ablain	  et	  al.	  2015).	  Cas9	  was	  expressed	  in	  neurons	  using	  the	  strong	  
pan-­‐neuronal	  promoter	  xla.tubb	   driving	  Gal4-­‐VP16	   to	  amplify	   the	  expression	  of	  UAS:Cas9-­‐
t2A-­‐eGFP	   and	   allowing	   visualization	   of	   potential	   KO	   cells	   (Figure	   4-­‐30b).	   The	   same	   flt1	  
specific	   sgRNA	   as	   used	   to	   generate	   flt1ka601	  mutants	   targeting	   flt1	   exon	   3,	  was	   expressed	  
under	  the	  control	  of	  a	  ubiquitously	  expressed	  zebrafish	  U6	  promoter	  (Ablain	  et	  al.	  2015).	  To	  
increase	  the	   likelihood	  of	  a	  biallelic	  KO,	   flt1ka601/+	  heterozygous	  mutants	  were	  used	  for	  the	  
tissue-­‐specific	  knockout	  experiment.	  In	  heterozygous	  flt1ka601/+	  mutants,	  rarely	  single	  ectopic	  
sprouts	  can	  be	  observed,	  suggesting	  that	  Vegfaa	  levels	  in	  heterozygous	  mutants	  are	  close	  to	  
the	  sprouting	  threshold	  (Figure	  4-­‐3b’’’).	  Mosaic	  expression	  of	  Cas9	  and	  sgRNAflt1E3	  resulted	  in	  
massive	   induction	   of	   hypersprouting	   reaching	   almost	   comparable	   sprouting	   levels	   as	   in	  
flt1ka601	   mutants	   (compare	   Figure	   4-­‐30a	   and	   a’’).	   This	   experiment	   strongly	   suggests,	   that	  




Figure	  4-­‐30.	  Loss	  of	  neuronal	  flt1	  induces	  spinal	  cord	  vascularization.	  
(a-­‐a’’)	   Neuron-­‐specific	   loss	   of	   flt1	   (flt1ΔNC)	   induces	   ectopic	   sprouting	   (e’’,	   sprouts	   in	   yellow	   dotted	   ellipse),	  
arrowheads	   indicate	   neuronal	   cells	  with	   Cas9	   expression.	   (b)	   Approach	   for	   generating	   a	   neuron-­‐specific	   flt1	  
mutant.	  Cas9	  was	  expressed	  under	  control	  of	  neuronal	  promoter	  XIa.Tubb;	  sgRNA	  was	  expressed	  ubiquitously,	  
resulting	   in	  Cas9	  activity	   in	  neuronal	  cells	  of	   flt1ka601/+	  only	   (domain	  marked	  by	  orange	  border).	  Heterozygous	  
flt1ka601/+	   were	   used	   to	   facilitate	   biallelic	   knockout.	   (c)	   Quantification	   of	   ectopic	   sprouting	   for	   indicated	  
genotypes.	  Note	  that	  neuron-­‐specific	   loss	  of	  flt1	  significantly	  augments	  ectopic	  sprouting	  (green	  bar)	  mean	  ±	  
s.e.m,	  n=16	  embryos.	  flt1ΔNC,	  neuron	  specific	  loss	  of	  flt1;	  dpf,	  days	  post	  fertilization.	  Scale	  bar,	  50µm.	  	  
	  
4.7.1 Transplanted	  flt1ka601	  neurons	  but	  not	  ECs	  are	  competent	  to	  induce	  hypersprouting	  
	  
To	   substantiate	   the	   results	   obtained	   from	   the	   tissue	   specific	   neuronal	   flt1	   knockout	  
experiment,	  blastula	  cell	  transplantations	  were	  performed	  (Figure	  4-­‐31a)	  (Kemp	  et	  al.	  2009).	  
Undifferentiated	   cells	   from	   flt1ka601;	   Tg(kdrl:EGFP)s843	   donor	   blastulas	   were	   transplanted	  
close	  to	  the	  margin	  into	  mesodermal	  regions	  (ECs)	  or	  in	  the	  middle	  between	  animal	  pole	  and	  
margin	  into	  ectodermal	  regions	  (spinal	  cord	  neurons)	  of	  Tg(kdrl:hsa.-­‐HRAS-­‐mcherry)s916	  wild	  
type	   hosts	   (Figure	   6-­‐31a).	   Obtained	   mosaic	   zebrafish	   embryos	   were	   assayed	   for	   the	  
emergence	   of	   ectopic	   sprouts	   as	   observed	   in	   flt1ka601	   mutants	   at	   4dpf.	   Remarkably,	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transplantation	   of	   high	   numbers	   of	   flt1ka601	   neuronal	   cells	   resulted	   in	   ectopic	   venous	  
sprouting	  as	  observed	  in	  flt1ka601	  mutants	  (Figure	  6-­‐33b).	  In	  contrast,	  transplantation	  of	  ECs	  
did	   not	   result	   in	   ectopic	   sprout	   formation	   suggesting	   that	   flt1	   depletion	   in	   ECs	   is	   not	  
sufficient	   to	   induce	   hypersprouting	   (Figure	   6-­‐33c).	   In	   summary,	   these	   data	   further	  
substantiate	   that	   neuronal	   cells	   are	   the	   relevant	   source	   of	   Flt1	   and	   that	   vascular	   Flt1	   is	  
dispensable	  for	  early	  sprouting	  angiogenesis	  in	  zebrafish.	  	  
	  
	  
Figure	  4-­‐31.	  Transplantation	  of	  flt1ka601	  NCs	  but	  not	  ECs	  induces	  ectopic	  sprouting.	  
(a)	   Schematic	   illustration	   of	   transplantation	   of	   50-­‐100	   cells	   from	   a	   flt1ka601	   Donor	   to	   a	   WT	   host.	   (b)	  
Transplantation	  of	  NCs	  (red)	  from	  a	  flt1ka601	  donor	  to	  a	  WT	  host	  (green	  ECs)	  induces	  ectopic	  hypersprouting	  at	  
the	  level	  of	  the	  neural	  tube,	  white	  arrow	  heads.	  4dpf.	  (c)	  Transplantation	  of	  ECs	  (green)	  from	  a	  flt1ka601	  donor	  
to	  a	  WT	  host	   (red	  ECs)	  does	  not	   induce	  ectopic	  sprouting,	  4dpf.	  EC,	  endothelial	   cell;	  NC,	  neuronal	  cell.	  Scale	  
bar,	  20µm.	  
	  
4.8 Neuronal	  soluble	  Flt1	  controls	  spinal	  cord	  vascularization	  
	  
mflt1ka605	  and	  neuronal	  specific	  flt1	  KO	  analysis	  suggest	  that	  indeed	  neuronal	  sFlt1	  and	  not	  
mFlt1	  is	  the	  major	  regulator	  of	  spinal	  cord	  vascularization	  in	  the	  zebrafish	  trunk.	  To	  examine	  
if	   neuronal	   sflt1	   expression	   is	   sufficient	   to	   explain	   the	   venous	   spinal	   cord	   hypersprouting	  
phenotype	  in	  flt1ka601	  mutants,	  sflt1	  was	  overexpressed	  in	  spinal	  cord	  neurons	  using	  the	  pan-­‐
neuronal	  xenopus	  beta-­‐tubulin	  promoter	  xla.tubb.	  Overexpression	  of	  even	  trace	  amounts	  of	  
neuronal	   sflt1	   during	   early	   zebrafish	   development	   completely	   abolished	   ISV	   formation	  
(Figure	   4-­‐32e).	   To	   circumvent	   impaired	   ISV-­‐formation,	   an	   inducible	   approach	   using	   the	  
Gal4ERt2/UAS	  system	  was	  utilized	  and	  activated	  after	  ISV	  remodeling	  at	  52hpf	  (see	  Figure	  4-­‐
32a	  for	  Gal4ERt2/UAS	  system	  and	  Figure	  4-­‐32e	  for	  experimental	  design).	  Strikingly,	  even	  few	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sFlt1	   expressing	   spinal	   cord	   neurons	   were	   sufficient	   to	   rescue	   flt1ka601	   spinal	   cord	  
hypervascularization	   (Figure	   4-­‐32b-­‐c).	   This	   experiment	   demonstrates	   that	   even	   trace	  
amounts	  of	  neuronal	  sFlt1	  are	  sufficient	  to	  keep	  the	  neural	  tube	  avascular.	  
	  
	  
Figure	  4-­‐32.	  Neuronal	  sFlt1	  gain-­‐of-­‐function	  rescues	  flt1ka601	  hypersprouting.	  
(a)	   Schematic	   of	   injection,	   expression	   induction	   and	   observation.	   (b)	   Schematic	   representation	   of	   endoxifen	  
inducible	  gain-­‐of-­‐function	  approach	  in	  zebrafish.	  In	  the	  present	  situation	  Gal4	  is	  under	  the	  control	  of	  neuron-­‐
specific	  promoters	  elavl	  or	  xIa.tubb.	  Expression	  can	  be	  observed	  within	  1.5hrs	  upon	  endoxifen	  application.	  (c)	  
Hyperbranching	  in	  flt1ka601	  mutants	  (dotted	  box).	  (c’)	  Endoxifen	  inducible	  neuron	  specific	  sflt1	  gain-­‐of-­‐function	  
rescues	  hyperbranching	  in	  flt1ka601	  mutants;	  compare	  dotted	  box	  in	  b’	  and	  b.	  Purple	  arrowheads	  indicate	  vISVs;	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endoxifen	  was	   applied	   at	   52hpf.	   (d)	  Quantification	   of	   rescue	   in	   (c,c’),	  mean	   ±	   s.e.m,	  n=5	   embryos.	   (e)	   Non-­‐
inducible	  overexpression	  of	  sflt1	  in	  neurons	  prevents	  ISV	  formation,	  rendering	  analysis	  impossible.	  GOI,	  gene	  of	  
interest;	  POI,	  protein	  of	  interest;	  flt1iNC,	  inducible,	  neuronal	  cell	  specific	  gain-­‐of-­‐function;	  ΔNC;	  dpf,	  days	  post	  
fertilization.	  Scale	  bar,	  50µm.	  
	  
4.9 Neuronal	  Vegfaa	  drives	  spinal	  cord	  vascularization	  in	  flt1ka601	  mutants	  
	  
To	   prove	   that	   neuronal	   Vegfaa	   promotes	   hyperbranching	   in	   flt1ka601	   mutants,	   inducible	  
neuronal	  vegfaa165	  gain-­‐of-­‐function	  zebrafish	  were	  generated.	  Expression	  was	  initiated	  by	  
adding	  endoxifen	  at	  52hpf	   immediately	  after	   ISV	  remodeling	   is	  completed.	  Rapidly	  ectopic	  
sprouts,	  resembling	  flt1ka601	  mutant	  sprouts,	  appeared	  (compare	  Figure	  4-­‐33a	  and	  b).	  As	  the	  
ectopic	   sprouts	   in	   flt1ka601	   mutants	   evolved	   in	   part	   from	   purely	   venous	   ECs,	   endothelial	  
responsiveness	   to	  Vegfc	  was	   evaluated	   in	   an	   analogous	   approach.	   Inducible	   expression	  of	  
vegfc	  in	  the	  spinal	  cord	  did	  not	  in	  a	  single	  instance	  induce	  hypersprouting	  at	  the	  spinal	  cord	  
level,	   suggesting	   that	   venous	   ECs	   after	   vISV	   incorporation	   lose	   their	   Vegfc	   responsiveness	  
(Figure	  4-­‐33c).	  	  
	  
	  
Figure	  4-­‐33.	  Vegfaa	  but	  not	  Vegfc	  induces	  hypersprouting	  in	  flt1ka601	  mutants.	  
(a,	  b)	  Endoxifen	   inducible	  neuron	  specific	  vegfaa165	  gain-­‐of-­‐function	   induces	  hyperbranching	  (arrowheads	   in	  
b)	  compared	  to	  WT	  (a).	  (c)	  Endoxifen	  inducible	  neuron	  specific	  vegfc	  gain-­‐of-­‐function	  (yellow	  arrowheads)	  does	  
not	  induce	  ectopic	  sprouting	  at	  level	  of	  neural	  tube.	  iNC,	  inducible,	  neuronal	  cell	  specific	  gain-­‐of-­‐function.	  Scale	  
bar	  25μm.	  
	  
On	  the	  other	  hand,	  reduction	  of	  Vegfaa	  levels	  using	  low	  dosage	  morpholino	  injections	  into	  
flt1ka601	   mutants	   resulted	   in	   complete	   rescue	   of	   the	   spinal	   cord	   hypervascularization	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phenotype,	   confirming	   Vegfaa	   to	   be	   the	   driver	   of	   the	   flt1ka601	   loss-­‐of-­‐function	   phenotype	  
(Figure	  4-­‐34).	  	  
	  
	  
Figure	  4-­‐34.	  Vegfaa	  reduction	  rescues	  flt1ka601	  hypersprouting.	  
(a,a’)	   Morpholino-­‐mediated	   reduction	   of	   vegfaa	   expression	   in	   flt1ka601	   mutants	   rescues	   sprouting	   defects;	  
compare	   dotted	   box	   in	   a	   and	   a’.	   (b)	   Quantification	   of	   rescue	   in	   (a,a’),	   mean	   ±	   s.e.m,	   n=5.	   dpf,	   days	   post	  
fertilization;	  MO,	  morpholino.	  Scale	  bar,	  50	  µm.	  
	  
In	   line	  with	   the	   vegfaa	  MO	   rescue	   experiment,	   blockade	   of	   the	   cognate	   receptor	   Kdrl	   by	  
application	   of	   the	   ki8751	   Kdrl	   tyrosine	   kinase	   inhibitor	   to	   the	   media	   of	   flt1ka601	   mutants	  
annihilated	  the	  formation	  of	  the	  ectopic	  neovascular	  network.	   In	  contrast,	  the	  Flt4	  specific	  
tyrosine	   kinase	   inhibitor	  MAZ51	  did	   not	   rescue	  hyperbranching	   in	   flt1ka601	  mutants	   clearly	  
showing	  that	  Vegfaa,	  but	  not	  Vegfc	  induces	  flt1ka601	  hypersprouting	  (Figure	  4-­‐35).	  
	  
	  
Figure	  4-­‐35.	  Flt1ka601	  hypersprouting	  is	  Vegfaa-­‐Kdrl-­‐dependent.	  
(a-­‐a’’)	   Flt1ka601	   	   mutant	   treated	   with	   DMSO	   (a);	   treated	   with	   Kdrl	   receptor	   signaling	   inhibitor	   ki8751	   (R2	  
inhibitor,	   a’);	   treated	  with	   Flt4	   tyrosine	   kinase	   inhibitor	  MAZ51	   (a’’,	   R3	   inhibitor).	   (b)	  Quantification	  of	   a-­‐a’’.	  
Mean	  ±	  s.e.m,	  n=11.	  R2,	  VEGF	  receptor	  2;	  R3,	  VEGF	  receptor	  3.	  Scale	  bar,	  50µm.	   Imaging	  and	  quantification	  
was	  performed	  together	  with	  Laetitia	  Preau.	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5 Discussion	  	  
	  
Angiogenesis	  is	  crucial	  for	  embryonic	  development,	  tissue	  regeneration	  upon	  ischemic	  tissue	  
injury	  and	  tumor	  growth.	  Vegfa	  has	  been	  recognized	  as	  the	  principle	  driver	  of	  angiogenesis,	  
involving	  signaling	   through	  Vegf	   receptor-­‐2/Kdrl.	  Vegfa	   levels	  have	   to	  be	  well	   regulated	  as	  
both	   loss-­‐	   and	   gain	   of	   Vegfa	   result	   in	   profound	   angiogenesis	   defects.	   It	   has	   long	   been	  
suggested	   that	   regulation	   of	   Vegfa	   levels	   involves	   Vegf	   receptor-­‐1/Flt1,	   acting	   as	   a	   Vegfa	  
scavenger	   limiting	   Vegfa	   bioavailability	   and	   Kdrl	   signaling.	   However,	   how	   Flt1	   actions	   are	  
coordinated	  and	  how	  this	  influences	  complex	  angiogenic	  cell	  behaviors	  culminating	  into	  the	  
formation	  of	  perfused	  branched	  arterial-­‐venous	  networks,	  is	  controversially	  discussed.	  	  
In	   the	   work	   presented	   in	   this	   dissertation	   the	   zebrafish	   model	   system	   was	   used	   to	  
characterize	  the	  function	  of	  Flt1	  in	  generating	  and	  shaping	  branched	  and	  perfused	  vascular	  
networks.	  Additionally,	  the	  function	  of	  Flt1	  at	  the	  neurovascular	  interface	  and	  how	  it	  affects	  
formation	   of	   neurovascular	   units	   is	   poorly	   described.	   Using	   a	   combination	   of	   global	   and	  
tissue-­‐specific	  mutants,	  substantiated	  by	  cell	  transplantation	  and	  inducible	  gain-­‐of-­‐function	  
experiments	   we	   find	   that	   neuronal	   Flt1,	   not	   vascular	   Flt1	   controls	   vascular	   branching	  
morphogenesis	   of	   the	   spinal	   cord	   vasculature.	  We	   furthermore	   provide	   evidence	   showing	  
that	  sFlt1,	  not	  mFlt1	  is	  the	  important	  mediator	  of	  spinal	  cord	  vascularization.	  Furthermore,	  
loss	   of	   Flt1	   or	   gain	   of	   neuronal	   Vegfaa	   induces	   a	   novel	   Kdrl-­‐dependent	   venous	   sprouting	  
form	   that	   based	   on	   cell	   kinetics	   and	   molecular	   signature	   differs	   from	   primary	   artery	   or	  
secondary	  venous	  sprouting.	  In	  accordance	  with	  previous	  sprouting	  designations	  we	  termed	  
this	   novel	   sprouting	   form,	   'tertiary	   sprouting',	   and	   show	   that	   spinal	   cord	  neurons	   and	   the	  
tertiary-­‐sprout	   capillary	   network	   form	   a	   compact	   neurovascular	   unit	   that	   is	   regulated	   by	  
tightly	   controlled	   neurovascular	   cross-­‐talk.	   This	   novel	   sprouting-­‐mode	   is	   also	   observed	  
during	   normal	   development,	   and	   there	   also	   contributes	   to	   spinal	   cord	   vascularization.	   In	  
contrast	  to	  previous	  reports,	  vascular	  Flt1	  was	  found	  to	  be	  dispensable	  for	  tip	  cell	  selection	  
and	  sprout	  guidance.	  
	  
5.1 Distinctive	  angiogenic	  cell	  behaviors	  in	  flt1ka601	  tertiary	  sprouts	  	  
	  
The	   tertiary	   sprouts	  observed	   in	   flt1ka601	  mutants	  are	  distinct	   from	  primary	  and	  secondary	  
sprouting	  events	  in	  the	  trunk	  (Isogai	  et	  al.	  2003;	  Ellertsdóttir	  et	  al.	  2010).	  Primary	  sprouting	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constitutes	  a	  special	   type	  of	  Vegfa-­‐Kdrl-­‐dependent	  arterial	  sprouting	  angiogenesis	  which	   is	  
for	  instance	  insensitive	  to	  loss	  of	  flow	  whereas	  secondary	  sprouting	  is	  Flt4-­‐Vegfc	  dependent.	  
As	   opposed	   to	   this,	   tertiary	   sprouting	   is	   Vegfaa-­‐Kdrl	   regulated	   and	   originates	   from	   the	  
venular	   side.	   These	   characteristics	   closely	   resemble	   tumor	   angiogenesis	   and	   angiogenic	  
processes	   during	   wound	   healing	   and	   therefore	   possibly	   constitute	   a	   better	   model	   for	  
angiogenesis	   research	   than	   primary	   and	   secondary	   sprouting	   in	   zebrafish	   (Risau	   1995;	  
Bergers	  &	  Benjamin	  2003).	  
	  
Of	   note,	   primary	   and	   secondary	   sprouts	   are	   resistant	   to	   loss	   of	   blood	   flow	   shear	   stress	  
(Watson	   et	   al.	   2013;	   Lawson	   et	   al.	   2003).	   flt1ka601-­‐tertiary	   sprouts	   in	   contrast	   are	   very	  
sensitive	   to	   loss	   of	   blood	   flow	   and	   even	   decline	   if	   blood	   flow	   intensity	   is	   decreased.	  
Moreover,	  flt1ka601-­‐	  tertiary	  sprouts	  from	  other	  in	  vitro	  sprouts	  as	  they	  rarely	  show	  shuffling	  
behavior	  as	  described,	  rather	  most	  of	  the	  sprouts	  consist	  of	  only	  a	  single	  cell	  and	  sometimes	  
sprouts	  even	  emanate	  from	  uni-­‐cellular	  tubes	  (Jakobsson	  et	  al.	  2010).	  Sprout	  characteristics	  
and	  differences	  between	  the	  three	  types	  of	  sprouting	  observed	  in	  the	  zebrafish	  trunk	  during	  
early	  development	  are	  depicted	  in	  Table	  5-­‐1.	  
	  
Table	  5-­‐1	  Zebrafish	  sprout-­‐type-­‐characteristics	  




EC	  origin	   Features	  
Primary	  
spouting	  
(arterial	   or	  
not	  specified)	  
Vegfa-­‐Kdrl	   Independent	  
of	  flow	  
Plcy-­‐Erk	   DA	   Very	  robust	  sprouts	  





Vegfc-­‐Flt4	   Independent	  
of	  flow	  
PI3K-­‐Akt	   PCV	   Purely	  venous	  sprouts	  
remodeling	  aISVs	  and	  







PI3K-­‐Akt	   DA	  and	  
PCV	  
Very	  similar	  to	  sprouting	  
processes	  during	  wound	  
healing/tumorangiogenesis.	  
Venular	  sprouts	  
anastomose	  with	  arterioles	  




It	  has	  been	  known	  for	  decades	  that	  nuclear	  positioning	  and	  nuclear	  migration	  are	  important	  
for	   cell	   divisions	   in	   neuroepithelia,	   a	   process	   known	  as	   interkinetic	   nuclear	  migration	   (Del	  
Bene	  2011;	  Strzyz	  et	  al.	  2015).	  However,	  nuclear	  positioning	  in	  endothelial	  biology	  has	  been	  
so	   far	   only	   poorly	   characterized	   (Gundersen	   &	  Worman	   2013).	   We	   could	   unambiguously	  
show,	  that	  endothelial	  nuclei	  migrate	  at	  high	  velocities	  of	  up	  to	  1µm·∙min-­‐1	  and	  position	  at	  
future	  sprout	  initiation	  sites	  of	  tertiary	  sprouts.	  It	  has	  been	  described	  that	  migrating	  ECs	  and	  
most	   other	   cell	   types	   position	   their	   nucleus	   rearwards	   in	   vitro	   and	   that	   this	   polarization	  
seems	   to	   be	   critical	   for	   migration	   to	   proceed	   (Gundersen	   &	   Worman	   2013).	   It	   can	   be	  
speculated	   that	   the	   entire	   cellular	   machinery	   including	   MTOC,	   Golgi	   and	   ER	   has	   to	   be	  
polarized	  to	  allow	  for	  efficient	  protein	  and	  lipid	  transport	  towards	  the	  side	  of	  migration.	  We	  
found	   that	   nuclear	   positioning,	  within	   5µm	   of	   the	   sprout	   initiation	   site,	   occurred	   prior	   to	  
tertiary	   sprout	   elongation.	   Such	   far	   distance	   nuclear	   migration	   behavior	   has	   to	   our	  
knowledge	  not	  been	  described	  before	  in	  migrating	  cells.	  One	  possible	  explanation	  could	  be	  
that	  migration	  events	  in	  cell	  culture	  cells	  are	  normally	  very	  short,	  since	  ECs	  in	  culture	  have	  a	  
spherical	  shape,	  and	  therefore	  nuclear	  migration	  could	  be	  difficult	  to	  detect	  (Gundersen	  &	  
Worman	  2013).	  In	  vivo	  endothelia	  in	  contrast,	  display	  large	  endothelial	  cells	  with	  lengths	  of	  
sometimes	  more	  than	  20µm	  in	  zebrafish.	  Future	  studies	  are	  important	  to	  untangle	  nuclear	  
migration	  events	  in	  sprouting	  endothelial	  cells	  and	  if	  nuclear	  positioning	  is	  also	  observed	  in	  
the	   vasculatures	  of	  other	  organs,	  different	   species	   if	   nuclear	  positioning	   in	   ECs	   is	   affected	  
under	   pathological	   conditions.	   A	   tempting	   possibility	   would	   be	   the	   pharmacological	  
inhibition	  of	  endothelial	  nuclear	  migration	  to	  block	  sprouting	  angiogenesis	  in	  disease.	  	  
	  
Current	  models	  describe	  vISV	  remodeling	  as	  a	  process	  of	  secondary	  sprout	  connection	  and	  
reprogramming	   of	   the	   dorsal	   arterial	   aspect	   into	   venous	   ECs	   after	   the	   onset	   of	   flow	  
(Bussmann	  et	  al.	  2010;	  Quillien	  et	  al.	  2014).	  Utilizing	   time-­‐lapse	   imaging	  of	  photoswitched	  
vECs	  from	  the	  PCV	  (vECsPCV),	  we	  could	  show	  that	  after	  connection	  of	  the	  secondary	  sprout	  to	  
the	   aISV,	   venous	   ECs	  migrate	   dorsally	   along	   the	   vISV	   and	   actively	   proliferate	   and	  displace	  
most	  arterial	  ECs	  (vECsISV),	  albeit	  few	  arterial	  ECs	  remain	  in	  the	  dorsal	  aspect	  of	  venous	  ISVs,	  
which	   become	   venularized	   (vaECsISV)	   and	   downregulate	   arterial	   markers	   such	   as	   Notch	  
(Quillien	   et	   al.	   2014)	   (Figure	   5-­‐2).	   Both	   venous	   EC-­‐subpopulations	   vECsISV	  and	   vaECsISV	   are	  
capable	  to	  respond	  to	  Vegfaa	  and	  form	  tertiary	  sprouts.	  This	  shows	  that	  ECs	   in	  remodeled	  
vISVs	  exhibit	  high	  heterogeneity	  in	  their	  origin	  but	  respond	  in	  a	  coherent	  manner.	  This	  type	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of	  endothelium	  with	  mixed	  origin	  may	  be	  similar	  to	  endothelia	  in	  adults,	  which	  originate	  not	  
only	   from	  one	   endothelial	   population	   but	  mix	   during	   network	   formation	   and	   display	   high	  
heterogeneity	  (Regan	  &	  Aird	  2012).	  A	  detailed	  schematic	  for	  venous	  EC	  nomenclature	  can	  be	  
found	  in	  Figure	  5-­‐1.	  	  
	  
	  
Figure	  5-­‐1.	  Origin	  of	  venous	  ECs	  in	  vISVs	  
vISVs	   are	   composed	   of	   two	   EC-­‐subtypes	   with	   arterial	   or	   venous	   origin.	   Venous	   ECs	   from	   the	   PCV	   form	  
secondary	  sprouts.	  These	  ECs	  are	  called	  here	  vECsPCV.	  After	  they	  intergrated	  into	  vISVs	  they	  are	  termed	  vECsPCV.	  
The	  other	  population	  of	  venous	  ECs	  in	  vISVs	  originates	  from	  the	  DA.	  Dorsal	  aorta	  ECs	  (aECsDA)	  emanate	  sprouts	  
and	   form	   the	   aISVs.	   aISV	   ECs	   are	   termed	   here	   aECsISV.	   When	   aISVs	   are	   remodeled	   into	   venous	   ISVs	   some	  
arterial	  EC	  in	  the	  aISV	  become	  venularized	  which	  are	  called	  here	  vaECs
ISV.	  
	  
Interestingly,	  we	  could	  demonstrate	  using	  inducible	  vegfc	  gain-­‐of-­‐function	  experiments	  that	  
vECsISV	   do	   not	   respond	   to	   Vegfc	   and	   instead	   acquire	   Vegfa	   responsiveness.	   It	   has	   been	  
shown	  that	  ectopic	  Vegfc	  expression	  in	  the	  floor	  plate	  activates	  hypersprouting	  in	  the	  dorsal	  
aspect	  of	   ISVs	  at	  48hpf	   (Le	  Guen	  et	   al.	   2014).	   It	  was	   reported	   that	   this	  phenotype	   can	  be	  
enhanced	   if	  Ccbe1	  and	  Vegfc	  are	  co-­‐expressed	   in	   the	   floor	  plate.	  As	  Ccbe1	   is	  expressed	  at	  
the	  level	  of	  the	  HMS	  and	  is	  necessary	  for	  the	  maturation	  of	  Vegfc	   it	  may	  be	  that	  vISVs	  are	  
only	  responsive	  to	  Vegfc	  expressed	  at	  the	  level	  of	  the	  HMS	  (source	  of	  Ccbe1)	  or	  at	  least	  close	  
to	  it,	  such	  as	  floor	  plate	  expression	  (B.	  Hogan	  et	  al.	  2009;	  Le	  Guen	  et	  al.	  2014).	  	  
	  
In	  conclusion,	  EC-­‐characteristics	  do	  not	  seem	  to	  be	  determined	  by	  preset	  genetic	  programs	  
but	   are	   dynamically	   programmed	   according	   their	   environment	   which	   is	   defined	   on	   both	  
sides	  of	  the	  endothelium	  –	  the	  blood	  and	  the	  surrounding	  tissue.	  It	  would	  be	  of	  interest	  why	  
vECsPCV	   migrate	   against	   the	   flow	   direction	   dorsally	   into	   the	   vISVs	   whereas	   vaECsISV	   never	  
migrate	   ventrally	   into	   the	   PCV.	   It	   would	   therefore	   be	   interesting	   to	   elucidate	   how	   this	  




Figure	   5-­‐2.	   Purely	   venous	   and	  
venularized	  arterial	  ECs	  display	  high	  
angiogenic	  potential.	  	  
(a)	   The	   venous	   endothelial	   cells	   that	   give	  
rise	   to	   the	   ectopic	   sprouts	   in	   flt1ka601	  
mutants	   show	   high	   heterogeneity	   and	   are	  
either	   purely	   venous	   originating	   from	   the	  
PCV	   vECsISV	   or	   venularized	   arterial	   ECs	  
(vaECs
ISV)).	   During	   the	   trunk	   AV	   remodeling	  
process,	  secondary	  venous	  sprouts	  connect	  
(arrow)	   to	   the	   ventral	   part	   of	   the	   pre-­‐
existing	   aISV	   (I).	   As	   a	   consequence	   the	  
ventral	  part	  of	  the	  aISV	  loses	  its	  connection	  
to	   the	   dorsal	   aorta	   (II).	   The	   dorsal	   part	  
forms	   a	   functional	   connection	   with	   the	  
cardinal	   vein-­‐derived	   ventral	   part	   (cells	   in	   blue),	   yielding	   an	   intersegmental	   vein	   carrying	   venous	   flow	   (III).	  
Subsequently	  venous	  ECs	  from	  the	  PCV	  migrate	  dorsally	  to	  the	  DLAV	  and	  displace	  the	  majority	  of	  arterial	  ECs	  
(aECsISV)	   (IV).	   Some	  arterial	   ECs	   remain	  and	  are	  venularized	   into	  venous	  ECs	   (avECs
ISV).	  Both	  EC	   subtypes	   can	  
form	  flt1ka601	  tertiary	  sprouts	  and	  are	  responsive	  to	  Vegfaa	  but	  not	  Vegfc.	  The	  dorsal	  aspect	  of	  intersegmental	  
veins	   thus	   has	   mixed	   identity	   (blue	   and	   red	   cells,	   IV)	   whereas	   un-­‐remodeled	   arterial	   ISVs	   contain	   only	   DA	  
derived	   endothelium	   (I)	   (aECsISV).	   EC,	   endothelial	   cell;	   ISV,	   intersegmental	   vessel	   (a-­‐arterial,	   v-­‐venous);	   DA,	  
dorsal	   aorta;	   PCV,	   posterior	   cardinal	   vein;	   DLAV,	   dorsal	   longitudinal	   anastomotic	   vessel;	   hpf,	   hours	   post	  
fertilization.	  
	  
In	   summary,	   tertiary	   sprouts	   exhibit	   greater	   similarity	   with	   physiological	   and	   pathological	  
sprouting	  angiogenesis	  than	  primary	  and	  secondary	  sprouts	  and	  are	  not	  restricted	  to	  flt1ka601	  
mutants	  but	  give	  also	  rise	  to	  the	  spinal	  cord	  vasculature	  during	  normal	  development	  at	  12-­‐
15dpf.	   Tertiary	   sprouts	   have	   venous	   origin,	   are	   blood	   flow	   sensitive	   and	   display	   high	   EC	  
heterogeneity.	  In	  addition,	  they	  require	  nuclear	  positioning	  prior	  to	  sprout	  initiation,	  which	  
is	  difficult	  to	  study	  in	  other	  models,	  hence	  flt1ka601	  tertiary	  sprouting	  constitutes	  a	  novel	  type	  
of	  sprouting	  depicting	  an	  exceptional	  model	  to	  study	  sprouting	  angiogenesis	  and	  would	  be	  





5.2 Neuronal	  Flt1	  –	  a	  new	  cellular	  source	  of	  an	  old	  player	  
	  
In	  zebrafish,	  mice	  and	  other	  vertebrates	  the	  most	  prominent	  expression	  domain	  of	  flt1	  is	  the	  
endothelium	  of	  blood	  vessels	  (Fong	  et	  al.	  1995;	  Bussmann	  et	  al.	  2010;	  Krueger	  et	  al.	  2011).	  
Recent	   evidence	   however	   showed	   that	   flt1	   is	   also	   expressed	   in	   other	   cell	   types	   such	   as	  
neurons,	  macrophages,	  monocytes	  and	  cancer	  cells	  (Sawano	  et	  al.	  2001;	  Ohkubo	  et	  al.	  2014;	  
Selvaraj	  et	  al.	  2015).	  	  
For	   instance,	   FLT1	   signaling	   in	   macrophages	   has	   been	   proposed	   to	   facilitate	  macrophage	  
guidance,	   as	  macrophage	  migration	   was	   impaired	   in	   Flt1	   KO	  mice	   (Hiratsuka	   et	   al.	   1998;	  
Hiratsuka	  et	  al.	  2005).	  Similarly,	  expression	  of	  Flt1	  in	  various	  neuronal	  cell	  populations	  such	  
as	  motor	  neurons,	  sensory	  neurons	  and	  dorsal	  root	  ganglia	  was	  shown	  to	  have	  neuronal	  cell-­‐
autonomous	   functions.	   These	   include	   sensing	   cancer	   pain	   in	   sensory	   neurons	   or	  
neurodegenerative	  functions	  in	  motor	  neurons	  (Poesen	  et	  al.	  2008;	  Storkebaum	  et	  al.	  2005;	  
Selvaraj	  et	  al.	  2015).	  These	  processes	  are	  thought	  to	   involve	  mFLT1	  signaling	  and	  the	  FLT1	  
ligand	  VEGFB.	  In	  the	  present	  study,	  we	  identified	  non-­‐cell	  autonomous	  functions	  of	  neuronal	  
sFlt1	  and	  could	   show	   that	  neuronal	   sFlt1	  affects	   vascular	  patterning	  by	   scavenging	  Vegfaa	  
secreted	   from	   the	   spinal	   cord	   (a	   schematic	  of	   the	  neurovascular	   interface	   in	   the	   zebrafish	  
spinal	  cord	  is	  shown	  in	  Figure	  5-­‐3).	  	  
	  
Figure	   5-­‐3.	   Flt1	   and	   Vegfaa	   at	   the	  
spinal	  cord	  neurovascular	  interface.	  
(a)	   Spinal	   cord	   neurons	   produce	   both	   Flt1	  
and	   Vegfaa	   in	   close	   proximity	   to	   the	   dorsal	  
aspect	   of	   intersegmental	   arteries	   and	   veins.	  










We	  identified	  the	  spinal	  cord	  as	  an	   important	  and	  functionally	  relevant	  source	  of	  sFlt1.	  An	  
outstanding	  question	  is	  which	  neuronal	  cell	  type	  produces	  physiologically	  relevant	  levels	  of	  
sFlt1	  and	  whether	   it	   is	  secreted	  at	  the	  cell	  soma,	  along	  axons	  and	  dendrites	  or	  only	  at	  the	  
synapse?	  In	  our	  overexpression	  experiments	  with	  Vegfaa165	  we	  observed	  that	  vessels	  align	  
along	  Vegfaa165-­‐secreting	  axons	  or	   soma,	   suggesting	   that	  not	  only	   the	   soma	  but	  also	   the	  
axons	  themselves	  can	  secrete	  factors	  such	  as	  sFlt1	  over	  the	  entire	  length	  of	  their	  projection.	  
In	   line	  with	   our	   findings,	  mouse	   and	   quail	   studies	   indicate	   that	   loss	   of	   neuronal	  Vegfa	   or	  
forced	   overexpression	   of	   sFlt1	   reduces	   neuronal	   vascularization	   and	   inhibits	   neuronal	  
differentiation	  (Bautch	  &	  James	  2009;	  Ruhrberg	  &	  Bautch	  2013).	  	  
	  
In	   current	   models	   it	   is	   assumed	   that	   vascular	   FLT1	   is	   an	   important	   regulator	   of	   sprout	  
guidance,	   although	   the	   experimental	   evidence	   is	   somewhat	   limited	   (Chappell	   et	   al.	   2009;	  
Jakobsson	  et	  al.	  2010;	  Ho	  et	  al.	  2012).	  We	   find	   that	  vascular	   flt1	   is	  dispensable	   for	   sprout	  
directionality	   in	   all	   sprouting	   processes	   investigated	   in	   zebrafish.	   In	   flt1-­‐depleted	   sprouts	  
backsprouting	   to	   the	   parent	   vessel	   as	   suggested	   by	   Chappell	   and	   coworkers	   was	   not	  
observed	  in	  the	  zebrafish	  model	  (Chappell	  et	  al.	  2009).	  	  
One	   issue	   regarding	   the	   interpretation	   of	   data	   may	   involve	   the	   use	   of	   morpholinos,	   for	  
further	   reading	   on	   this	   issue	   see	   introduction	   chapter	   “Morpholinos	   –	   friend	   or	   foe?”.	   In	  
flt1ka601	  zebrafish	  mutants	  we	  find	  that	  exclusively	  ectopic	  venous	  sprouting	  contributes	  to	  
the	  formation	  of	  the	  organ-­‐specific	  vasculature	  of	  the	  spinal	  cord.	  Previous	  studies	  suggest	  
that	  with	  flt1	  targeting	  morpholinos	  one	  can	  also	  observe	  ectopic	  arterial	  sprouting	  (Krueger	  
et	  al.	  2011).	  In	  this	  morpholino	  setting,	  Flt1	  morphants	  showed	  more	  tip	  cells	  and	  increased	  
branching	   of	   primary	   aISV-­‐sprouts.	   To	   uncover	   potential	   non-­‐specific	   effects	   induced	   by	  
morpholinos	   there	   is	   now	   largely	   consensus	   in	   the	   field	   to	   test	   different	   morpholinos	  
dosages	  in	  the	  mutant	  background	  of	  the	  corresponding	  gene	  (Rossi	  et	  al.	  2015;	  Stainier	  et	  
al.	   2015).	   We	   followed	   these	   new	   guidelines	   and	   show	   that	   low	   dosage	   flt1	   morpholino	  
injection	  (1ng)	  recapitulates	  the	  flt1ka601	  mutant	  phenotype	  and	  injection	  of	  this	  dosage	  into	  
flt1ka601	  mutants	  does	  not	   induce	  additional	  effects;	   in	  contrast	   injection	  of	  higher	  dosages	  
(>3ng)	   causes	   both	   early	   arterial	   and	   later	   venous	   hypersprouting,	   and	   the	   former	   is	   not	  
rescued	  in	  the	  flt1ka601	  mutant	  background.	  This	  suggests	  that	  the	  vascular	  changes	  observed	  
in	  previous	  studies	  may	  involve	  nonspecific	  side-­‐effects	  related	  to	  the	  high	  MO	  dosage.	  
Zygmunt	   and	   colleagues	   report	   that	   sFlt1	   acts	   downstream	   of	   the	   Sema3aa-­‐PlexinD1	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signaling	   pathway	   (Zygmunt	   et	   al.	   2011).	   In	   the	   zebrafish	   trunk,	   vascular	   PlexinD1	   and	  
somatically	  expressed	  Sema3aa	  are	  considered	  repulsive	  guidance	  cues	  relevant	  for	  guiding	  
arterial	   sprouts	   in	   between	   somites.	   At	   present,	   somites	   are	   also	   considered	   to	   be	   the	  
physiologically	   relevant	   source	   of	   Vegfaa	   driving	   both	   the	   initiation	   of	   sprouting	   and	   the	  
ventrodorsal	  expansion	  of	  the	  aISV.	  Loss	  of	  PlexinD1	  or	  Sema3aa	  results	   in	  hyperbranching	  
of	   aISVs	   into	   the	   somitic	   regions	   without	   penetrating	   the	   somites.	   The	   authors	   provided	  
evidence	   suggesting	   that	   the	   repulsive	   actions	   of	   vascular	   PlexinD1	   involve	   sFlt1.	   In	  
plxnd1Df(Chr08)fs31l/fs31l	  mutants,	  hypersprouting	  occurs	  between	  24-­‐48hpf	  with	  ectopic	  sprouts	  
branching	   from	   the	   aorta,	   and	   the	   aISVs.	   These	   authors	   show	   that	  morpholino	  mediated	  
targeting	   of	   sflt1	   pre-­‐mRNA	   induces	   a	   phenotype	   comparable	   to	   plxnd1Df(Chr08)fs31l/fs31l	  
whereas	  sFlt1	  gain-­‐of-­‐function	  rescues	  hypersprouting	  in	  plxnd1Df(Chr08)fs31l/fs31l.	  If	  indeed	  sFlt1	  
is	   the	   crucial	   mediator	   of	   the	   PlexinD1	   phenotype	   one	   would	   expect	   that	   the	   onset	   of	  
hypersprouting,	  and	  cell-­‐types	  involved	  should	  be	  comparable	  between	  plxnd1Df(Chr08)fs31l/fs31l	  
and	   flt1ka601	  mutants.	  We	  show	  that	   this	   is	  not	   the	  case,	  as	   the	   flt1ka601	  mutant	  phenotype	  
occurs	  2	  days	  after	  emergence	  of	  the	  plxnd1Df(Chr08)fs31l/fs31l	  phenotype.	  Moreover,	  the	  ectopic	  
sprouts	   in	   flt1ka601	   mutants	   arise	   from	   veins	   and	   not	   from	   arteries	   as	   reported	   in	  
plxnd1Df(Chr08)fs31l/fs31l.	  Additionally,	  experimental	  inadequacies	  may	  limit	  the	  reliability	  of	  the	  
data	  presented	  by	  Zygmunt	  and	   colleagues.	   To	   show	   that	   indeed	   sFlt1	   is	   the	  downstream	  
effector	  of	   PlxnD1	   they	  performed	  a	   knockdown	  of	   sflt1	   specifically	   targeting	   the	   I10E11a	  
splice	   acceptor	   and	   verified	   the	   successful	   targeting	   of	   the	   sflt1-­‐pre-­‐mRNA	   by	   RT-­‐PCR	  
spanning	   E10-­‐E11a.	   Successful	   depletion	   of	   sflt1	   splicing	   should	   in	   theory	   result	   in	   the	  
complete	   loss	   of	   a	   PCR	   product.	   Instead	   a	   PCR	   band	   with	   a	   somewhat	   smaller	   size	   as	  
expected	   could	   be	   observed,	   suggesting	   the	   presence	   and	   use	   of	   an	   upstream	   cryptic	  
acceptor	  splice	  site.	  Since	  E11a	  codes	  only	  for	  the	  last	  5	  amino	  acids	  of	  sFlt1,	  cryptic	  splicing	  
would	  most	  likely	  not	  result	  in	  protein	  truncation	  and	  loss-­‐of-­‐function.	  More	  likely	  the	  sflt1	  
targeting	  morpholino	  used	  by	  Zygmunt	  induces	  side-­‐effects	  or	  is	  not	  targeting	  sflt1.	  	  
For	   the	   future	   it	   will	   be	   important	   to	   determine	   (I)	   whether	   local	   sprout	   guidance	   is	  
necessary	  for	  sprout	  elongation	  and	  (II)	  if	  blood	  flow	  shear	  stress	  and	  physical	  constraints	  in	  
the	   tissue	   bed	   where	   the	   sprout	   extends	   give	   the	   sprout	   sufficient	   directionality.	   For	  
instance,	   perpendicular	   blood	   flow	   pressure	   from	   the	   parent	   vessel	   could	   be	   an	   efficient	  
mechanism	   to	   push	   the	   sprout	   away	   from	   the	   source	   as	   reported	   in	   vitro	   (Song	  &	  Munn	  
2011).	   In	   the	   case	   of	   tertiary	   sprouts,	   sprouting	   occurs	   from	   the	   vein	   toward	   the	   artery,	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hence	   against	   the	   direction	   of	   the	   pressure	   gradient.	   Lumen	   formation	   does	   occur	   in	   the	  
direction	  of	   the	  pressure	  gradient,	   yet	   the	  expansion	  of	   the	   tertiary	   sprouts	   could	  also	  be	  
advanced	  by	  venous	  flow	  as	  long	  as	  they	  did	  not	  anastomose	  with	  a	  adjacent	  aISV	  (Gebala	  et	  
al.	   2016).	   Contradictory	   to	   this	   idea,	   primary	   and	   secondary	   sprouts	   in	   zebrafish	   can	   find	  
their	  way	  and	  elongate	  away	  from	  the	  dorsal	  aorta	  even	  in	  the	  absence	  of	  flow	  (Lawson	  et	  
al.	  2003;	  Watson	  et	  al.	  2013).	  Although	  it	  may	  well	  be	  that	  these	  cases	  physical	  constraints	  
from	  the	  somites	  prevent	  backsprouting	  or	  directional	  changes.	  It	   is	  conceivable	  that	  some	  
sprout	   species	   require	   blood	   flow,	   and	   blood	   pressure	   for	   directionality,	   whereas	   others	  
sprouts	  may	  require	  Vegfa	  gradients.	  
Inducible	  depletion	  of	  Flt1	   in	   the	  mouse	   retinal	   plexus	  by	   crossing	  Rosa26	  Cre	  mice	  or	  by	  
injection	  of	  Ad-­‐Cre	  constructs	  into	  Flt1flox/flox	  mice	  resulted	  in	  increased	  tip	  cell	  and	  filopodia	  
numbers	  as	  well	  as	  increased	  numbers	  of	  bifurcations	  (Chappell	  et	  al.	  2009;	  Ho	  et	  al.	  2012).	  
Tip	   cell	   numbers	   per	   area	   increased	   from	   approx.	   4	   in	   Flt1flox/flox	   to	   5.5	   in	   Flt1∆/∆.mice.	  
However,	   these	  changes	  are	   rather	   subtle	  and	   the	  definition	  of	  a	   tip	  cell	   in	   the	   respective	  
statistical	   analyses	   is	   not	   clearly	   defined	   and	   therefore	  may	   be	   overinterpreted	   (Ho	   et	   al.	  
2012).	   Similarly,	   filopodia	   numbers	   and	   bifurcations	   were	   reported	   to	   be	   approx.	   2	   fold	  
increased	   in	   Ad-­‐Cre	   injected	   Flt1flox/flox	   retinas,	   although	   the	   overall	   vessel	   architecture	  
remained	  intact	  (Chappell	  et	  al.	  2009).	  These	  experiment	  show	  that	  loss	  of	  endogenous	  Flt1	  
may	  mildly	   increase	   angiogenic	   potential	   in	  mouse	   neonates	   but	   it	   does	   not	   address	   the	  
question,	   whether	   loss	   of	   neuronal	   or	   vascular	   Flt1	   or	   both	   contributes	   to	   increased	  
sprouting	   potential	   (Chappell	   et	   al.	   2009;	   Ho	   et	   al.	   2012).	   In	   the	   mouse	   retinal	   vascular	  
model	   astrocytes	   produce	   VEGF	   to	   activate	   retinal	   vascularization	   (Dorrell	   et	   al.	   2002;	  
Ruhrberg	  et	  al.	  2002;	  Gerhardt	  et	  al.	  2003).	  This	  is	  very	  similar	  to	  our	  findings	  in	  the	  spinal	  
cord;	  where	  neuronal	  cells	  secrete	  Vegfaa	  to	  induce	  spinal	  cord	  vascularization.	  In	  astrocytes	  
it	  has	  been	  shown	  that	  VEGFR-­‐2	  mediated	  uptake	  of	  VEGF	  limits	  sprouting	  angiogenesis,	  yet	  
it	   is	   unknown	  whether	   neuronal	   FLT1	   similarly	   restricts	   retinal	   angiogenesis	   (Okabe	   et	   al.	  
2014).	  To	  untangle	  the	  contribution	  of	  the	  neuronal	  and	  vascular	  FLT1,	  inducible	  Flt1	  loss-­‐of-­‐
function	  experiments	  should	  be	  repeated	  with	  vascular-­‐	  and	  neuronal-­‐specific	  Cre	  lines.	  	  
Moreover,	   tightly	   controlled	   VEGF	   levels	   were	   shown	   to	   maintain	   neuronal	   integrity	   and	  
safeguard	   neuronal	   survival	   and	   that	   decreases	   in	   VEGF	   levels	   in	   neurons	   can	   lead	   to	  
neurodegenerative	   disease.	   We	   find	   that	   neuronal	   sFlt1	   is	   important	   during	   embryonic	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development	  but	  it	  is	  tempting	  to	  speculate	  that	  neuronal	  Flt1	  in	  mature	  neurons	  in	  adults	  
can	  also	   influence	  their	   integrity	  and	  survival.	  Hence,	  any	  pathological	  changes	  resulting	   in	  
dysregulation	   of	   flt1,	   such	   as	   splice	   site	   mutations	   or	   mutations	   resulting	   in	   increased	  
promoter	  activity	  or	  protein	  stability	  could	  in	  principle	  promote	  neurodegenerative	  disease	  
and	  thus	  represent	  an	  important	  therapeutic	  target	  (Storkebaum	  &	  Carmeliet	  2004;	  Lange,	  
Storkebaum,	  et	  al.	  2016).	  	  
	  
5.3 The	  tip	  cell	  concept	  –	  we	  need	  new	  models	  for	  an	  old	  question	  
	  
Selective	   tip	   cell	   activation	   is	   strictly	   necessary	   to	   facilitate	   an	   orchestrated	   formation	   of	  
sprouts	  and	  vascular	  networks	   (Herbert	  &	  Stainier	  2011;	  Siekmann	  et	  al.	  2013).	  Hence,	  an	  
important	  question	   in	   the	  angiogenesis	   field,	  which	   is	   still	   not	  entirely	  understood,	   is	  why	  
only	   certain	   endothelial	   cells	   respond	   to	   growth	   factors	  whereas	  others	  do	  not.	   Following	  
initial	   sprout	   formation,	  endothelial	  behavior	  within	   the	  sprout	  has	   to	  be	  coordinated	   in	  a	  
way	   that	   the	   entire	   sprout	  migrates	   into	   a	   certain	   direction	   (Phng	  &	  Gerhardt	   2009).	   The	  
processes	   of	   selection	   and	   coordinated	   guidance	   have	   been	   explained	   with	   the	   “tip	   cell	  
concept”,	  proposing	  a	  model	   in	  which	  a	   leading	  tip	  cell	   is	  selected	  by	  lateral	   inhibition	  and	  
guides	   the	   sprout	   towards	   a	   growth	   factor	   gradient	   (Ruhrberg	  et	   al.	   2002;	  Gerhardt	   et	   al.	  
2003).	   Trailing	   stalk	   cells	   are	   considered	   to	   be	   the	   proliferative	   EC-­‐population	   promoting	  
sprout	  elongation.	  	  
We	   show	   here	   for	   the	   first	   time,	   that	   zebrafish	   vascular	   Flt1	   is	   dispensable	   for	   sprouting	  
angiogenesis.	   While	   our	   data	   show	   that	   during	   normal	   embryonic	   development,	   vascular	  
Flt1	   appears	   dispensable	   for	   tip/stalk	   differentiation,	   and	   branching	   morphogenesis,	   we	  
cannot	  rule	  out	  that	  vascular	  Flt1	  may	  play	  a	  role	  during	  different	  conditions.	  For	  instance,	  it	  
is	  possible	  that	  during	  tumor	  growth	  or	  severe	  tissue	  hypoxia,	  VEGF	  levels	  exceed	  thresholds	  
and	  vascular	  Flt1	  can	  to	  some	  extent	  modulate	  vascularization	  and	  sprout	  activation.	  Thus,	  
we	  do	  not	  exclude	  that	  vascular	  Flt1,	  especially	  under	  pathological	  conditions	  has	  important	  
functions.	  
	  
In	  reviews	  on	  sprouting	  angiogenesis	  it	  seems	  to	  be	  clear	  that	  vascular	  FLT1	  is	  an	  important	  
regulator	   of	   tip	   cell	   formation,	   limiting	   angiogenesis.	   However,	   careful	   analysis	   of	   the	  
available	   literature	   reveals	   that	   this	   is	   by	   far	   not	   the	   case.	   The	   first	   Flt1	   loss-­‐of-­‐function	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studies	   were	   conducted	   in	   non-­‐inducible	   Flt1	   KO	   mice,	   in	   which	   over-­‐commitment	   of	  
angioblasts	  leads	  to	  early	  lethality,	  preventing	  the	  analysis	  of	  sprouting	  angiogenesis	  at	  later	  
stages	  in	  these	  mice	  (Fong	  et	  al.	  1995;	  Fong	  et	  al.	  1996;	  Hiratsuka	  et	  al.	  2005;	  Chappell	  et	  al.	  
2009).	  To	  elucidate	  the	  function	  of	  FLT1	  during	  development	  and	  thus	  to	  overcome	  the	  first	  
severe	  angioblast	  phenotype,	  FLT1	   function	   in	  angiogenesis	  was	  addressed	   in	  vivo	  utilizing	  
morula	   transplantation	   experiments	   with	   the	   Flt1	   KO	   mouse	   (Fong	   et	   al.	   1999).	   This	  
laborious	  technique	  was	  used	  because	  inducible	  loss-­‐of-­‐function	  tools	  were	  not	  available	  by	  
the	  end	  of	  the	  1990s.	  Flt1-­‐depleted	  KO	  cells	  were	  transplanted	  into	  WT	  morulas	  at	  densities	  
allowing	   the	  morula	   to	   overcome	   the	   lethal	   angioblast	   over-­‐commitment	   phenotype.	   This	  
study	  showed	  that	  vessels	   lacking	  Flt1	   (lacZ+)	  can	  form	  normally	  and	  do	  not	  display	  severe	  
abnormalities	  (Fong	  et	  al.	  1999).	  As	  the	  lacZ	  staining	  used	  in	  these	  experiments	  allows	  only	  
for	   low-­‐resolution	   imaging	  and	  only	   yolk	   sac	  primary	  plexus	   formation	  has	  been	  analyzed,	  
subtle	   phenotypes	   have	   possibly	   been	   overlooked	   in	   these	   mosaic	   analyses	   (Fong	   et	   al.	  
1999).	  Nonetheless,	  mosaic	  mice	  survive	  to	  adulthood	  giving	  some	  evidence	  that	  FLT1	  is	  not	  
strictly	  necessary	  for	  vascular	  development	  after	  angioblast	  formation.	  	  
	  
As	   mentioned	   in	   the	   previous	   chapter,	   inducible	   Flt1	   loss-­‐of-­‐function	   studies	   have	   been	  
performed	   in	   the	   mouse.	   The	   authors	   reported	   that	   Flt1	   depleted	   retinal	   vessels	   exhibit	  
increased	   filopodia	   numbers	   and	   bifurcations,	   albeit	   the	   overall	   structure	   of	   the	   retinal	  
plexus	  is	  normal	  and	  even	  completely	  Flt1	  depleted	  neonates	  survive	  (Chappell	  et	  al.	  2009;	  
Ho	  et	  al.	  2012).	  The	  authors	  deduced	  from	  these	  data	  that	  FLT1	  has	  an	  important	  function	  in	  
vessel	   formation;	  however	   if	  one	  compares	  these	  phenotypes	  with	  other	  vascular	  mutants	  
such	  as	  Dll4,	  Kdr	  or	  Vegf	  the	  described	  phenotypes	  are	  rather	  mild	  suggesting	  that	  Flt1	  can	  
influence	  VEGF	  levels	  and	  angiogenic	  potential	  but	  does	  not	  regulate	  local	  sprout	  guidance	  
or	   tip	   cell	   formation	   (Suchting	   et	   al.	   2007;	   Hellström	   et	   al.	   2007;	   Carmeliet	   et	   al.	   1996;	  
Benedito	   et	   al.	   2012).	   Other	   authors	   claim	   that	   FLT1	   is	   specifically	   enriched	   in	   stalk	   cells	  
(Jakobsson	  et	  al.	  2010).	  We	  have	  no	  evidence	   in	  zebrafish	   for	   restricted	  expression.	  These	  
authors	  possibly	  overinterpreted	  their	  data	  since	  analysis	  of	  in	  vitro	  data	  can	  be	  problematic	  
as	  cells	  in	  culture	  do	  not	  carry	  flow	  and	  have	  no	  clear	  arterial	  or	  venous	  identity.	  This	  makes	  
interpretation	  of	  data	  deduced	  from	  experiments	  using	  in	  vitro	  sprouting	  models	  extremely	  
delicate.	  This	  is	  further	  enhanced	  by	  the	  fact	  that	  many	  factors	  thought	  to	  be	  involved	  in	  tip	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cell	   selection	   are	   also	   involved	   in	   AVD	   (Lawson	   et	   al.	   2001;	   Siekmann	   &	   Lawson	   2007;	  
Herbert	  &	  Stainier	  2011).	  	  
	  
In	  addition,	  the	  tip	  cell	  concept	  uses	  molecules,	  which	  are	  enriched	  or	  even	  restricted	  to	  the	  
arterial	  or	  to	  the	  venous	  domain,	  such	  as	  FLT1,	  NOTCH1,	  DLL4	  and	  FLT4	  (Herbert	  &	  Stainier	  
2011).	  This	  expression	  difference	  of	  these	  genes	  is	  obvious	  in	  the	  mouse	  retinal	  plexus	  and	  
very	  strict	  in	  the	  zebrafish	  vasculature	  (Lawson	  et	  al.	  2001;	  Siekmann	  &	  Lawson	  2007;	  Hogan	  
et	  al.	  2009).	  Here	  flt1,	  dll4	  and	  notch1a	  are	  strictly	  confined	  to	  the	  arterial	  domain,	  similarly	  
flt4	  is	  mostly	  found	  in	  venous	  ECs.	  Therefore,	  it	  is	  unlikely	  that	  one	  concept	  can	  explain	  the	  
tip	   cell	   selection	   process	   in	   the	  whole	   heterogenic	   landscape	   of	   endothelia.	   For	   instance,	  
secondary	   sprout	   selection	   in	   zebrafish	   seems	   to	   be	   Kdrl,	   Notch	   and	   Dll4-­‐independent	  
because	  these	  factors	  are	  not	  expressed	  in	  the	  PCV	  (Küchler	  et	  al.	  2006;	  Hogan	  et	  al.	  2009;	  
Koltowska	   et	   al.	   2015).	   Thus,	   a	   different	   mechanism	   is	   responsible	   for	   the	   coordinated	  
selection	   of	   tip	   cells	   in	   the	   PCV.	   It	   is	   possible	   that	   during	   evolution	   different	   selection	  
mechanisms	  evolved	  independently	  but	  it	  is	  also	  conceivable	  that	  tip	  cell	  selection	  in	  arteries	  
occurs	  indeed	  Dll4/Notch	  and	  Flt1	  independent.	  Taking	  into	  account	  our	  data	  that	  veins	  and	  
capillaries	  are	  the	  major	  side	  of	  angiogenesis	  we	  can	  even	  go	  a	  step	  further,	  and	  speculate	  
that	   during	   tumor	   angiogenesis	   or	  wound	   healing,	   other	  mechanisms	   that	   are	  most	   likely	  
Notch	  and	  Dll4-­‐independent	  are	  utilized	  for	  tip	  cell	  selection	  and	  sprout	  guidance,	  which	  has	  
obvious	   therapeutic	   implications.	  Accordingly,	   an	  alternative	  explanation	   for	   the	   increased	  
tip	  cell	   formation	   in	  Dll4-­‐depleted	   retinas	  would	  be	   that	   the	  deactivation	  of	  arterial	  genes	  
downstream	  of	  NOTCH,	   results	   in	   increased	  venous	   remodeling	  and	  thus	  an	  overall	  higher	  
angiogenic	  potential	  and	  vascular	  overgrowth	  (Suchting	  et	  al.	  2007;	  Hellström	  et	  al.	  2007).	  
Not	  only	  our	  data	  disagree	  with	  the	  tip	  cell	  concept,	  other	  research	  groups	  recently	  showed	  
that	  Kdr	  depleted	  retinal	  sprouts	  are	  also	  capable	  to	  make	  patent	  vessels	  and	  that	  Dll4	  is	  not	  
even	   expressed	   in	   tip	   cells	   in	   the	  mouse	   retina	   (Benedito	   et	   al.	   2012).	   As	   outlined	   above,	  
more	   and	  more	   in	   vivo	   findings	   relativize	   the	   tip	   cell	   concept	   (Benedito	   et	   al.	   2012)	   and	  
evidence	  is	  accumulating	  that	  venous	  ECs	  are	  the	  major	  source	  of	  sprouting	  angiogenesis,	  as	  
shown	  by	  us	  and	  others	  (Xu	  et	  al.	  2014;	  Hen	  et	  al.	  2015).	  	  
	  
As	   discussed,	   the	   Flt1	   KO	  mouse	   exhibits	   a	   very	   severe	   phenotype	   with	   angioblast	   over-­‐
commitment,	   resulting	   in	   early	   lethality	   around	   E8.5	   (Fong	   et	   al.	   1995).	   Therefore,	   it	   is	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surprising	  that	   flt1ka601	   zebrafish	  mutants	  do	  not	  display	  angioblast	   formation	  defects.	  This	  
has	   probably	   two	   reasons,	   first	   there	   is	   no	   vascular	   yolk	   plexus	   formed	   in	   zebrafish	   and	  
secondly,	  angioblast	  differentiation,	  proliferation	  and	  migration	  seems	  to	  be	  independent	  of	  
VEGF	   signaling	   in	   zebrafish,	   most	   likely	   involving	   APJ-­‐elabela	   signaling	   and	   possibly	   other	  
pathways	   (Helker	   et	   al.	   2015).	   This	   species-­‐specific	   difference	   could	   render	   the	   zebrafish	  
insensitive	   to	   increased	   VEGF	   bioavailability	   during	   angioblast	   formation,	   overcoming	   this	  
first	  phenotype	  in	  flt1ka601	  mutants.	  	  
	  
It	  will	  be	  interesting	  to	  investigate	  in	  future	  experiments	  if	  sprouting	  angiogenesis	  and	  spinal	  
cord	   vascularization	   are	   affected	   in	   inducible	   loss-­‐of-­‐function	   mice,	   which	   have	   already	  
exceeded	  angioblast	  differentiation	  and	  primary	  plexus	  formation,	  especially	  with	  regard	  to	  
neuronal	   FLT1	   contribution.	  Flt1	   is	  widely	   known	  as	   an	   arterial	  marker	   gene,	   but	  whether	  
Flt1	  has	  a	  function	  in	  AVD	  is	  unknown	  (Krueger	  et	  al.	  2011).	  We	  could	  show	  that	  vISV	  sprouts	  
aberrantly	  connect	  to	  aISVs	  in	  flt1ka601	  mutants.	  Remarkably,	  shunt	  formation	  appears	  not	  to	  
affect	   vascular	   development,	   since	   flt1ka601	   mutants	   survive	   to	   adulthood	   and	   have	   no	  
lymphatic	  or	  AVD	  defects.	   In	   zebrafish,	  parachordal	   lymphangioblasts	  differentiate	  directly	  
form	  secondary	  sprouts	  or	  indirectly	  from	  vISVs	  after	  aISV-­‐remodeling	  (Isogai	  et	  al.	  2003).	  In	  
flt1ka601	   mutants	   only	   the	   direct	   contribution	   of	   secondary	   sprouts	   but	   not	   the	   indirect	  
source	   from	   vISVs	   is	   inhibited.	   Therefore	  most	   likely,	   lymphatic	   differentiation	   from	   vISVs	  
can	   compensate	   for	   the	   loss	   of	   lymphatic	   secondary	   sprout	   contribution	   to	   the	   lymphatic	  
system.	   In	   conclusion,	   our	   data	   suggest	   that	   vascular	   Flt1	   might	   have	   some	   role	   in	  
arterialization	   and	   that	   aISVs	   in	   flt1ka601	   mutants	   for	   this	   reason	   cannot	   fully	   block	   the	  
anastomosis	  of	  venous	  sprouts	  in	  aISVs	  that	  are	  supposed	  to	  stay	  arterial	  and	  not	  to	  become	  
remodeled	  into	  vISVs.	  
5.4 Veins	  not	  arteries	  make	  new	  vessels	  
	  
We	  found	  that	  Vegfaa	  gain-­‐of-­‐function	  in	  flt1ka601	  mutants	  does	  not	  equally	  activate	  arterial	  
and	  venous	  sprouting	  but	  surprisingly	  exclusively	  promotes	  venous	  sprouting.	  Of	  note,	  there	  
is	  accumulating	  evidence	  that	  vascular	  growth	  and	  angiogenesis	  occurs	  predominantly	  from	  
the	  venular	  side	  (Risau	  1995;	  Bergers	  &	  Benjamin	  2003;	  Xu	  et	  al.	  2014;	  Hen	  et	  al.	  2015).	  For	  
instance,	  formation	  of	  the	  gut	  vasculature	  is	  initiated	  from	  the	  PCV	  and	  all	  intestinal	  arteries	  
and	  veins	  are	  formed	  from	  venous	  ECs	  originated	  from	  the	  PCV	  (Hen	  et	  al.	  2015).	  However	  in	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this	  model	  the	  PCV	  is	  the	  only	  vessel	  in	  close	  contact	  to	  the	  intestine,	  therefore	  it	  could	  be	  
argued	  that	  arteries	  do	  not	  respond	  to	  Vegfa	  as	  they	  are	  too	  far	  away	  from	  the	  source.	  We	  
in	  contrast,	  have	  a	  model	   in	  which	  vISVs	  and	  aISVs	  are	  both	   in	  close	  contact	   to	   the	  spinal	  
cord,	   which	   we	   identified	   as	   the	   major	   source	   of	   Vegfaa	   after	   2dpf.	   Therefore,	   the	  
observation	   that	   ectopic	   sprouting	   in	   flt1ka601	   mutants	   originates	   exclusively	   from	   venous	  
ISVs,	  cannot	  be	  explained	  with	  the	  anatomical	  position	  of	  the	  source	  of	  Vegfaa	  or	  responder	  
vessel.	  Thus	  the	  difference	  is	  most	  likely	  inherent	  to	  arterial	  and	  venous	  ECs	  (Figure	  5-­‐4).	  	  
	  
Figure	   5-­‐4.	   Neuronal	   sFlt1	   and	  
Vegfaa	   balance	   venous	   neuro-­‐
vascularization.	  
(a)	   Neuronal	   Flt1	   determines	   the	  
bioavailability	   of	   Vegfaa	   at	   the	  
neurovascular	   interface.	   Loss	   of	  
neuronal	  Flt1,	  or	  increases	  in	  neuronal	  
Vegfaa	   augment	   Vegfaa	   at	   the	  
neurovascular	   interface	   and	   promote	  
ectopic	   venous	   sprouting.	   Ectopic	  
venous	   sprouting	   involves	   endothelial	  
cells	   with	   a	   high	   Vegfaa-­‐Kdrl	  
responsiveness.	   Arteries	   at	   this	   stage	  
show	  a	  low	  Vegfaa	  responsiveness	  and	  
do	  not	  respond	  to	  loss	  of	  Flt1.	  
	  
Arterial	  ECs	  express	  Notch,	  which	  is	  the	  major	  driver	  of	  arterial	  differentiation	  (Lawson	  et	  al.	  
2001;	  Siekmann	  &	  Lawson	  2007;	  Quillien	  et	  al.	  2014).	  Therefore,	  we	  speculated	  that	  arterial	  
depletion	   of	   Notch	   signaling	   in	   flt1ka601	   mutants	   would	   result	   in	   dearterialization	   and	  
initiation	   of	   sprouting	   in	   aISVs.	   Interestingly,	   arterial-­‐specific	   Notch	   signaling	   inhibition	   in	  
flt1ka601	  mutants	   indeed	   activated	   some	   arterial	   sprouting,	   strongly	   suggesting	   that	   Notch	  
decreases	  the	  angiogenic	  potential	  of	  arteries	  in	  an	  Flt1-­‐independent	  manner.	  Flt1	  is	  widely	  
seen	  as	  a	  major	  effector	  activated	  by	  NOTCH	  (Funahashi	  et	  al.	  2010;	  Jakobsson	  et	  al.	  2010).	  
Taking	  our	  data	   into	  account,	   it	  will	   be	   interesting	   to	   identify	   the	   true	  Notch	  downstream	  
effectors	   inhibiting	   angiogenesis.	   It	   is	   possible	   that	   the	   arterialization	   of	   notch	   positive	  
vessels	   is	   sufficient	   to	   render	   vessels	   non-­‐	   or	   less	   responsive	   to	   angiogenic	   cues	   and	   that	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arterioles	  are	  by	  definition	  not	   intended	  for	  vascular	  growth.	  Furthermore,	   the	  differences	  
observed	  in	  sprouting	  potential	  between	  arteries	  and	  veins	  could	  additionally	  be	  regulated	  
by	   other	   factors	   including	   blood	   flow	   shear	   stress,	   pericyte	   coverage,	   adherens	   and	   tight	  
junctions-­‐tightness	   or	   other	   unknown	   inhibitors	   or	   activators	   in	   arteries	   or	   veins,	  
respectively.	  These	  factors	  could	  either	  directly	  affect	  sprouting	  or	  influence	  the	  notch	  status	  
of	   the	   vessel.	   For	   instance,	   shear	   stress	   has	   been	   shown	   to	   activate	   NOTCH	   signaling,	  
evidencing	   for	  a	   shear	   stress	   induced	  NOTCH-­‐dependent	   inhibition	  of	   sprouting	   in	  arteries	  
(Masumura	  et	  al.	  2009;	  Tu	  et	  al.	  2014).	  Adherens	  junctions	  and	  pericytes	  on	  the	  other	  hand,	  
are	  known	  to	  have	  lower	  expression	  levels	  and	  lower	  vascular	  coverage	  in	  veins	  compared	  to	  
arteries	  (Bergers	  &	  Song	  2005;	  Orsenigo	  et	  al.	  2012;	  Vestweber	  2015).	  	  
	  
5.5 Finding	   the	   balance	   –	   safeguarding	   supply	   without	   disrupting	   neuronal	  
differentiation	  
	  
It	   is	   widely	   accepted	   that	   neural	   stem	   cells	   need	   a	   low	   oxygen	   environment	   for	   their	  
expansion.	  During	  early	  mouse	  development	  this	  is	  achieved	  by	  keeping	  the	  stem	  cell	  niches	  
devoid	   of	   blood	   vessels.	   During	   later	   stages,	   upon	   vascularization	   of	   the	   brain	   oxygen	  
delivery	   is	   augmented	   and	   neural	   stem	   cell	   differentiation	   is	   promoted	   (Panchision	   2009;	  
Mannello	   et	   al.	   2011;	   Lange,	   Turrero	   Garcia,	   et	   al.	   2016).	   We	   propose	   that	   the	   spatio-­‐
temporal	   control	   of	   spinal	   cord	   vascularization	   is	   achieved	   via	   neuronal	   titration	   of	   sFlt1-­‐
Vegfaa	   levels	   at	   the	   neurovascular	   interface.	   High	   sFlt1	   levels	   during	   early	   spinal	   cord	  
formation	   keep	   blood	   vessels	   away	   from	   stem	   cells,	   whereas	   low	   sFlt1	   and	   high	   Vegfaa	  
attract	  blood	  vessels	  towards	  differentiating	  neurons.	  Hence,	   it	   is	  a	  compelling	  option	  that	  
radial	   glia	   cells,	   the	   stem	   cells	   in	   the	   spinal	   cord,	   produce	   sFlt1	   and	   thereby	   prevent	  
vascularization	  during	  early	  spinal	  cord	  development,	   thus	  ensuring	  sufficient	  expansion	  of	  
neuronal	   stem	   cells.	   To	   test	   this	   hypothesis,	   the	   sFlt1	   producing	   neuronal	   subpopulations	  
need	  to	  be	  identified	  and	  it	  should	  be	  verified	  whether	  premature	  spinal	  cord	  vascularization	  
in	   flt1ka601	   mutants	   influences	   neuronal	   development,	   stem	   cell	   numbers	   and	   neuronal	  
regenerative	  capacities.	  Furthermore,	   it	  will	  be	   important	  to	   identify	  the	  factors	  regulating	  
flt1	  expression	  and	  splicing	  in	  neurons	  in	  order	  to	  obtain	  a	  better	  understanding	  of	  neuronal	  




Flt1ka601	  mutants	  as	  well	  as	  other	  mutants	  with	  neuronal	  Vegfaa	  gain-­‐of-­‐function	  phenotype,	  
such	  as	  ptena−/−;ptenb−/−,	  dll4j16e1	  and	  vhlhu2117	  display	  massive	  hypersprouting	  at	  the	  level	  of	  
the	  spinal	  cord	  (Rooijen	  et	  al.	  2009;	  van	  Rooijen	  et	  al.	  2011;	  Choorapoikayil	  et	  al.	  2013;	  Leslie	  
et	   al.	   2007).	   Interestingly,	   the	   sprouts	   elongate	   along	   the	   spinal	   cord	   and	   vascularization	  
thus	  occurs	   laterally	   forming	  a	  PNVP	   in	   these	  mutants.	   Strikingly,	  we	   found	   that	   if	  Vegfaa	  
levels	  are	  increased	  further,	  using	  flt1ka601;	  vhlhu2117	  double	  mutants,	  tertiary	  sprouts	  do	  not	  
only	   laterally	   vascularize	   the	   spinal	   cord	   but	   also	   penetrate	   into	   the	   spinal	   cord.	   These	  
double	  mutants	  die	  at	  ~5dpf	  possibly	  due	  to	  premature	  internal	  invasion	  and	  destruction	  of	  
the	  spinal	  cord	  neuronal	  architecture.	  These	  data	  substantiate	  that	  (I)	  the	  neural	  tube	  is	  the	  
major	  source	  of	  Vegfaa	  after	  2dpf	  and	  (II)	  that	  these	  mutants	  affect	  different	  levels	  of	  VEGF	  
biology,	  namely	  transcription	  and	  protein	  bioavailability	  (Figure	  5-­‐5).	  
	  
Studying	   spinal	   cord	   vascularization	   in	  WT	  embryos	  we	   could	   show	   that	   the	   spinal	   cord	   is	  
laterally	  vascularized	  by	  a	  process	  we	  termed	  tertiary	  sprouting	  at	  ~11-­‐15dpf	  predominantly	  
from	  the	  venous	  side,	  analogous	  to	  flt1ka601	  mutants	  but	  ~7dpf	  later.	  In	  mice,	  the	  spinal	  cord	  
is	  internally	  vascularized	  by	  sprout	  invasion	  form	  the	  PNVP	  (Bautch	  &	  James	  2009;	  Ruhrberg	  
&	  Bautch	  2013).	   It	  will	  be	   important	   to	  determine	   in	   future	   studies,	   if	   the	  primitive	   spinal	  
cord	   vasculature	   formed	   at	   11-­‐15dpf	   in	   zebrafish	   is	   analogous	   to	   the	   PNVP	   in	   mice,	   and	  
whether	   the	   zebrafish	   spinal	   cord	   is	   analogously	   to	   the	   mouse	   spinal	   cord,	   internally	  
vascularized	   at	   later	   stages	   (James	   et	   al.	   2009;	   Ruhrberg	   &	   Bautch	   2013).	   Neuronal	  
vascularization	   promotes	   neural	   stem	   cell	   differentiation	   and	   untimely	   or	   excessive	  
vascularization	   may	   disrupt	   the	   highly	   orchestrated	   neuronal	   differentiation	   and	  
specification	  processes	  (Lange,	  Turrero	  Garcia,	  et	  al.	  2016;	  Lange,	  Storkebaum,	  et	  al.	  2016).	  	  
	  
We	   propose	   a	   two-­‐tiered	   checkpoint	   mechanism	   involving	   neuronal	   Vegfaa	   and	   sFlt1	  
regulating	  timely	   lateral	  vascularization	  and	  spinal	  cord	   invasion	  according	  to	  the	  demands	  




Figure	   5-­‐5.	   A	   two-­‐tiered	   sFlt1-­‐
Vegfaa	   mechanism	   regulates	  
lateral	   vascularization	   and	  
sprout	   invasion	   in	   the	  
developing	  spinal	  cord.	  
(a)	  Schematic	  representation	  of	  lateral	  
vascularization	  around	  the	  neural	  tube	  
in	  WT	  (top	  left),	  flt1ka601	  single	  mutant	  
or	   vhlhu2114	   single	   mutant	   (top	   right),	  
and	   flt1ka601;vhlhu2114	   double	   mutant	  
(bottom).	   Loss	   of	   flt1	   or	   vhl	   induces	  
the	   formation	   of	   a	   peri-­‐neural	   tube	  
network,	  and	  combining	  both	  mutants	  
in	   addition	   promotes	   sprout	   invasion	  
into	   the	  neural	   tube.	  NT,	  neural	   tube;	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6 Materials	  and	  Methods	  
6.1 Materials	  
6.1.1 Transgenic	  lines	  
The	   transgenic	   reporter	   lines	   Tg(fli1a:EGFP)y1,	   Tg(kdrl:hsa.-­‐HRAS-­‐mcherry)s916,	  
TgBAC(flt1:YFP)hu4624,	   Tg(fli1a:nGFP)y7,	   Tg(Xla.Tubb:DsRed)zf148,	   Tg(kdrl:EGFP)s843,	  
Tg(HuC:EGFP)as8,	   Tg(mnx1:GFP)ml2,	   Tg(flt1enh:tdTomato),	   Tg(flt4:mCitrine)hu7135,	  
Tg(kdrl:nlskikGR)hsc7	  and	  vhlhu2117	  mutants	  were	  used	  as	  published	  (B.	  Hogan	  et	  al.	  2009;	  Peri	  
&	   Nüsslein-­‐Volhard	   2008;	   Bussmann	   et	   al.	   2010;	   van	   Impel	   et	   al.	   2014);	   ptena−/−;ptenb−/+	  
zebrafish	  mutants	  were	  a	  gift	   from	  Jeroen	  den	  Hertog	   (Choorapoikayil	  et	  al.	  2013).	  Details	  
about	  the	  reporter	  lines	  used	  in	  this	  work	  can	  be	  found	  in	  Table	  6-­‐1.	  
	  
Table	  6-­‐1.	  Zebrafish	  transgenic	  reporter	  lines	  	  
	  
Transgenic	  line	   Fluorescent	  organs/cells	   Features	  
Tg(kdrl:EGFP)s843	   Green	  vascular	  reporter	   Well	  suited	  for	  vascular	  phenotype	  
analysis	  
Tg(fli1a:EGFP)y1	   Green	   fluorescence	   in	   the	  
vasculature	   and	   neural	   crest	   cells	  
(NCC)	  	  
Strong	   fluorescence,	   not	   suitable	  
for	  late	  trunk	  or	  brain	  analysis	  due	  
to	  strong	  NCC	  background	  
Tg(kdrl:hsa.-­‐HRAS-­‐mcherry)s916	   Red	   fluorescence	   restricted	   to	   the	  
membrane	  of	  ECs	  
Suitable	   for	   analysis	   of	   vascular	  
phenotypes,	  high	  resolution	  due	  to	  
membrane	  fixation	  of	  mcherry	  
Tg(flt1enh:tdTomato)	   Arterial	   specific	   expression	   (not	  
expressed	  in	  neurons)	  
Very	  strong	  arterial	  marker	  
TgBAC(flt1:YFP)hu4624	   Yellow	   fluorescence	   restricted	   to	  
the	   arterial	   domain	   and	   flt1+	  
neurons	  
Can	   be	   used	   to	   identify	   arteries	  
and	  to	  analyze	  flt1+	  neurons	  
Tg(flt4:mCitrine)hu7135	   Venous	  enriched	  reporter	   Strongly	   expressed	   in	   the	   PCV,	  
lower	  expression	  in	  ISVs,	  very	  weak	  
expression	  in	  the	  DA	  
Tg(fli1a:nGFP)y7	   Nuclei	  of	  blood	  vessels	  and	  NCCs	   Suitable	   for	   nuclei	   number	  
counting	  or	  EC	  migrational	  analysis	  
Tg(kdrl:nlskikGR)hsc7	   Expression	  of	   the	  photoswitchable	  
kikGR	  in	  the	  nuclei	  of	  ECs	  
Suitable	   for	   cell	   tracking	   and	  
counting	  after	  photoconversion	  
Tg(Xla.Tubb:DsRed)zf148	   Reporter	  for	  mature	  neurons	   Very	  strong	  neuronal	  reporter,	  well	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suited	   for	   analysis	   of	   axonal	  
projections	   or	   moto-­‐	   and	   sensory	  
neurons	  
Tg(HuC:EGFP)as8	   Pan-­‐neuronal	  reporter	   Strong	   expression	   in	   neurons	   of	  
the	   brain	   and	   spinal	   cord,	   not	  
suitable	  for	  axon	  analysis	  
Tg(mnx1:GFP)ml2	   Motoneuron	  reporter	   Expressed	   in	   primary	   and	  
secondary	  motoneurons	  
	  
Table	  6-­‐2.	  Commercial	  kits	  	  
Product/Kit	   Manufacturer	  
QuatiTect	  Whole	  Trascriptome	  kit	   QIAGEN	  
QIAprep	  Spin	  Miniprep	  Kit	  	   QIAGEN	  
QIAprep	  Spin	  Midiprep	  Kit	   QIAGEN	  
RNeasy	  Mini	  Kit	   QIAGEN	  
QIAquick	  Gel	  Extraction	  Kit	   QIAGEN	  
QIAquick	  PCR	  Purification	  Kit	   QIAGEN	  
Maxima	  cDNA	  First	  Strand	  Synthesis	  Kit	   Thermo	  Fisher	  
mMessage	  Machine	  SP6	  Transcription	  Kit	   Thermo	  Fisher	  
mMessage	  Machine	  T7	  ULTRA	  Transcription	  Kit	   Thermo	  Fisher	  
Maxi	  Script	  T7	  Transcription	  Kit	   Thermo	  Fisher	  
PowerUp	  SYBR	  Green	  Master	  Mix	   Thermo	  Fisher	  
	  
Table	  6-­‐3.	  Inhibitors	  and	  chemicals	  	  
Product	   Manufacturer	  
Ki8751	   Sigma-­‐Aldrich	  
Maz51	   Merck	  
DMSO	   Sigma-­‐Aldrich	  
DAPT	   Sigma-­‐Aldrich	  
LY-­‐411575	   Sigma-­‐Aldrich	  
	  
	  
Table	  6-­‐4.	  Kits	  and	  chemicals	  for	  RNAseq	  
Product/Kit	   Manufacturer	  
Random	  Hexamer	  Primer	   Thermo	  Fisher	  	  
RNAse	  out	   	   Thermo	  Fisher	  	  
SuperScriptII	  OR	  III	  Reverse	  Transcriptase	   Thermo	  Fisher	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5xSecond	  Strand	  Buffer	   Thermo	  Fisher	  
DNA	  Polymerase	  I	   Thermo	  Fisher	  
Agencourt	  AMPure	  XP	  Reagent	   Beckman	  coulter	  
RiboMinus™	  Eukaryote	  Kit	  v2	   Thermo	  Fisher	  




Table	  6-­‐5.	  Plasmids	  	  
Plasmid	   Manufacturer	  or	  provider	  
PGEM-­‐T	  Easy	   Promega	  
pCR8/GW/TOPO	   Thermo	  Fisher	  
pminiTol_flt1-­‐0.9	   Schulte-­‐Merker	  S,	  University	  of	  Münster,	  Germany	  
DR274	   DR274	  was	  a	  gift	   from	  Keith	  Joung	  (Addgene	  plasmid	  
#	  42250)	  
MLM3613	   MLM3613	   was	   a	   gift	   from	   Keith	   Joung	   (Addgene	  
plasmid	  #	  42251)	  
-­‐3.8NBT_tauGFP	   Amaya	  lab,	  University	  of	  Manchester,	  UK	  
p5E_NBT	   Cloned	  from	  from	  -­‐3.8NBT_tauGFP	  into	  p5E_MCS	  (this	  
work)	  
pME_gal4ERt2	   pME-­‐geta4	  was	  a	  gift	  from	  Strähle	  U,	  KIT,	  Germany	  
p5E_3.2elavl	   p5E_-­‐3.2HuC	  was	  a	  gift	  from	  Strähle	  U,	  KIT,	  Germany	  
Tol2Kit	   The	  Tol2kit	  was	  a	  gift	  from	  Kawakami	  K,	  NIG,	  Japan	  
pME_MAML-­‐GFP	   Was	  a	  gift	  from	  Burns	  C,	  CRC,	  Charlestown,	  USA	  
pME_GFP-­‐p2A_SmaI	   Cloned	  from	  Tol2Kit	  plasmid	  #455	  (this	  work)	  
pME_GFP-­‐p2A_vegfaa121	   Cloned	  by	  Anna	  Klaus	  using	  pME_GFP-­‐p2A_SmaI	  
pME_GFP-­‐p2A_vegfaa165	   Cloned	  by	  Anna	  Klaus	  using	  pME_GFP-­‐p2A_SmaI	  
pME_GFP-­‐p2A_vegfc	   Cloned	  by	  Anna	  Klaus	  using	  pME_GFP-­‐p2A_SmaI	  
pME_GFP-­‐p2A_sFlt1	   Cloned	  from	  pME_GFP-­‐p2A_SmaI	  (this	  work)	  
pME-­‐Cas9-­‐T2A-­‐GFP	   pME-­‐Cas9-­‐T2A-­‐GFP	   was	   a	   gift	   from	   Leonard	   Zon	  
(Addgene	  plasmid	  #	  63155)	  
pDestTol2CG2-­‐U6:gRNA	   pDestTol2CG2-­‐U6:gRNA	  was	   a	   gift	   from	   Leonard	   Zon	  
(Addgene	  plasmid	  #	  63156)	  
pDestTol2CG2-­‐U6:flt1E3	   Cloned	  from	  pDestTol2CG2-­‐U6:gRNA	  (this	  work)	  
pDestTol2CG2-­‐U6:flt1E3_	  Cas9-­‐T2A-­‐GFP	   Cloned	  by	   gateway	   cloning	  using	  pME_Cas9-­‐T2A-­‐GFP	  
and	  pDestTol2CG2-­‐U6:flt1E3	  (this	  work)	  
pCG2_elavl3.2_gal4ERt2	   Cloned	   by	   gateway	   cloning	   using	   pME_gal4ERt2	   and	  
p5E_elavl3.2	  (this	  work)	  
pCG2_UAS_GFP-­‐p2A-­‐vegfaa165	   Cloned	   by	   gateway	   cloning	   using	   pME_GFP-­‐p2A-­‐
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vegfaa165	  and	  p5E_UAS	  (tol2kit)	  (this	  work)	  
pCG2_UAS_GFP-­‐p2A-­‐vegfaa121	   Cloned	   by	   gateway	   cloning	   using	   pME_GFP-­‐p2A-­‐
vegfaa121	  and	  p5E_UAS	  (tol2kit)	  (this	  work)	  
pCG2_UAS_GFP-­‐p2A-­‐vegfc	   Cloned	  by	  gateway	  cloning	  using	  pME_GFP-­‐p2A-­‐vegfc	  
and	  p5E_UAS	  (tol2kit)	  (this	  work)	  
pCG2_UAS_GFP-­‐p2A-­‐sFlt1	   Cloned	  by	  gateway	  cloning	  using	  pME_GFP-­‐p2A-­‐sFlt1	  
and	  p5E_UAS	  (tol2kit)	  (this	  work)	  
pCG2_NBT_GFP-­‐p2A-­‐sFlt1	   Cloned	  by	  gateway	  cloning	  using	  pME_GFP-­‐p2A-­‐sFlt1	  
and	  p5E_NBT	  (tol2kit)	  (this	  work)	  
	  
Table	  6-­‐6.	  Morpholino	  sequences	  
Target	  gene	   MO	  sequence	   Injection	  
amount	  
MO	  type	  
flt1	   5ʹ′ATATCGAACATTCTCTTGGTCTTGC-­‐3’	   1-­‐3ng	   ATG-­‐MO	  
vhl	   5ʹ′-­‐GCATAATTTCACGAACCCACAAAAG-­‐3ʹ′	   6ng	   E1i1	  splice	  MO	  
vegfaa	   5ʹ′-­‐GTATCAAATAAACAACCAAGTTCAT-­‐3ʹ′	   0.3ng	   ATG-­‐MO	  
flt4	   5ʹ′-­‐CTCTTCATTTCCAGGTTTCAAGTCC-­‐3’	   4ng	   ATG-­‐MO	  
Ctrl	  MO	   5ʹ′-­‐CTCTTACCTCAGTTACAATTTATA-­‐3ʹ′	   10ng	   	  
	  
Table	  6-­‐7.	  Real-­‐time	  qPCR	  primer	  sequences	  
	  
gene	   name	   forward	  primer	   reverse	  primer	  







ef1a	   zef1a-­‐E4-­‐E5	   5'-­‐GTTGCCTTCGTCCCAATTTC-­‐3'	   5'-­‐CAATCTTCCATCCCTTGAACCA-­‐3'	  
mflt1	   zflt1-­‐E19	  
5'-­‐
GTGAACACAAGGCTCTAATGACAGA-­‐
3'	   5'-­‐TGCGCCGAGGAGATTGAC-­‐3'	  
sflt	   z-­‐sflt-­‐E11a	   5'-­‐TCCGTCCCAATTTACCATTCC-­‐3'	   5'-­‐TCTTGGGTGGCTGGATGAG-­‐3'	  
plgf	   z-­‐plgf-­‐E4-­‐E6	  
5'-­‐CACAAAGCCTGTGAATGTAGACT-­‐
3'	   5'-­‐TTCTCCTTCCTTTTTCTCCCTCTAT-­‐3'	  
lyve1a	  
zlyve1a_E4/5-­‐
E5/6	   5'-­‐GGCTCCACTGAAGCTGTTCC-­‐3'	   5'-­‐GCCTTGCAGGGTCTTTTCGT-­‐3'	  
angpt2a	   zanpt2a-­‐E4/5-­‐E6	   5'-­‐TGTGACAAGGCAAGGTAGCAA-­‐3'	   5'-­‐GTCCCCATGTCACAGTAGGC	  -­‐3'	  
aplnra	   zaplnra_E1	   5'-­‐GGACAAAACTCTGGGGGTGAA-­‐3'	   5'-­‐ACACTCGCATCCACTCATCG	  -­‐3'	  
esm1	   zesm1_E2-­‐E2/3	   5'-­‐TTGTGACAGAGAAACCGGCG	  -­‐3'	   5'-­‐AACCCACTTCATTACCTGCTTCA-­‐3'	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hbbe2	   zhbbe1_E1/2-­‐E2	   5'-­‐ACTGCAGAGGGCTTTGATTGT-­‐3'	   5'-­‐TGGCCTCAGCATTGTACAGG	  -­‐3'	  
	  
Table	  6-­‐8.	  sgRNA	  sequences	  used	  for	  CRISPR/Cas	  	  
	  
	  
Target	  gene	   sgRNA	  sequence	  (without	  PAM)	  
sflt1	  and	  mflt1	   sgRNAflt1E3:	  5'-­‐GGGACGGTGGGAGCTCCAGT-­‐3'	  
sflt1	  and	  mflt1	   sgRNAflt1E5:	  5'-­‐GGAATATCATCTGGAACAGC-­‐3'	  
mflt1	   sgRNAflt1E11#1:5'-­‐GGCAGTCCAGGACGAAGGAGG-­‐3'	  
mflt1	   sgRNAflt1E11#2:5'-­‐GGTGATGGTCAAGATGGGATTG-­‐3'	  
mflt1	   sgRNAflt1E11#3:5'-­‐GGTCAAGATGGGATTGTGGG-­‐3'	  
mflt1	   sgRNAflt1E11#4:5'-­‐GGAGAAGCCTCCTCCTTCGTCC-­‐3'	  
mflt1	   sgRNAflt1E11#5:5'-­‐GGATGGTCAAGATGGGATTGT-­‐3'	  
	  
Table	  6-­‐9.	  sgRNA	  oligos	  for	  oligo-­‐cloning	  into	  DR274	  
	  
oligo1	   oligo2	  
Flt1_E3_sgRNA_1+:	  TAGGGACGGTGGGAGCTCCAGT	   Flt1_E3_sgRNA_1-­‐:	  AAACACTGGAGCTCCCACCGTC	  
















Table	  6-­‐10.	  Primer	  sequences	  used	  for	  construct	  cloning	  and	  genotyping	  
	  




pME_GFP_p2A_rev	   5'-­‐TTGCTTTAACAGAGAGAAGTTAGTAGCTCCGCTTCCTGAATTCCCAGATCTTCCACCGCC-­‐3'	  
vegfc_p2A_fw	   	   5'-­‐ATCAGCGCTCACTTATTTGGATTTTCTGTC-­‐3'	  
vegfc_p2A_rev	   	   5'-­‐AGTCTCGAGTTAGTCCAGTCTTCCCCAGTATGTG-­‐3'	  
sflt1_p2A_fw	   	   5'-­‐ATGTTCGATATATTATTTGTGATGATATTTGG-­‐3'	  
sflt1_p2A_rev	   	   5'-­‐AAGTCTCGAGTCAGGCCAGCCGCGCCGGG-­‐3'	  
Vegfaa_p2A_fw	   	   5'-­‐AACTTGGTTGTTTATTTGATACAGTTATTTCTCGC-­‐3'	  
Vegfaa_p2A_rev	   	   5'-­‐AGTCTCGAGTCATCTTGGCTTTTCACATCT-­‐3'	  
U6_flt1E3_1	   	   5'-­‐GGGACGGTGGGAGCTCCAGTGT-­‐3'	  
U6_flt1E3_2	   	   5'-­‐ACTGGAGCTCCCACCGTCCCGA-­‐3'	  
Flt1_E3_gDNA_f	   	   5'-­‐CAGCTCAACACACACAGTATTGTTTTA-­‐3'	  
Flt1_E3_gDNA_r	   	   5'-­‐ACACCTGAAGCATCTTACCTGTGA-­‐3'	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Flt1E11A2386576F
	   	  
5'-­‐ATTCCCAAGAGACCTGAAATCGGAA-­‐3'	  
Flt1E11A2386151R




6.2.1 Ethics	  statement	  	  
	  
Zebrafish	  husbandry	  and	  experimental	  procedures	  were	  performed	  in	  accordance	  with	  the	  
German	   animal	   protection	   standards	   and	   were	   approved	   by	   the	   Government	   of	   Baden-­‐
Württemberg,	  Regierungspräsidium	  Karlsruhe,	  Germany	  (Akz.:	  35-­‐9185.81/G-­‐93/15).	  	  
	  
6.2.2 Morpholino	  injections	  
	  
Morpholino	  antisense	  oligomers	  (MOs;	  Gene	  Tools)	  were	  prepared	  at	  a	  stock	  concentration	  
of	  1mM	  according	   to	   the	  manufacturer.	  MOs	  were	   injected	   into	   the	  yolk	  of	  one-­‐cell	   stage	  
embryos	   as	   described	   (Krueger	   et	   al.	   2011;	   Hogan	   et	   al.	   2009;	   Santhakumar	   et	   al.	   2012;	  
Childs	  et	  al.	  2002).	  MO	  sequences	  can	  be	  found	  in	  Table	  6-­‐3.	  
	  
6.2.3 mRNA	  injection	  and	  generation	  of	  transgenic/mutant	  lines	  
	  
For	   the	   generation	   of	   mutants	   1nl	   of	   a	   mixture	   containing	   600ng	   µl-­‐1	   capped	   and	  
polyadenylated	   Cas9-­‐nls	   mRNA	   and	   50ng	   µl-­‐1	   sgRNA	   was	   injected	   into	   one-­‐cell	   stage	  
embryos	  (Hwang	  et	  al.	  2013).	  Cas9	  mRNA	  was	  produced	  by	   in	  vitro	   transcription	  using	  the	  
mMessage	  mMachine	  T7	  Ultra	  Kit	  (Ambion).	  For	  the	  generation	  of	  transgenic	  lines	  1nl	  of	  a	  
mixture	  of	  12,5ng	  µl-­‐1	  Transposase	  mRNA	  and	  25ng	  µl-­‐1	  plasmid	  DNA	  was	  injected	  into	  one-­‐
cell	  stage	  embryos.	  
6.2.4 Generating	  flt1	  mutants	  
	  
The	  zebrafish	   flt1	  gene	  consists	  of	  34	  exons	  encoding	  membrane-­‐bound	  Flt1	   (mFlt1)	  and	  a	  
shorter	  soluble	  Flt1	  (sFlt1)	  form.	  Soluble	  Flt1	  is	  generated	  through	  alternative	  splicing	  of	  flt1	  
mRNA	   at	   the	   exon	   10	   -­‐	   Intron	   10	   boundary	   (Supplementary	   Figure	   2a).	   To	   annihilate	   the	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production	   of	   both	  mflt1	   and	   sflt1	   and	   obtain	   flt1	   mutants,	   we	   targeted	   exon	   3,	   using	   a	  
CRISPR/Cas	  approach.	  We	  designed	  five	  sgRNAs	  targeting	  exon	  3,	  encoding	  the	  extracellular	  
Ig1	  domain	   relevant	   for	  Vegfaa	  binding.	  Oligonucleotides	   containing	   the	  GG-­‐N18	   targeting	  
sequence	  and	  overhangs	  were	  purchased	  from	  Eurofins	  (Ebersberg,	  Germany).	  The	  annealed	  
oligos	  were	  ligated	  into	  DR274	  which	  was	  a	  gift	  from	  Keith	  Joung	  (Addgene	  plasmid	  #	  42250)	  
(Hwang	  et	  al.	  2013).	  The	  corresponding	  genomic	  region	  (surrounding	  exon	  3)	  was	  amplified	  
by	  PCR	  using	  primer	  pair	   Flt1_E3_gDNA_r	  and	  Flt1_E3_gDNA_f	  and	   indels	  were	  quantified	  
with	   T7EI	   assay	   or	   direct	   Sanger	   sequencing	   of	   the	   PCR	   product	   as	   described	   (for	   primer	  
sequences	   see	   Supplementary	   Table	  6)(Hwang	  et	   al.	   2013).	   The	  T7EI	   cleavage	  products	  of	  
211	  and	  249	  bp	  were	  quantified	  using	  ImageJ.	  The	  sgRNAflt1E3	  (see	  Supplementary	  Table	  4)	  
with	  the	  highest	  cleavage	  rate	  (~70%)	  was	  used	  to	  generate	  the	  flt1	  mutants.	  WT	  embryos	  
were	   coinjected	   with	   sgRNAflt1E3	   plus	   capped	   and	   polyadenylated	   Cas9	   mRNA.	   Four	  
independent	  lines	  with	  frame	  shift	  mutations	  were	  investigated	  in	  more	  detail.	  The	  flt1ka601	  	  
(exon	  3	  -­‐1nt	  allele),	  flt1ka602	  (exon	  3	  -­‐5nt	  allele),	  flt1ka603	  (exon	  3	  +5nt	  allele)	  and	  flt1ka604	  (exon	  
3	   -­‐14nt	   allele)	  have	   a	  premature	   termination	   codon	   (PTC)	   resulting	   in	   a	   truncated	  protein	  
devoid	  of	  a	  functional	  extracellular	  Vegfaa	  binding	  domain.	  Embryos	  carrying	  the	  mutation	  
were	   raised	   and	   outcrossed	   to	   vascular	   and	   neuronal	   reporter	   lines	   (Tg(kdrl:eGFP)s843,	  
Tg(fli1a:eGFP)y1,	   Tg(fli1a:nGFP)y7,	   Tg(kdrl:hsa.HRAS-­‐mcherry)s916,	   and	  
Tg(Xla.Tubb:DsRed)zf148).	  	  
	  
6.2.5 Generation	  of	  mflt1	  specific	  mutants	  
	  
To	   generate	   mflt1	   mutants	   we	   used	   a	   CRISPR/Cas	   approach	   and	   designed	   an	   sgRNA	  
targeting	  E11b,	  the	  first	  specific	  mflt1	  exon	  (Krueger	  et	  al.	  2011).	  In	  this	  scenario	  splicing	  of	  
intron	   10	   and	   exon	   11a	   relevant	   for	   generating	   sflt1	   mRNA	   remains	   unaffected.	   Oligos	  
Flt1E11_O1_A_15	  and	  Flt1E11_O2_A_15	  were	  annealed	  and	  cloned	  into	  DR274	  as	  described	  
for	  flt1	  mutants.	  Founders	  were	  identified	  by	  PCR	  and	  subsequent	  Sanger	  sequencing,	  using	  
primers	  Flt1E11A2386576F	  and	  Flt1E11A2386151R.	  We	   identified	   four	   frame	  shift	  mutants	  
harboring	   a	  PTC	   in	   exon	  11b.	  Flt1ka605	  (exon	  11b	  +28nt),	   flt1ka606	  (exon	  11b	  +20nt),	   flt1ka607	  
(exon	   11b	   -­‐1nt)	   and	   flt1ka608	   (exon	   11b	   -­‐1nt	   and	   one	   mutation)	   mflt1	   mutants	   were	  
outcrossed	   to	   Tg(kdrl:EGFP)s843	   and	   Tg(Xla.Tubb:DsRed)zf148.	   All	   four	  mflt1	   mutants	   were	  
phenotypically	  comparable	  and	   in	  this	  manuscript	  only	  the	  mflt1	  mutant	  flt1ka605	   is	  shown.	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All	   sgRNA	   sequences	   and	   oligos	   used	   for	   annealed	   oligo	   cloning	   into	   DR274	   are	   listed	   in	  
Supplementary	  Table	  4,5.	  
	  
6.2.6 Generation	  of	  p5E_	  Xla.Tubb-­‐3.8	  and	  p5E_flt1enh	  
	  
The	  NBT_tauGFP	  plasmid	  was	  a	   kind	  gift	   by	  Enrique	  Amaya(Huang	  et	   al.	   2007).	   The	  3.8kb	  
regulatory	   element	   derived	   from	   neural	   specific	   beta	   tubulin	   was	   removed	   from	   the	  
NBT_tauGFP	   using	   SalI	   and	   HindIII	   and	   subcloned	   into	   SalI	   and	   HindIII	   digested	   and	  
dephosphorylated	  p5E_MCS	   (Kwan	  et	  al.	  2007).	  The	  1kb	   flt1	  enhancer/promoter	   fragment	  
from	   the	   pMiniTol2_flt1_ECR5a_pro_181_YFP	   (Bussmann	   et	   al.	   2010)	   construct	   was	  
subcloned	   into	  p5E_MCS	  using	  KpnI	   and	  HindIII.	   The	   resulting	  plasmids	  were	  named	  p5E_	  
Xla.Tubb-­‐3.8	  and	  p5E_flt1enh.	  
	  
6.2.7 Generation	  of	  pME_eGFP-­‐p2A_SmaI	  
	  
To	  easily	  detect	   transgenic	  cells	   the	  pME_eGFP	   (#455)	   from	  the	  Tol2kit	   (Kwan	  et	  al.	  2007)	  
was	  modified	  by	   site-­‐directed	  mutagenesis	   PCR.	   The	  p2A	   sequence	  was	   added	  before	   the	  
stop	  codon	  of	  GFP	  using	  pME_eGFP	  specific	  primer	  with	  5’end	  extension	  coding	  for	  the	  p2A	  
peptide	   and	   a	   SmaI	   restriction	   site	   just	   downstream	   of	   p2A	   for	   convenient	   subcloning	  
(pME_eGFP_p2A_fw	  and	  pME_eGFP_p2A_rev	  primer).	  	  
	  
6.2.8 pME_eGFP-­‐p2A_vegfaa	  165,	  vegfc	  and	  sflt1	  cloning	  
	  
pME_eGFP-­‐p2A_SmaI	  was	  digested	  with	  SmaI	  and	  XhoI.	  The	   inserts	  vegfaa	  165,	  vegfC	  and	  
sflt1	   were	   amplified	   from	   zebrafish	   cDNA	   using	   primers	   vegfaa	   _p2A_fw/rev,	  
vegfc_p2A_fw/rev	  and	  sflt1	  _p2A_fw/rev.	  The	  PCR	  products	  were	  digested	  with	  XhoI	  and	  gel	  
purified.	   Vector	   and	   inserts	  were	   ligated	   following	   the	  manufactures	   instructions	   (NEB	   T4	  
DNA	   Ligase).	   The	   resulting	  plasmids	  were	  named	  pME_eGFP-­‐p2A_vegfaa	   165,	   pME_eGFP-­‐
p2A_vegfc	  and	  pME_eGFP-­‐p2A_sflt1	  .	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6.2.9 	  Generation	  of	  gateway	  expression	  clones	  
	  
pME_DN-­‐MAML-­‐eGFP	  was	  kindly	  provided	  by	  Caroline	  Burns(Zhao	  et	  al.	  2014).	  p5E_flt1enh,	  
pME_DN-­‐MAML-­‐eGFP	  and	  p3E_polyA	  were	  recombined	  into	  pDestTol2CG2	  according	  to	  the	  
manufactures	   instructions	   (Thermo	   Fisher,	   LR	   Clonase	   II	   plus).	   The	   resulting	   plasmid	   was	  
named	  pCG2_flt1_	  DN-­‐MAML-­‐eGFP.	  p5E_Xla.Tubb-­‐3.8,	  pME_eGFP-­‐p2A_sflt1	  and	  p3E_polyA	  
were	   recombined	   into	   pDestTol2CG2	   (pCG2_Xla.Tubb-­‐3.8_eGFP-­‐p2A-­‐sflt1	   ).	   p5E_Xla.Tubb-­‐
3.8,	   pME_eGFP-­‐p2A_sflt1	   and	   p3E_polyA	   were	   recombined	   into	   pDestTol2CG2	  
(pCG2_Xla.Tubb-­‐3.8_eGFP-­‐p2A-­‐sflt1	   ).	   p5E_elavl-­‐3.2	   (unpublished),	   pME_gal4ERT2	   and	  
p3E_polyA	   were	   recombined	   into	   pDestTol2CG2	   (pCG2_elavl-­‐3.2_gal4-­‐ERT2).	   p5E_flt1enh	   ,	  
pME_gal4ERT2	   and	   p3E_polyA	   were	   recombined	   into	   pDestTol2CG2	   (pCG2_	   flt1enh_gal4-­‐
ERT2).	  	  
	  
6.2.10 	  Generation	  of	  tissue-­‐specific	  KO	  constructs	  
	  
pME-­‐Cas9-­‐T2A-­‐GFP	   and	   pDestTol2pA2-­‐U6:gRNA	   were	   a	   gift	   from	   Leonard	   Zon	   (Addgene	  
plasmid	   #	   63157	   and	   #	   63155)	   (Ablain	   et	   al.	   2015).	   pDestTol2pA2-­‐U6:gRNAflt1E3	   was	  
generated	  by	  annealed	  oligo	  cloning.	  Oligos	  U6_flt1E3_1	  and	  U6_flt1E3_2	  were	  cloned	  into	  
pDestTol2pA2-­‐U6:gRNA	   as	   described(Ablain	   et	   al.	   2015).	   To	   drive	   Cas9	   expression	  
specifically	   in	   neurons,	   the	   Gal4	   driver	   construct	   pCG2_Xla:Tubb-­‐3.8_gal4ERT2	   was	  
generated	  by	  recombining	  p5E_Xla.Tubb-­‐3.8,	  pME_gal4ERT2,	  p3E_polyA	  and	  pDestTol2CG2.	  
For	   the	   Gal4	   effector	   construct,	   p5E_UAS,	   pME_cas9-­‐t2a-­‐eGFP	   and	   p3E_polyA	   were	  
recombined	  into	  pDestTol2pA2-­‐U6:sgRNAflt1E3	  (pCG2_UAS_Cas9-­‐t2A-­‐eGFP_U6_gRNAflt1E3).	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6.2.11 	  FACS	  analysis	  
 
Approximately	   500	   embryos	   Tg(mnx1:GFP)ml2,	   Tg(HuC:EGFP)as8,	   Tg(Xla.Tubb:DsRed)zf148	   or	  
vhl	   MO	   injected	   Tg(Xla.Tubb:DsRed)zf148	   embryos	   were	   dechorionated	   at	   24	   hpf	   using	  
pronase	  (0.5	  mg/ml).	  Cells	  were	  dissociated	  using	  FACSMax	  as	  described	  (Manoli	  &	  Driever	  
2012).	   Tg(mnx1:GFP)ml2,	   Tg(HuC:EGFP)as8	   embryos	   were	   dissociated	   and	   sorted	   at	   24hpf,	  
control	  and	  vhl	  MO	  injected	  Tg(Xla.Tubb:DsRed)zf148	  embryos	  were	  dissociated	  and	  sorted	  at	  
3dpf.	  Dissociated	   cells	  were	   FACS-­‐sorted	  using	  BD-­‐FACS-­‐Aria	   I	   and	  Aria	   II.	   The	   sorted	   cells	  
(approx.	   0.5	   x	   106	   cells	   per	   experiment)	   were	   spinned	   down	   at	   310g	   for	   5	   min	   and	  
resuspended	  in	  lysis	  buffer	  contained	  in	  the	  RNeasy	  mini	  kit	  (Qiagen).	  RNA	  was	  extracted	  as	  
described	   in	   the	   manual.	   Due	   to	   limited	   amounts	   of	   RNA	   the	   QuantiTect	   Whole	  
Transcriptome	  Kit	  (Qiagen)	  was	  used	  to	  preamplify	  and	  reverse	  transcribe	  the	  RNA	  to	  make	  
cDNA.	  cDNA	  was	  diluted	  1:250	  for	  real-­‐time	  qPCR.	  
	  
6.2.12 	  Gene	  expression	  analysis	  by	  real-­‐time	  qPCR	  	  
	  
Total	   RNA	   of	   zebrafish	   embryos	   was	   isolated	   with	   TRIzol,	   purified	   with	   RNeasy	   mini	   kit	  
(Qiagen)	  and	  quantity	  and	  quality	  were	  measured	  using	  an	  Agilent	  2100	  Bioanalyzer	  (Agilent	  
Technologies)	   according	   to	   the	   manufacturer’s	   instructions.	   We	   performed	   DNase	   on-­‐
column	   digestion	   using	   RNase-­‐free	   DNase	   Set	   (Qiagen)	   according	   to	   the	   manufacturer,	  
followed	  by	  cDNA	  synthesis	  using	   the	  Thermoscript	  First-­‐Strand	  Synthesis	  System	  (Thermo	  
Fisher	  Scientific).	  qPCR	  was	  conducted	  with	  SYBR®	  Green	  PCR	  Master	  Mix	  (Thermo	  Scientific)	  
in	  a	  StepOnePlus™	  real-­‐time	  qPCR	  system	  (Applied	  Biosystems).	  Primers	  for	  real-­‐time	  qPCR	  
were	   ordered	   from	   Eurofins	   Genomics.	   Gene	   expression	   data	   were	   normalized	   against	  
zebrafish	  elongation	  factor	  1-­‐alpha.	  Primers	  and	  probes	  are	  listed	  in	  Table	  1-­‐3.	  
	  
6.2.13 	  RNA-­‐Seq	  library	  preparation	  and	  sequencing	  	  
	  
Zebrafish	  RNA	  was	  isolated	  and	  purified	  from	  4dpf	  zebrafish	  larvae	  using	  TRIzol	  and	  RNeasy	  
mini	   kit	   (Qiagen)	   as	   recommended	   by	   the	   manufacturers.	   A	   cDNA	   library	   was	   generated	  
using	  the	  TruSeq	  Ilumina	  RNA	  sample	  prepv2	  kit	  according	  to	  the	  manufacturer’s	  protocol.	  
The	  cDNA	  library	  was	  sequenced	  on	  a	  HiSeq2000	  according	  to	  the	  manufacturer’s	  protocols	  
(Illumina).	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6.2.14 	  Identification	  of	  differentially	  expressed	  genes	  
	  
Raw	   sequencing	   reads	   were	   mapped	   to	   the	   transcriptome	   and	   the	   zebrafish	   reference	  
genome	   (GRCz10	   danRer10)	   using	   Bowtie2.0	   and	   TopHat	   2.0	   (Trapnell	   et	   al.	   2012).	   On	  
average	  44,490,573	  reads	  (81,6%	  of	  total	  reads)	  were	  assigned	  to	  genes	  with	  Cufflinks	  and	  
HTSeq	   software	   package	   (Anders	   et	   al.	   2014).	   Differentially	   expressed	   genes	   (control	   vs.	  
mutant)	   were	   identified	   using	   DESeq	   and	   Cuffdiff	   (Anders	   &	   Huber	   2010;	   Trapnell	   et	   al.	  
2012).	  Genes	  were	  defined	  as	  differentially	  expressed	   if	  ≥	  2	  fold	  significantly	  regulated	   (P<	  
0.05)	  with	  two	  independent	  methods	  (DEseq	  and	  Cuffdiff).	  
	  
6.2.15 	  Zebrafish	  histological	  sectioning	  
	  
Dechorionated	   larvae	   were	   fixed	   in	   4%PFA	   for	   2h	   and	   subsequently	   transferred	   to	   20%	  
DMSO/	   80%	   Methanol	   and	   incubated	   overnight	   at	   -­‐20°C.	   Larvae	   were	   then	   washed	   in	  
100mM	  NaCl,	  100mMTris-­‐HCl,	  pH7.4	  for	  30	  min	  at	  room	  temperature.	  Washed	  larvae	  were	  
embedded	   in	   gelatin	   from	   cold	   water	   fish	   skin/	   sucrose	   (Sigma)	   as	   described	   (Fagotto	   &	  
Gumbiner	  1994).	  Larvae	  were	  sectioned	  (20µm)	  in	  a	  cryomicrotome.	  
	  
6.2.16 	  Inhibitor	  treatments	  
	  
All	   stock	   solutions	   were	   prepared	   in	   DMSO.	   Embryos	   were	   dechorionated	   at	   24hpf	   using	  
Pronase	   (Roche,	   Basel,	   Switzerland).	   Embryos	  were	   incubated	   from	  2.5dpf	  with	   100µM	  of	  
DAPT	  (Sigma,	  St	  Louis,	  MO,	  USA),	  25µM	  MAZ51	  (Merck	  Millipore,	  Billerica,	  Massachusetts,	  
USA)	  or	   0.125µM	  ki8751	   (Sigma,	   St	   Louis,	  MO,	  USA).	   Control	   embryos	  were	  mock	   treated	  
with	  DMSO	  (Sigma,	  St	  Louis,	  MO,	  USA).	  Embryos	  were	   randomly	  assigned	   to	  experimental	  
groups.	  Investigators	  were	  blinded	  to	  inhibitor	  treatment.	  
	  
6.2.17 	  Gal4ERT2	  endoxifen	  activation	  
	  
Endoxifen	   (Sigma)	   was	   solved	   in	   DMSO.	   Zebrafish	   embryos	   expressing	   Gal4ERT2	   were	  
incubated	  from	  52hpf	  onwards	  in	  0.5µM	  endoxifen	  in	  E3	  medium	  in	  the	  dark.	  GFP	  positive	  
cells	  could	  be	  observed	  approximately	  1.5	  hours	  after	  induction.	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6.2.18 	  Vascular	  network	  analysis	  
	  
To	  assess	  sprout	  number	  and	  length,	  we	  developed	  a	  semi-­‐automated	  analysis	  of	  the	  DLAV-­‐
ISV	   vessel	   network	   using	   ImageJ	   (Supplementary	   Figure	   1e).	   Image-­‐stacks	   of	   ISVs	   were	  
acquired	  using	  the	  Leica	  SP8	  confocal	  microscope.	  Stack	  projections	  of	  one	  side	  of	  the	  trunk	  
were	   generated.	  Dorsal	   region	  of	   the	   ISVs	  was	  used	   for	   analysis.	  Using	   ImageJ	   a	  Gaussian	  
blur	  filter	  was	  applied	  followed	  by	  a	  black/white	  threshold	  and	  subsequent	  skeletonization	  
to	  generate	  a	  skeleton	  of	  the	  vasculature.	  Segment	  number,	  branch	  point	  number	  and	  total	  
branch	   length	   were	   calculated	   using	   the	   “analyze	   skeleton”	   plugin.	   The	   semi-­‐automated	  
pipeline	  was	  applied	  for	  analysis	  of	  4dpf	  vascular	  networks,	  while	  sprout	  numbers	  in	  2-­‐3dpf	  
zebrafish	  embryos	  were	  counted	  manually.	  
	  
6.2.19 	  Imaging	  
	  
Zebrafish	   larvae	   were	   embedded	   in	   0.7%	   low	  melting	   agarose	   with	   0.112mg/mL	   Tricaine	  
(E10521,	   Sigma)	   and	   0.003%	   PTU	   (P7629,	   Sigma)	   in	   glass	   bottom	   dishes	   (MatTek,	   P35G-­‐
0.170-­‐14-­‐C).	   Images	   presented	   in	   this	   study	   were	   acquired	   using	   a	   Leica	   SP8	   confocal	  
microscope	  with	  LAS	  X	  software.	   Images	  were	  processed	  using	   ImageJ.	  Vascular	  branching	  
was	  quantified	  using	  a	  semi-­‐automated	  ImageJ	  pipeline	  (Supplementary	  Figure	  1e).	  Animal	  
numbers	  used	  are	  indicated	  in	  figure	  legends.	  For	  zebrafish	  mutants	  more	  than	  100	  embryos	  
per	   genotype	   were	   analyzed.	   In	   morpholino	   experiments	   morphologically	   malformed	  
embryos	  were	  excluded	  from	  analysis.	  
	  
6.2.20 	  Statistical	  analysis	  
	  
Statistical	   analysis	   was	   performed	   using	   GraphPad	   Prism	   6.	   Each	   dataset	   was	   tested	   for	  
normal	  distribution	  (D’Agostino	  and	  Pearson	  test).	  Parametric	  method	  (unpaired	  Students	  t-­‐
test)	  was	  only	  applied	  if	  the	  data	  were	  normally	  distributed.	  For	  non-­‐normal	  distributed	  data	  
sets,	  a	  non-­‐parametric	  test	  (Mann	  Whitney	  U	  test)	  was	  applied.	  When	  appropriate	  in	  case	  of	  
multiple	   comparisons,	   Bonferroni	   correction	  was	   applied.	   P	   values	   <0.05	  were	   considered	  
significant.	   Data	   are	   represented	   as	  mean	   ±	   s.e.m.,	   unless	   otherwise	   indicated.	   *P<	   0.05,	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aISV	   	   	   arterial	  intersegmental	  vessel	  
Alk2/3	  	   	   activin	  receptor-­‐like	  kinase	  
ANG-­‐2	  	   	   Angiopoetin	  2	  
APLN	   	   	   Apelin	  
APLNR	  	   	   Apelin	  receptor	  
AV	   	   	   arteriovenous	  
AVD	   	   	   arteriovenous	  differentiation	  
	  
BAD	   	   	   Bcl-­‐2-­‐associated	  death	  promoter	  
BCL-­‐2	   	   	   B	  cell	  lymphoma	  2	  
BMP	   	   	   bone	  morphogenic	  protein	  
BMPR	   	   	   bone	  morphogenic	  protein	  receptor	  
	  
CDH5	   	   	   cadherin	  5	  (VE-­‐Cadherin)	  
CNS	   	   	   central	  nervous	  system	  
COUP-­‐TFII	   	   chicken	  ovalbumin	  upstream	  promoter	  transcription	  factor	  2	  
CRISPR/Cas	   Clustered	  Regularly	  Interspaced	  Short	  Palindromic	  Repeats/Cas	  
CV	   	   	   cardinal	  vein	  	  
	  
DA	   	   	   dorsal	  aorta	  
DAG	   	   	   diacylglycerol	  
DLAV	   	   	   dorsal	  longitudinal	  anastomotic	  vessel	  
DLL4	   	   	   delta	  like	  4	  (mouse/human	  protein)	  
Dll4	   	   	   delta	  like	  4	  (mouse	  gene)	  
Dll4	   	   	   delta	  like	  4	  (zebrafish	  protein)	  
dll4	   	   	   delta	  like	  4	  (zebrafish	  gene)	  
dpf	   	   	   days	  post	  fertilization	  
	  
EC	   	   	   endothelial	  cell	  
ECM	   	   	   extracellular	  matrix	  
Ela	   	   	   Elabela	  (zebrafish	  protein)	  
eNOS	   	   	   endothelial	  nitric	  oxide	  synthase	  
ER	   	   	   Endoplasmatic	  reticulum	  
ERK1/2	   	   extracellular-­‐signal-­‐regulated	  kinase	  1/2	  
ERR-­‐α	   	   	   Estrogen-­‐related	  receptor	  alpha	  
ETS	  domain	   	   E26	  transformation-­‐specific	  domain	  
etsrp	   	   	   Ets1-­‐related	  protein	  (zebrafish	  gene	  aka	  etv2)	  
etv2	   	   	   ETS	  variant	  2	  (zebrafish	  gene)	  
	  
F-­‐actin	  	   	   filamentous	  actin	  
FAK	   	   	   focal	  adhesion	  kinase	  
FDA	   	   	   Food	  and	  Drug	  Administration	  
FGF	   	   	   Fibroblast	  Growth	  Factor	  
Fli1a	   	   	   Fli1	  proto-­‐oncogene	  
FLT1	   	   	   Fms-­‐related	  tyrosine	  kinase	  1	  (mouse/human	  protein)	  
Abbreviations 
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Flt1	   	   	   Fms-­‐related	  tyrosine	  kinase	  1	  (mouse	  gene)	  
	  
Flt1	   	   	   Fms-­‐related	  tyrosine	  kinase	  1	  (zebrafish	  protein)	  
flt1	   	   	   Fms-­‐related	  tyrosine	  kinase	  1	  (zebrafish	  gene)	  
FLT4	   	   	   Fms-­‐related	  tyrosine	  kinase	  4	  (mouse/human	  protein)	  
Flt4	   	   	   Fms-­‐related	  tyrosine	  kinase	  4	  (mouse	  gene)	  
Flt4	   	   	   Fms-­‐related	  tyrosine	  kinase	  4	  (zebrafish	  protein)	  
flt4	   	   	   Fms-­‐related	  tyrosine	  kinase	  4	  (zebrafish	  gene)	  
	  
foxc1a/b	   	   forkhead	  box	  C1a/b	  
FOXO1	  	   	   Forkhead	  box	  protein	  O1	  
	  
Gja5	   	   	   gap	  junction	  protein	  alpha	  5	  (connexin-­‐40)	  
	  
HDAC	   	   	   histone	  deacetylase	  
HMS	   	   	   horizontal	  myoseptum	  
hpf	   	   	   hours	  post	  fertilization	  
HRE	   	   	   hypoxia	  response	  element	  
HSPGs	  	   	   heparane	  sulfate	  proteoglycans	  
	  
Ig	   	   	   immunoglobulin	  
IP3	   	   	   inositol-­‐1,4,5-­‐triphosphate	  
ISV	   	   	   intersegmental	  vessel	  
	  
JMJD6	  	   	   Jumonji	  domain-­‐containing	  protein	  6	  (mouse/	  human	  protein)	  
	  
kDa	   	   	   kilo	  Dalton	  
KDR/VEGFR2	   	   kinase	  insert	  domain	  receptor	  (mouse/human	  protein)	  
Kdr	   	   	   kinase	  insert	  domain	  receptor	  (mouse	  gene)	  
Kdrl	   	   	   kinase	  insert	  domain	  receptor-­‐like	  (zebrafish	  protein)	  
kdrl	   	   	   kinase	  insert	  domain	  receptor-­‐like	  (zebrafish	  gene)	  
	  
LECs	   	   	   lymphatic	  endothelial	  cells	  
PLs	   	   	   parachordal	  lymphangioblasts	  
	  
MAPK	   	   	   mitogen-­‐activated	  protein	  kinase	  
mFlt1	   	   	   membrane-­‐bound	  Flt1	  (zebrafish	  protein)	  
mflt1	   	   	   membrane-­‐bound	  Flt1	  (zebrafish	  gene)	  
MMP	   	   	   matrix	  metalloproteases	  
MTOC	   	   	   microtubule	  organizing	  center	  
	  
NC	   	   	   notochord	  
NCK	   	   	   non-­‐catalytic	  region	  of	  tyrosine	  kinase	  adaptor	  protein	  1	  
NGF	   	   	   nerve	  growth	  factor	  
NICD	   	   	   Notch	  intercellular	  domain	  
NO	   	   	   nitric	  oxide	  
NRPs	   	   	   non-­‐ribosomal	  peptides	  




PCV	   	   	   posterior	  cardinal	  vein	  
PDK	   	   	   phosphoinositide-­‐dependent	  kinase	  
PGC-­‐1α	   	   Peroxisome	  proliferator-­‐activated	  receptor-­‐gamma	  coactivator	  	  
PHDs	   	   	   prolyl	  hydroxylase	  domain	  1,2,3	  
PI3K	   	   	   phosphoinisitide-­‐3	  kinase	  
PIGF	   	   	   placental	  growth	  factor	  
PIP2	   	   	   phosphatidyllinositol	  (4,5)-­‐biphosphate	  
PIP3	   	   	   phosphatidyllinositol	  (3,4,5)-­‐triphosphate	  
PKC	   	   	   protein	  kinase	  C	  
PLCy	   	   	   Phospholipase	  C	  gamma	  1	  
PLGF	   	   	   placental	  growth	  factor	  
Plxnd1	  	   	   PlexinD1	  (zebrafish	  protein)	  
PNVP	   	   	   perineural	  vascular	  plexus	  
PTEN	   	   	   phosphate	  and	  tensin	  homolog	  
pVHL	   	   	   von	  Hippel-­‐Lindau	  protein	  
	  
R	   	   	   tyrosine	  
RGC	   	   	   radial	  glia	  cell	  
RTK	   	   	   receptor	  tyrosine	  kinase	  
	  
Sema3a	   	   Semaphorin	  3a	  (zebrafish	  protein)	  
Sema3aa	   	   Semaphorin	  3aa	  (zebrafish	  specific	  isoform	  a)	  
sENG	   	   	   soluble	  endoglin	  
sFlt1	   	   	   soluble	  Flt1	  (zebrafish	  protein)	  
sflt1	   	   	   soluble	  Flt1	  (zebrafish	  gene)	  
SHB	   	   	   SH2	  domain	  containing	  protein	  B	  
shh	   	   	   sonic	  hedgehog	  	  
	  
TSAd	   	   	   T	  cell-­‐specific	  adapter	  protein	  
	  
VE-­‐cadherin	   	   vascular	  endothelial	  cadherin	  (cdh5)	  
VEGF	   	   	   Vascular	  Endothelial	  Growth	  Factor	  (VEGFA	  –	  human/mouse	  protein)	  
Vegfa	   	   	   Vascular	  Endothelial	  Growth	  Factor	  A	  (mouse	  gene)	  
Vegfa	   	   	   Vascular	  Endothelial	  Growth	  Factor	  A	  (zebrafish	  protein-­‐isoform	  a	  or	  b)	  
vegfa	   	   	   Vascular	  Endothelial	  Growth	  Factor	  A	  (zebrafish	  gene)	  
Vegfaa	  	   	   Vascular	  Endothelial	  Growth	  Factor	  A	  (zebrafish	  protein-­‐isoform	  a)	  
vegfaa	  	   	   Vascular	  Endothelial	  Growth	  Factor	  A	  (zebrafish	  gene-­‐isoform	  a)	  
VEGFR	  	   	   Vascular	  Endothelial	  Growth	  Factor	  Receptor	  (human/mouse	  protein)	  
vISV	   	   	   venous	  intersegmental	  vessel	  
VPF	   	   	   vascular	  permeability	  factor	  (VEGF)	  
VRAP	   	   	   VEGF	  receptor	  associated	  protein	  
	  
WASP	   	   	   Wiskott-­‐Aldrich	  syndrome	  protein	  
WAVE	   	   	   WASP-­‐family	  verprolin-­‐homologous	  protein	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